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Abstract 
 
 
Background: The traditional Omani diet of dates, milk, rice, brown bread, fish and 
vegetables has undergone considerable change, now resembling a Western diet that is 
high in calories, high glycaemic index carbohydrates, total fat and saturated, trans and 
omega 6 fatty acids, and low in omega-3 fatty acids and essential micronutrients. The 
available data on daily food intake and its impact on micro- and macro-nutrients are 
scanty in the Arab world. Obtaining these data is especially important in light of the 
growing prevalence of non-communicable diseases (NCDs) – cardiovascular diseases, 
diabetes, cancer and respiratory diseases – which now account for more than 60% of the 
global disease burden and mortality, and contribute to more than 50% of annual deaths in 
Arabian countries, including Oman. Moreover, obesity, an antecedent of NCDs, has 
reached epidemic proportions in the region. Since NCDs develop gradually during the 
course of the lifespan, various national and international committees on NCDs have 
recommended that children and young adults be the primary focus of any action plan that 
aims to prevent and control non-communicable diseases. 
Specific aims: The aims of the study are: 
a) To assess the nutrient intake, body composition, blood lipids, blood pressure, 
blood glucose and cognitive behaviour of Omani school children; 
b) To assess the level of Vitamin A, D, E, and Beta Carotene among the Omani 
school children 
c) To assess the level of red blood cell fatty acids of Omani school children 
d) To investigate the effect of fish consumption on red blood cell omega-3 fatty 
acids and plasma fat-soluble vitamins; 
e) To investigate the impact of omega-3 fatty acids obtained from fish oil capsule on 
the red blood cell omega-3 fatty acids and plasma fat-soluble vitamins;  
Methods: Children ages 9 and 10 years (n = 314) were recruited from three randomly 
selected schools in the Muscat Governorate. The schools were assigned to a fish, fish oil, 
or control group and the children were accordingly provided a lightly grilled oily fish, a 
re-esterified triacylglycerol fish oil capsule, or no fish for 12 weeks. Baseline body 
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weight, height and body mass index were assessed and a non-fasting blood sample 
collected at baseline and after 12 weeks of intervention. Data on food intake were 
gathered using a 24-hour recall questionnaire; also collected were data on weight, height, 
blood pressure, triglycerides and fasting glucose. In addition, teachers completed the 
National Initiative for Children’s Health Quality Vanderbilt Assessment Scales-Teacher 
Assessment Scale to assess the prevalence and sub-types of ADHD. 
Results: At baseline, a significant number of the children had low levels of vitamin D, 
and omega-3 fatty acids. The low levels of vitamin D and omega-3 fatty acids were 
ameliorated significantly by fish consumption and fish oil supplementation. In terms of 
weight, the prevalence of overweight or obesity for the total sample was 28.2% (10%, 
46%) and 22.6% (8%, 38%). That is, about one fourth of the study subjects were 
overweight or obese. With regards to ADHD, the prevalence rate of PIS, PHIS and 
ADHDCIH among Omani school children was 7.3%, 3% and 8.8%, respectively. 
After 12 weeks intervention, the children who received fish oil (54.1±17.5 nmol/L; 
p<0.001) and fish (49.2±17.4 nmol/L; p<0.05) had elevated levels of vitamin D than 
those who did not (42.3±17.5 nmol/L). The fish oil (1.2±0.70 μmol/L) and fish (1.20±0.7 
μmol/L) groups also had higher concentrations of beta carotene than the placebo group 
(0.85±0.43 μmol/L; p<0.0001). Systolic and diastolic blood pressure (p=0.0001) and 
plasma triglycerides (p<0.05) but not HDL, LDL and total cholesterol (p>0.05) were 
lower in the fish oil group compared with those who were fed oily fish.  
Conclusions: This study provides important and underreported data on nutrient intake 
levels by school children in Arab world. For the first time, these data will be available as 
a benchmark for future research and health programs in the region. A large number of 
boys and girls had diets that failed to provide the recommended levels of daily nutrients. 
This study also indicates that ADHD is relatively common among Omani school 
children; additional studies are needed to assess the generalisability of these findings.  
Vitamin D deficiency is prevalent in Omani school children, but can be mitigated with 
omega-3 fatty acid supplementation. This study also provides evidence that Omani pre-
adolescents have a low level n-3 fatty acid index that can be ameliorated by fish oil 
supplementation or consumption of oily fish. Hence, there is a need for a child-focused 
program of food fortification, school feeding programmes, targeted intervention with n-3 
fatty acid enriched food products, family nutrition education and outdoor activities to 
alleviate the problem.  
18 
 
 
 
 
 
CHAPTER 1:  
Introduction, Hypothesis  
and Specific Aims 
 
19 
 
The second half of the 20th century witnessed major health transitions in the 
world, propelled by socio-economic and technological changes that profoundly altered 
life expectancy and ways of living. These changes also created an unprecedented human 
capacity to use science to prolong and enhance life.  
In the past, life expectancy was often limited by uncontrolled epidemics. But 
after the Second World War, due to the development of the vaccine and antibiotics, as 
well as the improvement of life conditions, NCDs emerged as a major problem in 
industrialized countries. Heart disease, mental disorders, cancer, diabetes, and chronic 
pulmonary disease became a burden for health systems unprepared for these 
developments. For a while, these diseases were associated with economic development 
and considered diseases of the rich. By the dawn of the third millennium, however, 
NCDs began to sweep the entire globe, with developing countries suddenly confronted 
by the double burden of infectious and non-infectious diseases in a poor environment 
characterized by ill-prepared health systems (World Health Organization, 2003b). 
Today, NCDs are the leading worldwide cause of death. They are strongly 
influenced by four main behavioural risk factors – unhealthy diet, insufficient physical 
activity, and use of tobacco and alcohol – which lead to elevated blood pressure, raised 
blood glucose and cholesterol levels, and excess body weight.  
1.1 Non-Communicable Diseases (NCDs) – Definition  
A non-communicable disease is a medical condition or a disease state which, by 
definition, is non-infectious and non-transmissible : they may be chronic diseases of long 
duration and slow progression, or they may result in rapid death such as some types of 
stroke. According to the World Health Organization (2005), NCDs are the major cause 
of adult mortality and morbidity worldwide, primarily cardiovascular diseases (including 
heart disease and stroke), diabetes, cancer and chronic respiratory diseases (including 
chronic obstructive pulmonary disease and asthma). 
Non-communicable diseases (NCDs) impose a large burden on human health 
worldwide. Currently, more than 60% of all deaths are due to NCDs (Figure 1-1). 
Moreover, what were once considered “diseases of affluence” have now encroached on 
developing countries. In 2008, for example, WHO reported that roughly four out of five 
NCD deaths occurred in low- and middle-income countries (World Health Organization, 
2011a), a sharp increased from just under 40% in 1990 (Murray and Lopez, 1997). NCDs 
are also affecting persons of all ages, with one-quarter of all NCD-related deaths 
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involving persons below the age of 60 (World Health Organization, 2011a). NCDs also 
account for 48% of the healthy life years lost (Disability Adjusted Life Years–DALYs) 
worldwide, versus 40% for communicable diseases, maternal and perinatal conditions 
and nutritional deficiencies, and 1% for injuries (World Health Organization, 2005). 
As an umbrella category, NCDs have been a difficult group to define. Even the 
term “non-communicable diseases” is a misnomer, since NCDs include some diseases – 
notably, cancers of the liver, stomach, and cervix – that are at least partly caused by 
infection, and usually exclude mental illnesses, despite their significant contribution to 
long-term disability.  
1.1.1 Prevalence of NCDs Worldwide 
According to WHO estimates, NCDs were responsible for 36 million deaths 
globally in 2008, accounting for 63% of 57 million total deaths (Hunter and Reddy, 
2013). The global mortality due to NCDs increased from 57% of total mortality in 1990 
to 65% in 2010 (Murray and Lopez, 2013). In 2008, 80% of the world’s 36 million 
NCD-related deaths occurred in low- and middle-income countries, which are home to 
most of the world’s population (World Health Organization, 2011a). NCDs are unequally 
distributed within populations, as well, often disproportionately affecting the 
socioeconomically disadvantaged (Leeder et al., 2004).  
The World Health Organization reports that NCDs are by far the leading cause of 
death in the world, representing over 60% of all deaths. Out of the 36 million people who 
died from NCDs in 2005, half were under age 70 and half were women (Alwan et al., 
2010). Risk factors such as a person's background, lifestyle and environment are known 
 
Figure 1-1: NCSs constitute more that 60% of deaths worldwide 
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to increase the likelihood of certain NCDs. Hence, each year, at least 5 million people 
die because of tobacco use and about 2.8 million die from being overweight. In the same 
way, high cholesterol accounts for roughly 2.6 million deaths and 7.5 million die because 
of high blood pressure. 
1.1.2 Cardiovascular Disease 
The six types of cardiovascular disease (CVD) include the heart muscle (coronary 
heart disease), brain (cerebrovascular disease), arms and legs (peripheral arterial disease) 
and the associated blood vessels. Deep vein thrombosis or pulmonary embolism is the 
last type, and involves blood clots which dislodge from veins in the leg and move to the 
heart or lungs (World Health Organization, 2013c).  
The risk factors for developing CVDs (with the exception of congenital and 
rheumatic heart diseases) involve modifiable behavioural risk factors, metabolic risk 
factors and non-modifiable risk factors. Non-modifiable risk factors include a person’s 
age, ethnicity, family history and gender. The modifiable behavioural risk factors include 
the harmful use of alcohol, physical inactivity, unhealthy diets and tobacco use (Alwan, 
2008, Alwan, 2011). The metabolic risk factors are caused by these behavioural risk 
factors and increase the risk of developing CVD, and include increased blood pressure 
(hypertension), increased blood sugar (diabetes) and increased blood cholesterol, as well 
as overweight/obesity (Mendis et al., 2011, World Health Organization, 2009).  
Coronary Heart Disease (CHD) is the type of CVD with the highest rate of 
mortality in developed countries (38%) and the highest cause for burden of disease in 
developing countries (28%) (Wagner and Brath, 2012, Gaziano et al., 2010). However, it 
is predicted that the rate in developing countries will increase by as much as 137% for 
men and 120% for women (Leeder et al., 2004).  
Overweight/Obesity is an important risk factor to be considered since it is related 
to other metabolic risk factors, such as raised blood pressure, raised blood sugar, raised 
blood lipids (cholesterol and triglycerides) and dyslipidaemia for the development of a 
CVD (National Heart Lung and Blood Institute, 2002, Grundy, 2004). As an individual’s 
BMI increases, so does the risk for coronary heart disease, stroke and diabetes (World 
Health Organization, 2000).  
Raised blood pressure, also known as hypertension, is not only one of the major 
risk factors for coronary heart disease and stroke, but can also cause heart failure, renal 
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impairment, blindness, peripheral vascular disease and the rupture of blood vessels 
(Mendis et al., 2011, World Health Organization, 2013b, World Health Organization, 
2009, World Health Organization and International Society of Hypertension Writing 
Group, 2003). The prevalence of hypertension was 40% in all adults over 25 years 
globally, with approximately 1 billion people were suffering from uncontrolled 
hypertension in 2008 alone (Alwan, 2011). Hypertension causes 12.8% of total deaths 
and is responsible for 3.7% of global DALYS (Alwan, 2011, World Health Organization, 
2009).  
Impaired glucose tolerance and impaired fasting glycaemia are two other 
important risk factors for the development of diabetes and CVD (World Health 
Organization and UNAIDS, 2007). The risk of developing a CVD or atherosclerotic 
disease is higher for those with either Type 1 or Type 2 diabetes (Laing et al., 2003, 
Kannel and McGee, 1979), with 60% of mortality in those with diabetes being attributed 
to a CVD (Mendis et al., 2011). Research suggests that CVD mortality is directly related 
to plasma glucose, and the risk increases in those with a CVD and diabetes, as compared 
to those with just CVD (DECODE Study Group, 2003, Eberly et al., 2003).  
Approximately one third of strokes are caused by high cholesterol (World Health 
Organization, 2009, Mathers et al., 2008), which increases the risk of atherosclerosis, 
and therefore the risk of heart disease and stroke (World Health Organization and 
UNAIDS, 2007). Raised blood cholesterol refers to a lipoprotein profile which contains 
high levels of low density lipoprotein cholesterol (LDL), also known as ‘bad’ 
cholesterol, and triglycerides. High levels of LDL cholesterol are deposited into blood 
vessels, which can then cause atherosclerosis (World Health Organization, 2009, Mendis 
et al., 2011). In 2008, raised blood cholesterol had a prevalence of 39%, causing 2.6 
million deaths and 29.7 million DALYS worldwide (Alwan, 2011, World Health 
Organization, 2009).  
1.1.3 Diabetes Mellitus 
Diabetes Mellitus is a chronic disease that involves the body’s production or 
utilization of insulin, and is identified as either Type 1 or Type 2. Type 1diabetes has its 
onset in childhood when the pancreas fails to produce the insulin required to break down 
glucose in the blood stream. Type 2 (adult onset) diabetes results from the inability of the 
body to effectively utilize insulin which leaves it unable to break down the glucose in the 
blood stream (World Health Organization, 2014c). An excess of blood glucose in the 
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blood stream, known as hyperglycaemia, can cause serious complications including 
damaging nerves and blood vessels. When left untreated, this can lead to amputation, 
blindness and cardiovascular disease (Mendis et al., 2011).  
It is estimated that 347 million people have Type 2 diabetes, with 1.5 million 
deaths in 2012 directly attributable to the disease (Danaei et al., 2011, Mathers et al., 
2014). Type 2 diabetes accounts for 90% of global diabetes cases (World Health 
Organization Consultation, 1999), with an estimated 175 million of these cases being 
undiagnosed (Aguiree et al., 2013).  
Type 1 diabetes, also known as childhood-onset diabetes, is found in 
approximately 497,100 children between 0-14 years globally of which approximately 
64,000 are found in the Middle East/North Africa region, with 10,700 new cases being 
enrolled each year. Because Type 1 diabetes involves the inability of the pancreas to 
produce insulin, these children need regular insulin-therapy is needed to break down 
their blood glucose (Aguiree et al., 2013).  
1.1.4 Cancer 
There are over 100 different types of cancers, each affecting different areas of the 
body. While each type of cancer is its own disease, there are five main recognized types: 
(1) cancers that involves the skin or tissues lining internal organs (carcinoma), (2) those 
that involve the bone, cartilage, fat, muscle, blood vessels and connective or supportive 
tissue (sarcoma), (3) those that start in bone marrow (leukaemia), (4) in the cells of the 
immune system (lymphoma and myeloma), and (5) in the brain and spinal cord (central 
nervous system cancers) (National Cancer Institute, 2014). Each of these cancers occurs 
when new cells are created without a cause and old or injured cells do not undergo 
apoptosis when necessary. The accumulation of these extra cells produces a mass of 
tissue called a tumour.  
Tumours can be benign or malignant. Benign tumours are non-cancerous tumours 
that can be safely removed without the need for further treatment. Malignant tumours are 
cancerous and grow to other areas of the body, a process known as metastasis, which is 
the major cause of death from cancer (World Health Organization, 2014b).  
While both men and women are affected by cancer, they are susceptible to 
different forms of the disease: men are vulnerable to lung, prostate, colorectum, stomach 
and liver cancers; whereas women are prone to breast, colorectum, lung, cervix and 
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stomach cancers (World Health Organization, 2014b). Overall, the most common 
cancers are lung, liver, stomach, colorectal, breast and oesophageal cancers, with almost 
8.2 million cancer-related deaths worldwide (Stewart and Wild, 2014).  
1.2 Risk Factors for NCDs 
The prevalence of risk factors varies between countries by incomes group, 
according to specific risk factors, and by sex. High, middle, and low-income countries 
present differing risk profiles. Some risk factors are high or are becoming higher in 
middle-income countries, such as tobacco use among men, which is highest among the 
lower-middle-income countries of the Western Pacific Region and the European Region. 
The rate of overweight and obesity among adults is highest in upper-middle-income 
countries, while physical inactivity is highest in high-income countries. The rates of 
inactivity in middle-income countries are rising among women, and have already 
reached parity with high-income country levels among men. Several key risk factors are 
highest in high-income countries, including: adult per capita alcohol consumption; 
physical inactivity among women, total fat consumption and elevated total cholesterol. 
The WHO objectives from the 2008–2013 Action Plan for the Global Strategy for 
Prevention and Control of NCDs (World Health Organization, 2008) highlight several 
interventions for reducing the shared behavioural risk factors implicated in the 
development of NCDs. Unfortunately, the 2008–2013 Action Plan did not discuss the 
brain or brain disorders, even though, brain disorders (neurological, neurosurgical and 
psychiatric diseases together) have risen and overtaken all other burdens of chronic 
diseases. Numerous epidemiological studies on mental disorders throughout the world 
have shown that approximately one-third of the adult population suffers from a mental 
disorder each year (Kessler et al., 2009). According to one estimates, brain disorders 
account for approximately 13% of global disease, surpassing both cardiovascular 
diseases and cancer (Collins et al., 2011).  
1.2.1 Smoking and Tobacco Use 
Smoking increases the risk of developing respiratory diseases, CVD, diabetes and 
cancer (Patton et al., 2012). Jha and Chaloupka (1999) estimate that, globally, 82,000-
99,000 youth below the age of 20 start smoking daily, with the majority of adult smokers 
having started below the age of 25. According to one study, 10% of children between age 
13-15 smoke cigarettes and 10% use other tobacco products (Viner et al., 2012). It has 
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also been estimated that approximately 40% of all children worldwide are exposed to 
second hand smoke (Eriksen et al., 2012). 
It has been suggested that tobacco smoke, whether direct or through second-hand 
exposure, is responsible for 10% of all cases of CVD (World Health Organization, 
2009). Tobacco increases the risk of dying from CVDs by 2-3 fold and the risk of lung 
cancer 20-30 fold, and is thus one of the most important risk factors to address in the 
prevention of NCDs (Boutayeb and Boutayeb, 2005). There is established evidence that 
quitting smoking results in a decrease in mortality from coronary heart disease (World 
Health Organization and UNAIDS, 2007), and that those who quit smoking between 35 
and 44 years have the same survival rates as non-smokers (Doll et al., 2004). 
However, tobacco consumption in developing countries continues to rise by 3.4% 
each year (Boutayeb and Boutayeb, 2005), while the disease burden attributed to both 
direct and second-hand tobacco smoke accounted for the deaths of 5.4 million people in 
2004. This is expected to increase to 8.3 million by 2030, at which point tobacco-
attributed deaths will account for 10% of total global mortality (Mathers et al., 2008) and 
6.3% of DALYs in 2010 (Murray and Lopez, 2013).  
1.2.2 Excessive Use of Alcohol 
The harmful use of alcohol is frequently identified as one of the modifiable risk 
factors implicated in social and psychological harms, and the development of NCDs. The 
specific physical harm caused by alcohol has been linked to the formation of toxic 
acetaldehyde and free radicals (Tuma and Casey, 2003). 
Alcohol has been implicated as a risk factor in the development of 8 types of 
cancer: cancers of the oral cavity, pharynx, larynx, oesophagus, liver, colon, rectum and 
breast (Baan et al., 2007, International Agency for Research on Cancer, 1988, Singletary 
and Gapstur, 2001, Klatsky et al., 1988). The amount of alcohol consumed on a daily 
basis and the risk of developing one of these types of cancers is unique to each type of 
cancer.  
Alcohol consumption has also been linked to the risk of developing hypertension 
or atrial fibrillation in a dose-dependent fashion for both men and women (Taylor et al., 
2009, Samokhvalov et al., 2010). With heavy alcohol consumption the risk for stroke 
increases (Patra et al., 2010). Harmful alcohol use is also associated with liver cirrhosis, 
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pancreatitis and Type 2 diabetes (Kao et al., 2001, Wannamethee et al., 2003, Irving et 
al., 2009, Rehm et al., 2010). 
Harmful use of alcohol is estimated to account for 45% DALYS globally, where 
"harmful use" is defined by the level and frequency with which alcohol is ingested, 
where a high level and ‘binge’ pattern of consumption is identified as most harmful 
(Mendis et al., 2011).  
1.2.3 Physical Inactivity 
A sedentary lifestyle is the biggest factor that can lead to becoming overweight 
and obese, which can then cause metabolic changes implicated in the development of 
NCDs. In contrast, it has been shown that moderate to high fitness levels substantially 
reduce the risk of developing a CVD (Habib and Saha, 2010), and is also a protective 
factor in men with diabetes at all BMI levels (World Health Organization, 2010).  
Objective Three in the 2008–2013 WHO Action Plan (2008) endorses the 
promotion of physical activity in member states in order to reduce the effect of a 
sedentary lifestyle on the development of NCDs and to assist in the management of 
existing NCDs. The Action Plan also endorses the implementation of school-based 
physical activity programs and the creation of a physical environment that is supportive 
of safe recreational activity (Alwan, 2008). These goals are important for promoting 
physical activity among youth and for reducing the rise of overweight and obesity. 
The global targets identified in the 2013–2020 WHO Action Plan (World Health 
Organization, 2013a) include a 10% reduction in physical inactivity, a 25% reduction in 
raised blood pressure, improvements in the physical education available at educational 
settings, and the creation of opportunities for physical activity before, during, and after 
the school day.  
1.2.4 Unhealthy Diet and NCDs 
The consumption of foods high in saturated fats, trans fats, salt and sugar have 
been found to lead to 14 million (40%) of overall deaths caused by NCDs each year 
(World Health Organization, 2004). Certain types of cancer are increased by eating 
preserved foods and consuming large amounts of alcohol, while the risks of certain types 
of cancer are reduced by increasing fruit and vegetable intake, since aspects of 
chemoprevention are found in foods with a high fibre content, Vitamin A and Vitamin C 
(Habib and Saha, 2010).  
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The changing nature of food itself is a contributory factor for the development of 
many chronic diseases. In fact, the way food is being grown, harvested, stored and 
transported plays a significant role in the nutritional quality of food, especially fruits and 
vegetables. This becomes vital in the context of Oman where the harsh weather 
conditions and high salinity of soil makes the country unsuitable for farming and, 
therefore, has to rely on the importation of food from other countries. It is well-known 
that food grown locally is higher in nutritional quality food that has been packed and 
shipped over long distances: cooking and storing food in aluminium vessels, cans and 
foil, may increase its aluminium content, particularly in cases of salty, acidic or alkaline 
foods (Ribes et al., 2008); aluminium is also implicated in some neurodegenerative 
disorders (Domingo, 2006). The quality of food has also changed drastically due to 
commercial farming. Wang et al. (2010) reported that the DHA content of chicken meat, 
which was about 170mg/100g in 1970, is now only 13 mg/100g; concurrently, the fat 
content has increased. Hence, to receive the same amount of DHA from a chicken, one 
now has to consume a larger – and fattier – portion, as compared with chicken produced 
in 1970.  
Dietary habits when paired with a sedentary lifestyle are also major factors that 
lead to overweight and obesity. Globally, in 2005, 1 billion people were overweight and 
300 million were obese (World Health Organization, 2009).  
The highest number of DALYs for NCD risk factors are attributed to an 
unhealthy diet and a high BMI (Rahim et al., 2014b). In 2008, 2.3% of global DALYs 
were attributed to overweight and obesity (World Health Organization, 2009), while in 
2010, an unhealthy diet and a sedentary lifestyle together accounted for 10.2% of the 
global DALYs. As already noted, dietary habits and obesity that result in an increase in 
BMI are the main risk factors for the development of Type 2 diabetes, stroke, CVDs, and 
some types of cancers (World Health Organization, 2009). This is due to the metabolic 
changes that are implicated in the development of insulin resistance, an increase in blood 
pressure, an increase in cholesterol and heart failure (Kenchaiah et al., 2002, World 
Health Organization, 2003b).  
1.2.4.1 Nutritional Problems and Hazards of Western and Intensified Food 
Patterns 
As previously mentioned, changing dietary habits are in large part responsible for 
the increased availability in sugars, animal fats, animal products, and a decrease in the 
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availability of vegetables (Madanat et al., 2008). Globalization and urbanization not only 
impact the types of food people eat but also increases their level of physical inactivity 
(Popkin, 2009). This is called a ‘nutritional transition’ that is a global change in dietary 
habits that affect the most important risk factors for NCDs. The primary processes 
through which globalization affects income, lifestyles and food availability are increased 
mechanization and industrialization, which alter diet patterns and physical activity 
(Popkin, 2006). The current nutritional transition is often characterized as shift towards a 
‘Western’ diet which contains high energy and high fat intake, added free sugars, salty 
foods and low levels of dietary fibre, vegetables and fruits (Popkin, 1993, Jacka et al., 
2010).  
 Cordain et al. (2005b) examined the evolution of the Western diet from that of 
our ancient ancestors and determined that the current Western diet is primarily composed 
of foods that affect glycaemic load, fatty acid composition, macronutrient composition, 
micronutrient density, acid-base balance, sodium-potassium ratio and fibre content. The 
foods that are implicated include “dairy products, cereals, refined cereals, refined sugars, 
refined vegetable oils, fatty meats, salt and combinations of these foods” (Cordain et al., 
2005b).  
 Simopoulos (2002a) posits that the way the human body metabolizes food has 
been relatively constant despite nutrition transitions, and is optimized for the types of 
food more characteristic of the human diet 40,000 years ago. The Agricultural 
Revolution 10,000 years ago changed the availability and types of foods in ways that are 
drastically different from the optimal diet for human physiology and metabolism. It is 
suggested that our bodies are not suited for the current environment characterized by an 
over-abundance of the kinds of food associated with the “Western” diet. 
1.2.4.2 Glycaemic index  
Refined grains, sugars and carbohydrate-rich foods have a higher glycaemic 
index than unprocessed foods such as fruits and vegetables. The impact of these foods on 
blood glucose can be measured by the Glycaemic Index and the Glycaemic Load. The 
Glycaemic Index measures the potential of a food or combination of foods to raise blood 
glucose (Jenkins et al., 1981). It takes into account a number of factors, including the 
fibre, fat and protein content, the method of preparation or physical form, the nature of 
the starch (and its interaction with fibre), the particle size and rate of digestion (Thorne et 
al., 1983, Krezowski et al., 1986). The Glycaemic Load assesses the total glycaemic 
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effect of the diet and involves both the Glycaemic Index of specific foods and total 
dietary carbohydrates (Salmerón et al., 1997, Salmeron et al., 1997). 
Both of these measures are essential for understanding the effect of diet on the 
development of disease. When blood glucose is elevated, the pancreas is stimulated to 
produce insulin, thereby increasing insulin levels in the blood (Cordain et al., 2005b). 
The long-term consumption of high glycaemic foods can result in chronic 
hyperglycaemia (high glucose in the bloodstream) and hyperinsulinemia (high insulin in 
the blood stream). Both conditions are pivotal in the development of insulin resistance, 
which can lead to obesity, chronic heart disease, Type 2 diabetes, hypertension and 
dyslipidemia (Ludwig, 2002, Liu and Willett, 2002).  
A diet with high GL and with a low intake of cereal dietary fibre was associated 
with an increased risk of Type 2 Diabetes in both men and women (Salmeron et al., 
1997, Salmerón et al., 1997). It has also been found that when glucose is absorbed over a 
long period of time, there is a prolonged suppression of free fatty acids and lower blood 
glucose concentrations (Jenkins et al., 2002). In addition, increase in glucose is 
associated with a decrease in antioxidants in the blood, and it has been found that 
supplementation with vitamin E improves insulin function (Paolisso et al., 1993, Ceriello 
et al., 1998). 
The risk of colorectal cancer is increased with the intake of high GI and GL 
foods, although some doubts persist as to whether women are equally susceptible to this 
risk as are men (Franceschi et al., 2001, Michaud et al., 2005). There has also been a 
demonstrated relationship between a higher GI and the risk of developing breast and 
ovarian cancer (Augustin et al., 2001, Augustin et al., 2003). Those who consume a 
Western diet are also at a significantly higher risk of developing COPD than those with a 
prudent or traditional diet (Varraso et al., 2007).  
In contrast, a low GI diet was associated with high levels of HDL cholesterol, 
which is important in maintaining cardiovascular health (Jenkins et al., 2002).  
1.2.4.3 Refined/Readily Soluble Carbohydrates 
Carbohydrates account for up to 80% of the diet (Asp, 1994), of which there are 
two types. The first is the digestible type, which is primarily composed of 
monosaccharides that provide glucose to the tissues, found in such foods as white breads, 
refined and processed foods and sweetened beverages (Harvard School of Public Health, 
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2015). The second type is the undigestible type, which is fermented in the colon to short-
chain fatty acids and include oligosacchardies and dietary fibre (Asp, 1994). Foods that 
contain undigestible carbohydrates are not or only minimally processed or refined, but 
include fruits and vegetables, as well as whole-grains and legumes (Harvard School of 
Public Health, 2015). Mann et al. (2007) indicate that foods containing undigestible 
carbohydrates are the most appropriate source of carbohydrates in the diet. The WHO 
suggests that the optimal intake of carbohydrates should come from vegetables and fruits 
and should make up 55-75%, or 400 g/day of total energy (World Health Organization, 
2003a). 
Carbohydrates have been studied extensively, particularly concerning their 
effects on CVD and diabetes. Gross et al. (2004) found a significant correlation between 
Type 2 diabetes and, when controlled for energy intake, corn syrup, which is a 
commonly found digestible-type carbohydrate. They also found that a high intake of 
refined carbohydrates and a low intake of dietary fibres are significantly associated with 
Type 2 diabetes. An inverse relation between dietary intake of whole-grain foods and the 
development of coronary heart disease, cardiovascular diseases and Type 2 diabetes have 
been well documented in the literature (Liu, 2002, Liu et al., 1999, Truswell, 2002, 
McKeown et al., 2002, Mellen et al., 2008). In one study (Knekt et al., 1994) found 
lower risk of developing CVD in men and women, had higher dietary intakes of vitamin 
C and carotenoids (antioxidants). They further suggested that vegetables and fruits 
contain other factors that conferred the protective effects against CVD. WHO has also 
suggested that increasing the consumption of fruits and vegetables, as well as whole-
grains and legumes, is associated with a decreased risk of developing a CVD (World 
Health Organization, 2003a). 
 Consumption of refined sugars, vegetable oil, dairy products and alcohol all of 
which contain little fibre (Cordain, 2002) and constitute 48.2% of the energy intake of a 
typical US diet. Refined grains, which are 85% of the grains consumed in the US, 
contain 400% less fibre than whole grains and are also implicated in the low dietary fibre 
content of the US diet (Cordain et al., 2005b). Dietary fibre has been found to slow the 
digestion and absorption of food and regulate metabolic hormones which results in an 
improved glycaemic response, lower serum insulin concentrations and plasma lipids 
(Anderson and Akanji, 1991, Vinik and Jenkins, 1988, Chandalia et al., 2000). In 
particular, insoluble fibre in whole-grains has been found to have an inverse association 
with the risk of developing diabetes. Therefore, when looking at carbohydrates, it 
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appears that the fibre content may partially account for the beneficial effects of the non-
refined foods (Pereira et al., 1998, Romieu et al., 2004). 
1.2.4.4 Salt Intake 
Salt (sodium chloride) is found in many natural foods, but is particularly high in 
processed foods, such as breads and meats, as well as snack foods, condiments and stock 
cubes (World Health Organization, 2013b). The World Health Organization recommends 
that the daily intake of salt should be limited to 5g/day. However, the average salt intake 
per person in most countries is between 9 and 12 g/day with the highest levels found in 
China (World Health Organization, 2007, Stamler et al., 2003).  
Salt is an important consideration when examining the relationships between diet 
and NCDs since a high dietary intake of salt can lead to hypertension, and has been 
associated with a greater risk of a stroke, cardiovascular event, gastric cancer and Type 2 
diabetes (Strazzullo et al., 2009, Tsugane, 2005, Shikata et al., 2006).  
 Morgan et al. (1978) demonstrated that blood pressure can be reduced in those 
who suffer from hypertension by reducing the dietary intake of salt The World Health 
Organization, has attributed 62% of strokes and 49% of coronary heart diseases to high 
blood pressure and hypertension (He and MacGregor, 2010).  
Hypertension is also a risk factor in Type 2 diabetes, and can result in the 
development of a CVD or mortality from a CVD. But high blood pressure can also be 
reduced in those with Type 2 diabetes by restricting their salt intake. This reduction in 
blood pressure may also protect organs from the damage that results from diabetes 
(Ekinci et al., 2011).  
Gastric cancer has also been associated with higher intake of salt and salty foods, 
which may occur in one of two ways. First, salt and salty foods may increase the risk of 
developing a Helicobacter pylori infection, a known risk factor for the development of 
gastric cancers. Second, high levels of salt may produce hypertonicity which can result in 
atrophic gastritis, thereby increasing the risk of stomach cancer (Joossens et al., 1996, 
Tsugane, 2005). This is also supported by the World Health Organization (2003a).  
1.2.4.5 Cholesterol 
 Cholesterol is a fat-like substance with a waxy consistency that is produced in the 
liver. Every human cell needs a minute amount of cholesterol in order to function 
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properly, so a limited supply of cholesterol is obligatory. Due to its waxy consistency, 
cholesterol can stick to the interior of blood vessel walls. Over time, cholesterol, fat and 
other substances can accumulate, thereby narrowing the blood vessels. This is the initial 
stage of atherosclerosis. Atherosclerosis is responsible for coronary heart diseases, stroke and diseases of peripheral circulatory system. But Okuyama et al. (2007) and Perlmutter 
and Lober (2013) reject the claim that cholesterol is the main culprit for heart-related 
diseases, arguing instead that some lipoproteins. such as LDL, have phospholipids that 
form highly potent inflammatory agents on oxidation, regardless of cholesterol. And 
death from heart attack is a death from ischemia, which is worsened by arrhythmia, and 
from thrombosis, brought on by a predisposition to inflammatory plaques in the arteries.  
 Cholesterol is the chief sterol found in humans, and apart from being the 
precursor of steroid hormones and bile acids, it has a crucial role in the structure of the 
cell membranes where it adjusts their fluidity by reducing it in the areas where 
unsaturated fatty acids predominate and increasing it in the areas where saturated fatty 
acids prevail. 
 The daily cholesterol intake of westerners generally varies between 600 and 
1,000 mg. The actual cholesterol absorbed is restricted to 50% of the amount ingested up 
to 500 mg, above which absorption falls to 35%. High cholesterol intake raises plasma 
cholesterol, although there is a negative feedback mechanism in which the liver reduces 
its endogenous synthesis of cholesterol when the exogenous cholesterol supply increases 
and vice-versa (Behrman and Gopalan, 2005). 
 Plasma cholesterol is, in fact, only partially regulated by dietary intake of 
cholesterol. However, the type of fatty acids ingested is extremely important since 
saturated fatty acids raise cholesterol whereas unsaturated fatty acids lower it: 
 If the dietary cholesterol is lowered to 100 mg/day, it was found that the serum 
cholesterol is decreased by 5 mg/dl. 
 If the dietary fat is highly saturated fatty acids, a +300 mg cholesterol intake 
results in an increase in serum cholesterol by 40 mg/dl. 
 If the dietary fat is rich in monounsaturated fatty acids such as olive oil, a + 300 
mg cholesterol intake leads to a neutral effect, i.e. no effect is observed on serum 
cholesterol level. 
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 If the dietary fat is rich in polyunsaturated fatty acids such as cotton seed, corn 
and soy bean oil, a + 300 mg cholesterol intake leads to a decrease or reduction in 
serum cholesterol by 35 mg/dl (Hegsted et al., 1965).  
Furthermore, it should be noted that the cholesterol absorbed from food is not the only 
source of blood cholesterol, since cholesterol can be synthesized endogenously by the 
liver and gastrointestinal tract cells from acetyl-CoA (an intermediate metabolite). Thus 
hexoses, glycerol, fatty acids and certain deaminated amino acids can contribute a carbon 
skeleton or atoms for the denovo synthesis of cholesterol if their intake is high (Behrman 
and Gopalan, 2005). 
1.2.5 Oxidative Stress and Antioxidant Nutrients 
1.2.5.1 Oxidative stress and NCDs 
Oxidative stress is damage to cell structure and cell function by overly reactive 
oxygen-containing molecules, and occurs when there is an imbalance between free 
radical production and antioxidant capacity. Actually, the generation of free radicals is a 
normal and continuous cell process (Shami and Moreira, 2004). In adequate proportions, 
their presence enables the production of energy through adenosine triphosphate (ATP), 
phagocytosis, cell growth regulation and defence during the infectious process. However, 
once formed, the highly reactive free radicals can start a chain reaction producing toxic 
effects (Barreiros and Jorge, 2006) that damage all vital components of the cell, 
including proteins, lipids, and DNA (Badid et al., 2010, Halliwell, 2011). In humans, 
oxidative stress is thought to be involved in the development of cancer (Halliwell, 2007), 
Parkinson's disease, Alzheimer's disease (Valko et al., 2007, Pohanka, 2013), 
atherosclerosis, heart failure (Singh et al., 1995), myocardial infarction (Ramond et al., 
2013, Dean et al., 2011), fragile X syndrome (de Diego-Otero et al., 2009), Sickle Cell 
Disease (Amer et al., 2006), lichen planus (Aly and Shahin, 2010), vitiligo (Arican and 
Kurutas, 2008), autism (James et al., 2004), infection (Pohanka, 2013), and chronic 
fatigue syndrome (Kennedy et al., 2005). However, reactive oxygen species can be 
beneficial, as they are used by the immune system to attack and kill pathogens (Segal, 
2005).  
 There is increasing evidence in both experimental and clinical studies that 
chronic oxidative stress plays a major role in the pathogenesis of both types of diabetes 
mellitus. Free radicals are formed disproportionately in diabetes by glucose oxidation, 
nonenzymatic glycation of proteins, and the subsequent oxidative degradation of 
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glycated proteins. (Maritim et al., 2003). Information about the use and benefits of 
antioxidants in persons with diabetes is also limited. Persons with diabetes may be more 
prone to oxidative stress because hyperglycemia depletes natural antioxidants and 
facilitates the production of free radicals. Other factors such as homocysteine, insulin 
resistance, and aging may also be contributory (Penckofer et al., 2002). 
Oxidative stress has also been associated with the development of cardiovascular 
disease, although the exact role of antioxidants in the primary and secondary prevention 
of coronary heart disease is still under study. Epidemiologic evidence indicates that 
antioxidants may decrease cardiovascular risk, but clinical trial data remain inconclusive 
(Penckofer et al., 2002).  
The cellular redox imbalance created by oxidative stress is found to be present in 
cancerous as opposed to normal noncancerous cells, which has led many researchers to 
suspect that such imbalances may be pivotal in the development of various forms of 
cancer. It is thought that DNA mutation plays a crucial role in the process, although the 
precise mechanism remains unknown (Valko et al., 2006).  
1.2.5.2 Antioxidants and Oxidative Stress 
As noted above, oxidative stress denotes an imbalance between oxidants and 
antioxidants in favour of oxidants. Since antioxidants are intimately involved in the 
prevention of cellular damage – the common pathway for cancer, aging, and a variety of 
other diseases – this imbalance robs the body of its own capacity to detoxify and repair 
damaged cells. 
An antioxidant is a molecule that inhibits the oxidation of other molecules, it can 
safely interact with free radicals and terminate the chain reaction before vital molecules 
are damaged. Antioxidants terminate these chain reactions by being oxidized themselves. 
So, antioxidants are often reducing agents such as thiols, ascorbic acid, or polyphenols 
(Sies, 1997). Both plants and animals maintain complex systems of antioxidants, such as 
glutathione, vitamin C, vitamin A, and vitamin E as well as enzymes such as catalase, 
superoxide dismutase and various peroxidases.  
Although there are several enzyme systems within the human body that scavenge 
free radicals, the principle micronutrient antioxidants are vitamin E, beta-carotene, and 
vitamin C. Additionally, selenium, a trace metal that is required for proper function of 
one of the body's antioxidant enzyme systems, is sometimes included in this category. 
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Since the body cannot manufacture these micronutrients, they must be supplied in the 
diet (Greenberg et al., 1994). On the other hand, Poston et al. (2004) did not find any 
improvements in pregnant women with pre-eclampsia, when supplemented daily with 
1000 mg vitamin C and 400 IU vitamin E from the second trimester of pregnancy until 
delivery. Instead, they found an increase the rate of babies born with low birth weight. In 
other words, vitamins alone cannot work wonders since they occur in nature with a range 
of other nutrients and it is likely that their interactions are vitally important. 
Vitamin E (d-alpha tocopherol) is a fat soluble vitamin present in nuts, seeds, 
vegetable and fish oils, whole grains (especially wheat germ), fortified cereals, and 
apricots. The current recommended daily allowance (RDA) is 15 IU per day for men and 
12 IU per day for women. 
Vitamin C (ascorbic acid) is a water soluble vitamin present in citrus fruits and 
juices, green peppers, cabbage, spinach, broccoli, kale, cantaloupe, kiwi, and 
strawberries. The RDA is 60 mg per day. Intake above 2000 mg may be associated with 
adverse side effects in some individuals. 
Beta-carotene (a precursor to vitamin A, retinol) is present in liver, egg yolk, 
milk, butter, spinach, carrots, squash, broccoli, yams, tomato, cantaloupe, peaches, and 
grains. Because beta-carotene is converted to vitamin A by the body there is no set 
requirement. Instead, the RDA is expressed as retinol equivalents (Hennekens et al., 
1994). 
1.3 Fatty Acids: An Overview 
Fatty acids are carboxylic acids with a long aliphatic tail (chain) which may vary 
from 4 to 30 carbon atoms. Most of the fatty acids found in plasma membrane have 
between 16 and 24 evenly numbered carbon atoms. The predominant fatty acids are 
straight chain, and can be saturated (SFA) or unsaturated (USFA). Fatty acids are the 
major lipids, and therefore one the most fundamental categories of biological lipids. 
 Several systems of nomenclature are used for fatty acids. Trivial or common 
names are the historical names most frequently used in literature. The International 
Union of Pure and Applied Chemistry (IUPAC) system of nomenclature numbers the 
carbon atoms in fatty acids sequentially from the end of the chain. The double bond 
configuration is labelled using Z/E notation (Z for cis and E for trans). In the cis 
configuration, the two hydrogen atoms are situated on the same side of the double bond, 
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whereas in the trans configuration, the two hydrogen atoms lie on each side of the 
double bond.  
Another system of nomenclature in use is the delta system, in which the Greek 
delta symbol (∆) is used to indicate the position of double bond. Here, the Greek symbol 
omega (ω), or the letter n, denotes the position of the first double bond from the methyl 
end. The delta symbol is preceded by a cis- or trans- prefix indicating the configuration 
of the double bond.  
1.3.1 Saturated Fatty Acids (SFAs) 
Saturated fatty acids (SFAs) contain only single carbon-carbon bonds; there are 
no double bonds within the acyl chain. Most SFAs occurring in nature have an 
unbranched and even number of carbon atoms, with the general formula: CH3 (CH2) n 
COOH, where n varies from 7-21 depending on the source. SFAs are extremely stable, 
being the least reactive of chemical compounds; their melting point increases with chain 
length. Hence, decanoic and longer chain fatty acids are solid at room temperature. 
Saturated fatty acids are further classified into three subgroups: short, medium 
and long chain fatty acids. Short chain fatty acids contain less than eight carbon atoms. 
Butyric (4:0), and caproic (6:0) are the most important members of this group, and occur 
mainly in milk fat. Medium chain fatty acids are fatty acids with 8-14 carbon atoms. 
Capric (10:0), lauric (12:0) and myristic (14:0) are members of this group. The long 
chain fatty acids contain more than 14 carbon atoms, of which plamitic (16:0) stearic 
(18:0) are the most important (plamitic acid is the most widely occurring SFA). 
Saturated fatty acids longer than stearic (18:0), arachidic (20:0), behenic (22:0) and 
lingcreic (24:0) are minor dietary components (Ratnayake and Galli, 2009). 
1.3.2 Unsaturated Fatty Acids (USFAs) 
Unsaturated fatty acids (USFAs) are organic compounds containing one or more 
double bonds and, hence, are capable of undergoing additional reactions. They are 
further classified into monounsaturated (MUFA) and polyunsaturated fatty acids 
(PUFA).  
Monounsaturated fatty acids (MUFAs) contain a single carbon-carbon double 
bond. The presence of a single double bond allows for the two (cis and the trans) 
configurations. The cis configuration results in a non-straight structure, which confers 
more fluidity to membranes. The trans configuration creates a straight chain, which 
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increases cell membrane rigidity, with properties similar to saturated fatty acids. The 
double bond is most frequently located at the ∆9 position. Oleic acid (cis-9-
octadecenoic) is the most common cis-MUFA and is the most widely distributed of all 
natural lipids. The fatty acids present in animal cell membranes have cis configurations 
(Shantha and Napolitano, 1992). 
1.3.3 Polyunsaturated Fatty Acids (PUFAs) 
Polyunsaturated fatty acids (PUFAs) have two methylene-interrupted double 
bonds, i.e., with two or more double bonds of the cis-configuration separated by a single 
methylene group. The presence of several double bonds lowers their melting point and 
produces extremely flexible molecules. The influence of a fatty acid’s structure on its 
melting-point is such that branched chains and cis double bonds will lower the melting 
point compared with that of equivalent saturated chains. The melting point of a fatty acid 
also depends upon whether the chain is even- or odd-numbered; the latter have higher 
melting points (Rustan and Drevon, 2005). Therefore, the high “liquidity” of cell 
membranes is usually due to the presence of unsaturated fatty acids. Besides their vital 
role in cellular membranes, PUFAs are also the major constituents of plasma lipoprotein 
particles, phospholipids, triglycerides, and cholesterol esters (Le et al., 2009). 
The natural PUFA with methylene-interrupted double bonds (with cis 
configuration) can be divided into twelve families, depending upon the location of the 
double bond (from the n-1 to n-12 position) (Gunstone, 1999). In term of human health 
and nutrition, the most important families are n-3, n-6 and n-9, all of which are 
metabolized using the same group of enzymes. The three types of omega-3 fatty acids 
involved in human physiology are α linolenic acid (ALA), found in plant oils, and 
eicosapentaenoic acid (EPA) and docosahexaenoivc acid (DHA), both commonly found 
in marine oils; marine algae and phytoplankton are primary sources of omega-3 fatty 
acids. 
1.3.4 Essential Fatty Acids (EFAs) 
An 'essential' nutrient is one that is needed for the normal development and 
function of cells throughout the life cycle (Cunnane, 2003). The phrase "essential fatty 
acid" was first coined by Burr and Burr in 1929 when these FAs were used to reverse the 
adverse symptoms in young rodents fed on a fat-free diet. The fat-free diet resulted in 
dermatitis, kidney lesion, infertility, impaired growth, and premature death. These 
symptoms were reversed with the introduction of linoleic acid (LA) and α-linoleic acid 
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(ALA) in their diets (Burr and Burr, 1973). It was discovered, however, that ALA was 
not as effective as LA in reversing the symptoms.  
In humans, the importance of LA was not realized until 1958 when Arild Hansen 
and his colleagues demonstrated that LA deficient milk was associated with skin 
symptoms and growth retardation (Hansen et al., 1958, Holman et al., 1982). The 
essentiality of ALA for humans was established later when it was discovered that ALA 
deficiency caused neurological and visual impairment and that these lesions were 
treatable by supplementation with ALA (Holman et al., 1982).  
It is increasingly recognized that PUFAs are essential for the human diet, as the 
body is unable to synthesize LA and ALA, and the de novo synthesis of EPA and DHA 
do not meet the body's metabolic needs (Gomez Candela et al., 2011). EFA deficiency 
can occur in both young and old subjects and its effects are both rapid and extreme; on 
the other hand, after supplementation, the symptoms can disappear (Holman, 1960). It is 
now accepted that the clinical manifestations related to LA and ALA are due to the 
deficiency of their longer chain metabolites, such as arachidonic acid (AA), 
eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids. Hence, AA, EPA, and DHA 
are considered conditional EFAs since their production may be inadequate under certain 
conditions, thereby requiring exogenous supplementation (Le et al., 2009). 
1.3.5 Endogenous Synthesis of Long-Chain Polyunsaturated Fatty Acids 
Long-chain polyunsaturated fatty acids (LCPUFAs) are important components of 
membrane lipids in all tissues. The most important of these are omega-6 fatty acids, 
linoleic acid, and the omega-3 fatty acids. Among these three families of PUFAs, only 
oleic acid (OA), a parent n-9 fatty acid, can be synthesized by mammals from simple 
carbon precursors. Both the parent n-3 and n-6 fatty acids must be ingested, since 
mammals cannot insert the double bonds required to produce ALA and LA (Pudelkewicz 
et al., 1968). Once ingested, ALA and LA can be desaturated and elongated to varying 
degrees (Innis, 1991, Wang et al., 2005) The pathway leading to the biosynthesis of 
DHA in mammals from docosapentaenoic acid (DPA) has only recently been 
deciphered, called the Sprecher pathway (Voss et al., 1991, Sprecher et al., 1995), which 
is now accepted as a working model for the process, although the exact enzymes and 
mechanism involved in retro-conversion are not yet fully delineated (Pereira et al., 
2003). 
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1.3.6 Clinical and Biochemical Markers of Essential Fatty Acid Deficiency 
Essential fatty acid deficiency (EFAD) typically occurs when less than 1-2% of 
total calories are provided by EFAs (Holman, 1960). In humans, biochemical changes 
consistent with EFAD can occur in as little as a few days in infants. In older patients, the 
symptoms of EFAD may take 4-6 weeks to appear. Clinical signs of EFAD include 
growth retardation, hair loss, infertility, coagulopathies, dry and scaly skin (Alfin-Slater 
and Aftergood, 1968). The biochemical indicator of EFAD is increased oleic acid (OA) 
conversion to mead (MA, 20:3 n-9) and di-homo mead (22:3 n-9) acids (Siguel et al., 
1987). Conversion of OA to MA (n-9) only occurs when there are low dietary levels of 
both ALA and LA. Hence, a mead and arachidonic acid ratio of less than 0.2 is equated 
with linoleic acid sufficiency (Mascioli et al., 1996).  
 
Figure 1-2: Pathway of metabolism and synthesis of n-3, n-6, and n-9 Long-Chain 
Polyunsaturated Fatty Acids (from Le et al. (2009)) 
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Likewise, an insufficient intake of DHA, if n-6 fatty acids are not limiting, leads 
to a decrease in DHA and a simultaneous increase in n-6 docosapentaenoic acid (22:5n-
6) synthesized from n-6 docosatetraenoic acid (22:4n-6). Because of this, the ratios of 
22:5n- 6/22:4n-6 and DHA/22:5n-6 are regarded as reliable DHA markers of status. 
1.3.7 Dietary Requirements of Long-Chain Polyunsaturated Fatty Acids  
The minimum intake values for essential fatty acids to prevent deficiency 
symptoms are estimated to be 2.5%E LA plus 0.5%E ALA. Based on epidemiologic 
studies and randomized controlled trials of CHD events, the minimum recommended 
value of total PUFA consumption for lowering LDL and total cholesterol concentrations, 
increasing HDL cholesterol concentrations and decreasing the risk of CHD events is 
6%E. In similar experimental studies, the risk of lipid peroxidation may increase with 
high (>11%E) PUFA consumption, particularly when tocopherol intake is low. 
Therefore, the acceptable range for total PUFA (n-6 and n-3 fatty acids) can range 
between 6 and 11%E. The adequate intake to prevent deficiency is 2.5–3.5%E. Thus, 
according to the 2008 Joint FAO/WHO Expert Consultation (2009), the recommended 
range (ADMR) for PUFA is 6–11%E. 
Because LA is abundantly available in the human diet, the amount of AA almost 
always exceeds the level needed to maintain the metabolic needs of n-6 fatty acids, 
which are abundantly present in liquid vegetable oils. In rodents, AA alone has been 
shown to be as effective as LA in preventing symptoms of essential fatty acids 
deficiency (EFAD) (Thomasson, 1962, Hansen et al., 1986) demonstrating that AA can 
replace LA as the sole source of dietary omega-6 fatty acids (Le et al., 2009). 
Unlike n-6 fatty acids, however, n-3 fatty acids do not occur naturally in plants 
(and the western diet) in amounts necessary to meet metabolic needs. Moreover, the 
ALA conversion process to EPA and DHA in humans is not efficient, as only 5-10% are 
converted to EPA, and a mere 2-5% to DHA (Arterburn et al., 2006). However, n-3 fatty 
acids are abundantly present in fish, shellfish and other seafood; and fish-oil supplements 
typically contain 30-50% of n-3 fatty acids (Russo, 2009).  
The current adequate intake (AI) of ALA is 1.6g/ day for men 19-47 years and 
1.1 g/ day for women 19-47 years (Institute of Medicine of the National Academies, 
2005). The acceptable macronutrient distribution range (AMDR) for ALA is 0.6-1.2% of 
energy, approximately 10% of which can be consumed as EPA and/or DHA. The 
Institute of Medicine's dietary guidelines (2005) also note that consumption of 
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approximately two servings of fish per week (about 224 g) may reduce the risk of 
mortality from coronary heart disease. However, since the physiological potency of EPA 
and DHA is greater than ALA, and in light the growing evidence of the health benefits of 
omega-3 fatty acids (Mozaffarian and Rimm, 2006), the International Society for the 
Study of Fatty Acids and Lipids (ISSFAL) recommends a minimum DHA and EPA 
intake of 500 mg/day (ISSFAL, 2004). 
Another important, although controversial, aspect in LCPUFA dietary intake is 
the appropriate n-6/ n-3 fatty acid ratio for optimal health (Crawford, 2000, Griffin, 
2008, Simopoulos, 2009). Nevertheless, it can be stated that an adequate intake of both 
n-3 and n-6 fatty acids is essential for good health, although it remains unclear whether 
the ratio between the two is of crucial importance, or not (Willett, 2007). 
1.3.8 The Biomedical Importance of n-6 and n-3 LCPUFAs 
Polyunsaturated fatty acids play an important role in the composition of cell 
membranes as they maintain homeostasis for proper membrane protein function and help 
maintain the membrane fluidity that regulates cell signalling processes, cellular functions 
and gene expression (Das, 2006). 
The n-6 fatty acid Arachidonic Acid (AA) is present in all biological membranes 
and represents up to 15% of the total fatty acids in phospholipids. Studies have shown 
that low AA in maternal and cord blood is associated with low birth weight, reduced 
head circumference (Crawford et al., 1989, Leaf et al., 1992), intrauterine growth 
retardation (Vilbergsson et al., 1994) and impaired growth in preterm infants (Carlson et 
al., 1993). AA is a precursor in the production of eicosanoids, particularly 
prostaglandins, thromboxanes, leukotrienes and lipoxins, which, if formed in large 
amounts, contribute to the inflammatory state, allergic reactions, and the formation of 
thrombus. Thus a high n-6/n-3 ration may shift the physiological state to one that is 
prothrombotic and proaggregatory, with increases in blood viscosity, vasospasm, and 
vasoconstriction (Ferrucci et al., 2006, Simopoulos, 2009). 
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) play important 
roles in various physiological processes that impact normal health and chronic diseases 
(Benatti et al., 2004), such as the regulation of gene function and metabolism (Sampath 
and Ntambi, 2005), cardiovascular and immune function (Cottin et al., 2011), and 
neuronal and visual development (Haag, 2003, Crawford et al., 1976a). DHA is involved 
in the expression of several hundred genes in the brain (Kitajka et al., 2004). The 
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genomic evidence suggests that an abundant dietary source of preformed DHA, actually 
stimulated the evolution of the brain, and that a lack of DHA would have been restrictive 
(Brenna et al., 2009, Broadhurst et al., 2002, Crawford et al., 1999, Kitajka et al., 2004, 
Morgan, 1997). Since DHA is a major constituent of the signalling membranes of the 
brain and visual system, the superabundance of DHA with its irreplaceable role in neural 
cell signalling, allowed for the synaptic evolution of self-awareness and symbolic 
thinking and behaviour (Crawford et al., 2013). 
Between 50%-60% of the brain's dry weight is lipid, and approximately 35% of 
these lipids are LCPUFAs, particularly DHA. In the outer segments of photoreceptor 
cells, DHA constitutes 60% of total fatty acids (Jeffrey et al., 2001). Evidence from 
animal studies suggests that DHA deficiency can decrease brain DHA levels, increase 
the n-6/n-3 ratio in nerve membranes and result in poor functioning (Auestad and Innis, 
2000). Martinez (2001) has provided compelling evidence about the fundamental role of 
DHA in the brain by showing that DHA supplements to patients with Zellweger 
syndrome (generalized peroxisomal disorders) improved myelination, vision, liver 
function, muscle tone, and social contact. In addition, studies have shown enhanced 
visual development and cognitive performance due to increased intakes of DHA 
(Moriguchi et al., 2000, Neuringer, 2000, Helland et al., 2003).  
The cardio-protective effects of DHA and EPA supplementation have been 
studied extensively since their importance was first highlighted by Dyerberg and Bang 
(1979). It is now widely accepted that DHA and EPA supplementation decreases the risk 
of cardiovascular diseases (von Schacky and Harris, 2007), such as fatal Coronary heart 
disease (Hu and Willett, 2002), and stroke (He et al., 2004). These cardio-protective 
effects of DHA and EPA have been attributed to their anti- inflammatory properties, 
anti-arrhythmic and anti-aggregatory action, as well as their beneficial effect on vascular 
and endothelial functions. DHA and EPA supplementation have also been beneficial in 
atopic diseases (Calder, 2003), chronic inflammatory states such as arthritis (Calder and 
Zurier, 2001), and inflammatory bowel disease (Calder, 2008). 
In addition, both EPA and DHA are precursors of a novel class of lipid mediators 
involved in the resolution of inflammation (Serhan and Chiang, 2008). Anti-thrombotic 
properties of fish oils were initially attributed to EPA, however both animal and human 
studies suggest that DHA is a more potent anti-aggregatory agent than EPA at high doses 
(Adan et al., 1999, Woodman et al., 2003, Cottin et al., 2011). DHA and EPA 
supplementation have also been beneficial in atopic diseases (Calder, 2003), chronic 
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inflammatory states such as arthritis (Calder and Zurier, 2001), and inflammatory bowel 
disease (Calder, 2008).  
Although the role of individual fatty acids in (human) cancer risk has been poorly 
investigated, epidemiological and experimental data have linked a high dietary intake of 
n-6 PUFA – especially in association with a low intake of n-3 PUFA – to an increased 
risk for cancers of the breast, colon, and possibly prostate (Benatti et al., 2004). 
Eicosanoids are signalling molecules derived from 20-carbon essential fatty acids 
and which play a variety of roles in human physiology, in both health and disease. 
Eicosanoids include the prostanoids: prostaglandins, thromboxanes, prostacyclin, 
leukotrienes and lipoxins (Cook, 2005, Miller, 2006, Wang and Dubois, 2010). The 
eicosanoides contribute significantly to the regulation of inflammation (Dobrian et al., 
2011), renal function (Imig, 2006, Harris, 2008), vascular function (Feletou et al., 2011), 
insulin secretion (Luo and Wang, 2011), and reproduction (Olson and Ammann, 2007, 
Roldan and Shi, 2007). 
1.4 Health Effects of Omega-3 and Omega-6 Fatty Acids 
1.4.1 The Ratio of Omega-3 to Omega-6 Fatty Acids 
As noted above, the changing Western diet has drastically altered the omega-6 to 
omega-3 fatty acid ratio. In an effort to reduce cholesterol levels and lead healthier 
lifestyles, many Americans have substituted vegetable oils, which are high in omega-6 
fatty acids, in place of saturated fat from animals. This change in diet has led to an 
enormous increase in omega-6 fatty acid consumption and has elevated the typical 
omega-6 to omega-3 fatty acid ratio from 2:1 to 25-50:1. The ratio LA:LnA, calculated 
from food balance sheets, is roughly 10:1 in the UK (Taylor et al., 1979) and other 
western countries (Budowski and Crawford, 1985). Actual analysis seems to yield a 
higher ratio (e.g. 14:1) in a French farming community (Renaud et al., 1980). Cordain et 
al. (2005a) have also concluded that the current Western diet has adversely impacted the 
ω-3:ω-6 ratio. 
In ancient hunter-gatherer societies, the ratio of ω-3:ω-6 was closer to 2:1 or 3:1 
(Simopoulos, 2004). Other researchers have reported ω-3:ω-6 values ranging from 2: I to 
4:1 in muscle phospholipids of wild animals (Crawford et al., 1969, Crawford et al., 
1970b, Crawford et al., 1970a, Crawford and Woodford, 1971). The wild plants and 
animals which provided food for prehistoric man were not only low in fat, but their lipids 
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were also rich in PUFA (Crawford and Stevens, 1981). An analytical survey of thirty-
two wild animal species in Africa yielded average ratios of 1:1 in brain ethanolamine 
phosphoglycerides (EPG), the major phospholipid receptacle for PUFA in brain grey 
matter, and 1:1 in liver (Crawford et al., 1976a). LnA predominates in the chloroplasts of 
green, leafy plants, while seeds are richer in LA (Hitchcock and Nichols, 1971). 
Simopoulos (2002a) suggests that cereal grains have become the predominant food 
source since the Agricultural Revolution, which contain high levels of carbohydrate and 
ω-6 but little ω-3. Furthermore, technological innovations and advancement in crop 
production and processing has changed the ratio of n3 and n6 fatty acids (Budowski, 
1984). 
The dietary increase in the omega-6 fatty acid ratio can have profound effects on 
an individual’s health since omega-6 fatty acids do not provide the same health benefits 
as omega-3 fatty acids. Although omega-6 fatty acids are an important part of the cell 
membrane, replacing phospholipids EPA and DHA (derivatives of omega-3 fatty acids) 
with arachidonic acid (derivative of omega-6 fatty acids).  
The balance between ω-3 and ω-6 is therefore quite important as these two types 
of unsaturated fatty acids are in direct competition to be metabolized by cyclooxygenase 
(COX). COX is also the enzyme that catalyses arachidonic acid (AA), which is a ω-6 
fatty acid, into the precursor molecule responsible for inflammatory reactions in the body 
(Lee, 2013). These ω-6 fatty acids create a physiological state which is prothrombotic, 
proaggregatory, increases blood viscosity, vasospasm, vasoconstriction and decreases 
bleeding time. This decrease in bleeding time is associated with several aspects of CVD 
including myocardial infarction, hypercholesterolemia, atherosclerotic disease as well as 
diabetes (Simopoulos, 2002a, Brox et al., 1983). 
Whelan (1996) summarizes some of the most important differences in health 
effects between omega-3 and omega-6 fatty acids as follows: 
1. Omega-3 fatty acids reduce inflammation; omega-6 fatty acids increase 
inflammation.  
2. Omega-3 fatty acids are antithrombotic, omega-6 fatty acids increase blood 
clotting.  
3. Omega-3 fatty acids are non-immunoreactive; omega-6 fatty acids are 
immunoreactive.  
45 
 
These differences have profound implications for heart diseases, cancer, arthritis, 
allergies and other chronic diseases. The current scientific consensus is that the ratio of 
omega-6 to omega-3 fatty acids should be less than 5:1 (Sugano, 2001). 
1.4.2 Omega-3 Fatty Acids and Brain and Retinal Function 
The dry weight of the human brain is composed predominantly of lipids: 22% of 
the cerebral cortex and 24% of white matter consist of phospholipids. It therefore 
requires a regular intake of “good fats” such as Omega-3s for normal neurogenesis and 
synaptogenesis. DHA accounts for 40% of all PUFAs in the brain and is considered to be 
the most important fatty acid for brain function and development (Singh, 2005, Haag, 
2003).  
Thus, DHA is essential for normal neurological development. Low DHA levels 
have been linked to low brain serotonin levels which are connected to an increased 
tendency to depression, suicide, and violence (Hamazaki et al., 1996, Hibbeln, 1998). 
DHA concentrated mainly in serine and ethanolamine phosphoglycerides (Svennerholm, 
1968) and predominantly found in retina (Benolken et al., 1973) and cerebral cortex 
(Breckenreidge et al., 1971). Early studies have reported that a low concentration of 
DHA results in impaired retinal function (Neuringer and Connor, 1986, Neuringer et al., 
1984, Weisinger et al., 1999) and altered cognitive function (Neuringer et al., 1994). The 
majority of DHA studies have focused on its role in the cerebral cortex and only a few 
have focused on DHA concentrations in the most deep CNS structures, but no studies 
about DHA concentrations in the basal ganglia has been done so far, even though these 
complex structures are involved in a wide array of integrative functions such as motor 
coordination, integration of visual signals, and psychiatric and personality phenomena 
(Ring and Serra-Mestres, 2002). DHA and AA concentrations in the CNS are highly 
region-specific and high amount of DHA is found in the deep CNS regions embedded in 
white matter of much lower DHA and AA concentration (Diau et al., 2005). 
Furthermore, deficiency of this fatty acid is associated with a loss of 
discriminative learning ability, while intake of DHA may restore lost learning ability 
(Yamamoto et al., 1987). Consistent with these findings, it was demonstrated that 
chronic administration of DHA enhances long-term memory in both the young and old 
(Gamoh et al., 1999). Daily oral supplementation of 100-600 mg DHA improves the 
neurological condition in Zellweger’s syndrome, in which there is serious mental 
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retardation and damage to the protective covering (myelin) around the nerves (Martinez 
et al., 1993).  
Disorders such as ADHD and Autism Spectrum Disorder (ASD) have both been 
associated with reduced blood levels of PUFAs (Vancassel et al., 2001, Sinn and Bryan, 
2007). Some researchers have suggested that both behavioural and learning problems 
associated with ADHD can be reduced by supplementing ω-3 fatty acid (Richardson and 
Puri, 2002, Sinn and Bryan, 2007). In their systematic review of the effects of omega-3 
on ADHD, Bloch and Qawasmi (2011) found that omega-3 fatty acids, but specifically 
EPA, was comparable to pharmacological treatment of ADHD. Richardson and Puri 
(2002) found that children with symptoms of ADHD secondary to learning disabilities 
(primarily dyslexia) scored much higher for attention, anxiety and disruptive behaviour 
(than the control group) after receiving ω-3/ ω-6 supplements.  
 As already noted, DHA represents a small percentage of the fatty acids in most 
tissues of the human body, it reaches levels of 30-40% of total fatty acids in rod 
photoreceptor outer segments of the retina (Menon and Dhopeshwarkar, 1982). DHA 
influences retinal photoreceptor structural development and function, thereby increasing 
retinal light sensitivity. A deficiency in DHA can result in decreased visual acuity and an 
abnormal electroretinogram (Rotstein et al., 1998). In one study, researchers found that 
more frequent consumption of fish (which contain DHA) appeared to protect against late 
age-related macular degeneration. Only a moderate intake of fish was necessary for this 
protective effect (Levine, 1997). 
In rhesus monkeys, diets deficient in omega-3 fatty acid induced profound 
functional changes such as reduced vision, abnormal electroretinograms, impaired visual 
evoked potential, more stereotypic behaviour (e.g., pacing) and probable disturbances of 
cognition (Neuringer et al., 1986). 
1.4.3 Omega-3 Fatty Acids and Foetal Development 
Two essential fatty acids, lenoleic acid (C18:2, n- 6) and lenolenic acids (C18:3, 
n- 3), derived from plants, do not present in brain tissues. After elongation and 
desaturation in the liver, they form long chain fatty acids including arechidonic acid 
(AA, C20:4, n- 6) and docosahexaenoic acid (DHA, C22:4, n-3). These two fatty acids 
are essential, structural and functional constituents of cell membranes (Crawford et al., 
1976b) and are required for the growth and function of the brain and vascular systems 
which are the primary biofocus of human foetal growth. The foetal brain can accumulate 
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AA and DHA during cell division. It is observed that very preterm babies are born with 
minimal fat stores and suboptimal circulating levels of these nutrients. Postnatally, they 
lose the biomagnification of the proportions of AA and DHA provided by the placenta 
for the foetus. No current nutritional management repairs these deficits. The resultant 
foetal FA profile closely resembles that of the vascular endothelium and not the brain. 
Without this nourishment, cell membrane abnormalities would be predicted (Crawford et 
al., 2003). 
Omega-3 fatty acids (DHA and EPA) from fish oils are of major importance for 
proper nutrition during pregnancy, not only for foetal development, but for the mother's 
health, as well. There are 2 critical periods for the acquisition of these essential omega-3 
fatty acids: during foetal development itself and then after birth until the biochemical 
development of the brain and retina is completed. A deficiency or excess of any number 
of nutrients can lead to birth defects or complications for the mother (Allen and Harris, 
2001). 
   DHA is brain food for a developing baby. It constitutes more than half of a 
newborn’s brain mass, and during the first three months of life, the DHA content of the 
infant’s brain increases threefold (Barrett et al., 2014). The fatty acid accretion increases 
as gestation progresses, reaching a maximum rate of accretion toward the end of 
gestation. DHA as a percentage of total fatty acids increases, whereas AA decreases in 
both the cerebrum and liver during the last trimester of gestation. The higher 
concentration of brain DHA is consistent with the rapid formation of synapses and 
dendritic spines taking place during this period (Martinez and Ballabriga, 1978, Pupura, 
1975). An increase in the percentage of DHA can be due to the rapid development of the 
photoreceptor cells during the last half of gestation. Furthermore, n-3 fatty acids do not 
stop increasing after birth. The very rapid prenatal increase becomes more moderate but 
is still quite significant until at least 2 years of age (Martinez, 1992). 
Since developing foetuses cannot make their own omega-3 fatty acids, they 
depend upon their mothers to meet their nutritional needs. Therefore, DHA and other 
essential nutrients should be obtained by the mother through her diet or supplementation, 
which can then be passed along to the foetus (Carlson, 1999). This vital nutrient is 
particularly important during the third trimester, as this is when much of the foetus' 
neurological, visual and nervous system development occurs (Carlson, 1999, Valenzuela 
and Nieto, 2001).  
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Human milk is the best and only time-proven source of DHA in the infant’s diet. 
In well-nourished mothers, approximately 6% of total calories in human milk take the 
form of essential fatty acids and their metabolites. The conversion efficiency of dietary 
EFA into milk fatty acids is not clear; however, an additional 1 to 2% of calories in the 
form of EFA is recommended during the first 3 months of a mother's lactation. Another 2 
to 4% of calories above the basic requirement is recommended thereafter (Makrides and 
Gibson, 2000).  
Studies show that breast-fed babies have IQ advantages over babies fed formula 
without DHA. Unfortunately, DHA levels in the breast milk of U.S. women are among 
the lowest in the world. In addition, the United States is the only country in the world 
where infant formula is generally not fortified with DHA despite a 1995 WHO 
recommendation that all baby formulas should provide 40 mg of DHA per kilogram of 
infant body weight. Scientists believe that postpartum depression, attention deficit 
disorder (ADD), and low IQs are all linked to the low DHA intake commonly found in 
the U.S. Furthermore, several studies have shown that infants with an adequate supply of 
DHA developed better visual acuity and retinal response to light and scored higher when 
evaluated for mental development (Cunnane et al., 2000, Birch, 1999, Birch et al., 1998).  
The constant drain on a mother's DHA reserves can easily lead to a deficiency. 
Some researchers believe that pre-eclampsia (pregnancy-related high blood pressure) and 
postpartum depression could be linked to such DHA deficiency (Chiu et al., 2004). 
Deficiency of DHA in the foetus has also been linked to premature births and abnormally 
low birth weights (Olsen et al., 2003). 
Fish and fish oil consumption during pregnancy has been shown to affect the 
mental development of the child. Maternal ω-3 at delivery predicted better attention in 
infants during the first 2 years of life and better hand-eye coordination at 2.5 years 
(Dunstan et al., 2008, Colombo et al., 2004). Infants with higher DHA at birth and at 4 
months also demonstrated better visual development (Malcolm et al., 2003, Lauritzen et 
al., 2004). At 4 years of age, children born to mothers who took cod liver oil during 
pregnancy and lactation had a higher score on the Mental Processing Scale for the 
Kaufmann ABC test, although this effect was not present at 7 years of age (Helland et 
al., 2008b, Helland et al., 2003).  
Researchers have also identified other benefits associated with omega-3 fatty 
acids: 
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• Omega-3 fatty acids may promote an easier birth, and prevent preterm delivery.  
• Omega-3 intake is associated with more mature neonatal sleep-state patterning 
(the baby sleeps longer through the night in early life).  
• Omega-3 fatty acid supplemented infants show higher levels of cognitive 
function.  
• Omega-3 intake can reduce the chances of a child developing allergies.  
• Omega-3 intake is associated with increased foetal development, specifically as it 
relates to the brain and vision.  
• Children are less likely to have behavioural and learning problems (Olsen et al., 
2003, Cheruku et al., 2002, Prescott and Calder, 2004, Birch et al., 2000). 
1.4.4 Omega-3 Fatty Acids and Cardiac Disease 
There has been significant promotion of fish intake in recent years since it is a 
good source of high-quality protein, low fat, vitamins and minerals, but particularly 
omega-3 fatty acids which have been associated with cardiovascular health benefits. 
Nowadays, nutritionists recommend at least two servings of fish per week to achieve 
cardio-protective effects (Chan and Egeland, 2004, Nordoy et al., 2001). 
For the last two decades, many studies have reported the beneficial effects of 
seafood consumption for reducing the risk of coronary heart disease mortality (Kromhout 
et al., 1985, Daviglus et al., 1997, He et al., 2004, Whelton et al., 2004). Intake of fish 
and fish oil is also thought to decrease the risk of other cardiovascular diseases, such as 
hypertension, stroke and cardiac arrhythmias (Sidhu, 2003).  
The protective effects of omega-3 fatty acids on coronary heart disease have been 
demonstrated in hundreds of experiments in animals, humans, tissue culture studies, and 
clinical trials. Omega-3 fatty acids from fish have been shown to be protective of heart 
disease and are also capable of preventing deaths from coronary disease, particularly 
cardiac arrest (Paganelli et al., 2001, Shekell et al., 1985, De Caterina and Madonna, 
2002, Norell et al., 1986, Kromhout et al., 1985, He et al., 2004, GISSI-Prevenzione 
Investigators, 2000, Kris-Etherton et al., 2003).  
The unique properties of these fatty acids in coronary heart disease first became 
apparent in investigations into the health of Greenland Eskimos who consumed diets 
very high in fat content, and yet had a low rate of coronary heart disease. Further studies 
clarified this paradox: the fat consumed by the Eskimos contained large quantities of the 
very-long-chain and highly polyunsaturated fatty acids of EPA and DHA, which are 
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naturally abundant in fish, shellfish, and sea mammals but which are quite scarce or 
absent in land animals and plants. EPA and DHA are synthesized by phytoplankton, 
aquatic plants at the base of the food chain for marine life (Bang et al., 1976).  
The American Heart Association identifies the cardiovascular benefits of DHA as 
follows: 
• Prevents arrhythmias (ventricular tachycardia and fibrillation). 
• Serves as a prostaglandin and leukotriene precursor.  
• Has an anti-inflammatory property. 
• Inhibits synthesis of cytokines and mitogens. 
• Stimulates endothelial-derived nitric oxide. 
• Has an antithrombotic role. 
• Inhibits atherosclerosis.  
• Protects against plaque fat ruptures leading to strokes and heart attacks. 
• Relaxes blood vessels (vasodilatation). 
• Lowers blood pressure, and lessens heart stress (Kris-Etherton et al., 2003). 
ω-3 fatty acids are crucial in the development of a CVD. Firstly, ω-3 is involved in 
decreasing the body’s inflammatory response by increasing the production of anti-
inflammatory molecules and decreasing the production of inflammatory molecules 
(Calder, 2006). This anti-inflammatory effect is implicated in stabilizing arterial plaques, 
thereby decreasing the risk of CVD events (Thies et al., 2003). 
Blood pressure has also been found to be reduced by ingesting only 3.7 g/d of 
fish oil (Geleijnse et al., 2002), and serum triglycerides, a risk factor for the development 
of CVDs, have been reduced by up to 30% by the use of ω-3 fatty acids supplements 
(Austin, 1991, Harris, 1997). Atherosclerotic plaque formation may also be lessened by 
the reduction in growth factors after fish-oil consumption (Wijendran and Hayes, 2004).  
Dietary studies in which the effects of a diet rich in salmon oil were compared 
with those of a vegetable oil and a diet high in saturated fat. Fish oil in particular was 
shown to lower plasma cholesterol and triglyceride concentrations (Connor, 2000).  
Based on the findings of two large scale reviews, the American Heart Association 
has recommended that adult patients without documented CHD eat a variety of 
(preferably oily) fish at least twice a week and include oils and foods rich in alpha-
linolenic acid (flaxseed, canola and soybean oils, flaxseeds and walnuts). This is 
equivalent to 0.3 to 0.5 g/d of EPA and DHA which is essential for healthy individuals to 
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reap specific heart health benefits. For those with documented CHD, the AHA 
recommends consuming 1 g/d of EPA and DHA, preferably from oily fish, although 
supplements may be considered advisable upon consulting a physician. The AHA reports 
that consumption of one fatty fish meal (85 g portion) per day (or the equivalent fish oil 
supplement) could result in EPA and DHA intakes of approximately 0.9g/d, which 
researchers have shown to reduce CHD mortality rates in patients with coronary disease 
(Nigel et al., 2007). Similarly, König et al. (2005) has found that even a small quantity of 
fish consumed regularly was associated with a 17% reduction in CVD mortality and each 
additional serving of fish increased the reduction in CVD mortality by 3.9%. 
On the other hand, some researchers have cautioned against overstating the 
benefits of omega-3 fatty acids. For example, Kwak et al. (2012) did not observe any 
effect of omega-3 supplements on the prevention of CVD events or mortality in those 
who already had a history of CVD. Similarly, the meta-analysis by Hooper et al. (2006) 
found no effect of omega-3 on total mortality, strokes or CVD events.  
1.4.5 Omega-3 Fatty Acids and Other Diseases 
1.4.5.1 Cancer 
Researchers have not yet reached any concrete conclusions about the effects of ω-
3 fatty acids for the prevention and treatment of cancer. Recent studies have not found 
any positive effect of ω-3 fatty acids in reducing cancer mortality (MacLean et al., 2006, 
Hooper et al., 2006). However, low levels of any type of fatty acid can promote cell 
growth in the prostate while high levels of EPA inhibits this growth (Pandalai et al., 
1995). In another study, men who consumed higher levels of EPA and DHA through 
dietary ω-3 consumption had a lower risk of prostate cancer (Norrish et al., 1999), while 
Kimura et al. (2007) found a non-significant but inverse relationship between dietary ω-3 
and colorectal cancer, especially distal colon cancer.  
On the other hand, Cave (1986) has suggested that fish oil consumption can delay 
or reduce tumour development in breast cancer Studies have also shown that a high 
blood level of omega-3 fatty acids, when combined with a low level of omega-6 acids, 
reduces the risk of developing this disease (Simonsen et al., 1998). In a similar vein, 
daily supplementation with as little as 2.5 grams of fish oils has been found effective in 
preventing the progression from benign polyps to colon cancer (Yang et al., 1999). 
Gonzalez and Riboli (2006) suggest that fish consumption may decrease the risk of 
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colorectal cancer. Other researchers have found that fish oil supplementation improves 
survival and quality of life in terminally ill cancer patients. 
1.4.5.2 Overweight and Obesity 
Omega-3 fatty acids have a profound effect on obesity. It has been found that 
obese individuals have lower concentration of ω-3 fatty acids in their blood when 
compared to healthy, non-obese controls (Micallef et al., 2009). Couet et al. (1997) 
found that a fish oil diet corresponded to a 0.88 kg reduction of body fat when compared 
a control diet. Kabir et al. (2007) found that postmenopausal overweight and obese 
female subjects with type 2 diabetes also experienced a reduction in their total body fat 
after adding 3 g/d of fish oil (1.08 g EPA + 0.72 g DHA) for two months.  
 In a similar study, Thorsdottir et al. (2007) placed men and women on one of four 
types of energy restricted diets: a control diet with no fish, with lean fish, with fatty fish 
or with fish oil. They found that after four weeks, men had lost approximately 1 kg more 
after eating lean or fatty fish or taking fish oil supplements.  
Epidemiological studies have also shown that fish consumption within a healthy 
eating pattern is associated with lower body weight (Shubair et al., 2005, Schulze et al., 
2006). However, less is known about the health impact of fish consumption and fish oil 
supplementation, when paired with physical activity, on the nutritional status of school 
children, body composition, blood biochemistry and mental and physical abilities. 
Dietary intervention studies which included fish and fish oil in a weight loss diet are also 
limited (Thorsdottir et al., 2009, Mori et al., 1999). 
The recently conducted randomized dietary intervention study SEAFOOD plus 
YOUNG showed promising results: lean and fatty fish consumption three times a week 
for eight weeks was associated with significantly lower body weight in humans 
compared to an isocaloric control diet without seafood.  
1.4.5.3 Diabetes 
Fish intake might also increase insulin sensitivity (Ramel et al., 2008) and 
decrease the risk of non-insulin-dependent (type II) diabetes (Kromann and Green, 1980, 
Nkondjock and Receveur, 2003).  
Some data are available in the literate that show a positive impact of ω-3 fatty 
acids on diabetes. Norris et al. (2007) found an inverse relationship between higher 
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intake of ω-3 fatty acids and the risk of developing islet autoimmunity, the destruction of 
insulin-producing beta cells in the islets of the pancreas. Similarly, in another study, 
children who ingested cod liver oil were found to be at a significantly lower risk of 
developing type 1 diabetes (Stene and Joner, 2003). It has also been demonstrated that ω-
3 is effective in decreasing the level of triglycerides in Type 2 diabetes, although no 
comparable effect on the fasting glucose level or glycaemia was found (Montori et al., 
2000). 
1.4.6 Omega-3 Fatty Acids: Sources and Dosage 
The best source of DHA is seafood, especially coldwater fish. Omega-3 fatty 
acids are nature's antifreeze: in general, the colder the fish's natural environment, the 
higher the omega-3 content in the fish oil. Popular sources of DHA are wild salmon (not 
farm raised), sardines, tuna (especially blue fin tuna), mackerel, shellfish, herring, black 
cod and anchovies. The fish meats with the highest ω-3 content that fulfil the ω-3 criteria 
of the American Heart Association are salmon, mackerel, red mullet and, to a lesser 
extent, squid and hake (Domingo et al., 2007). Eggs and some organ meats (liver and 
brain) have a small amount of DHA, but the healthiest source of dietary DHA is seafood 
(Holub, 2001). 
Despite the known benefits of regular fish consumption, the risks must be 
considered, as well. Fish are known to contain chemical pollutants which may be 
dangerous to consume regularly or at the frequency suggested by the AHA (Kris-
Etherton et al., 2002a). Domingo et al. (2007) analysed the ω-3 content and the chemical 
pollutants present in 14 types of fish, and found that, when consumed according to the 
AHA guidelines, most marine specifies did not pose a risk. On the other hand, swordfish 
and tuna contained high levels of methylmercury; clam, mussels and shrimp contained 
high levels of the carcinogen polycyclic aromatic hydrograms (PAB); and red mullet 
contained high levels of polychlorinated dibenzodioxins and furans (PCDD/F). On this 
basis, it would appear that the safest fish to consume at the level suggested by the AHA – 
with the most ω-3 – would be salmon and mackerel.  
Besides fish oils, vegetable oils (primarily flaxseed, soy, walnuts and canola) are 
also rich sources of omega 3 fatty acids, with flaxseed oil being the best. The main 
component of flaxseed and walnut oils is alpha-linolenic acid (ALA) while the 
predominant fatty acids found in fatty fish and fish oils are eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA). The most beneficial and active of these fatty acids are 
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EPA and DHA. Alpha-linolenic acid (ALA) can be converted to EPA and DHA in the 
body, but the conversion process is inefficient, especially in older people. The two F's – 
fish and flax – are the top brain-building foods for growing children, and adults (Holub, 
2001, Conquer and Holub, 1996). Certain microalgae also contain DHA and are used as 
a vegetarian source of this nutrient in some supplements. For infants, breast milk 
contains significant amounts of DHA, while infant formula often has none (Cunnane et 
al., 2000).  
  People without a CHD should eat fatty, oily fish twice a week and include oil 
and foods that have a high amount of alpha linoleic acid (Kris-Etherton et al., 2003), 
whereas people with CHD should ingest 1.0g of EPA+DHA every day from oily fish. In 
patients who need to lower their triglyceride levels, they recommend 2-4 grams of 
EPA+DHA per day, taken in capsule form (Kris-Etherton et al., 2003).  
1.5 Genesis and Prevention of NCDs in Childhood 
1.5.1 Children and Adolescents are Heavily Impacted by NCDs 
 Childhood NCDs are on the rise globally. The following identify some of the 
most significant ways children and adolescents are affected: 
• 1.2 million children and youth under the age 20 died of NCDs in 2002 (Mathers, 
2009). 
• More than 25% of obese adolescents have signs of diabetes by age 15 (Goran et 
al., 2003). According to Mathers (2009), this accounts for approximately 486,000 
children under 15 years of age. 
• Despite improvements in the survival rate for some childhood cancers, this rate is 
much lower in resource-poor countries (Proimos and Klein, 2012).  
• Approximately 90% of the 1 million children born each year with congenital 
heart disease live in areas without adequate medical care (Cancer Research UK, 
2002).  
• Tobacco smoke causes asthma, otitis, and respiratory infections in children 
(Tchervenkov et al., 2008). 
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• Mental health disorders (Cancer Research UK, 2002) motor vehicle trauma, 
homicide, and suicide (Gore et al., 2011) cause significant morbidity and 
mortality in children and youth. 
It has been suggested that when risk behaviours begin in childhood and continue 
into adulthood, there is an increased risk of developing disease (Law, 2000), and the 
risks increase as the individual ages (World Health Organization, 2013a).  
 In one longitudinal study, Porkka et al. (1994) tracked children between 3-18 
years of age for 12 years, and found that serum lipids (such as HDL, LDL and total 
cholesterol) tracked into adulthood and that 50% of those in the extreme ranges for these 
measures remained unchanged. They also found that men tracked these factors into 
adulthood more consistently than women. Similar results were found in a study 
following children in Louisiana, finding that the same pattern held at the other extreme: 
42% of those in the lower range for HDL cholesterol remained in the lower range 
(Webber et al., 1991).  
Blood pressure and BMI have also been found to track into adulthood from 
childhood, and that these measures are related to adult blood pressure, fasting insulin and 
lipid levels (Juhola et al., 2011, Sinaiko et al., 1999). McGill et al. (2008b) suggest that a 
high risk of developing advanced coronary artery lesions continues to increase with age. 
It has also been found that risk factors for cardiovascular disease in childhood predicts 
cardiovascular pathologies in adulthood, probably due to the changes in the 
cardiovascular system caused by the presence of risk factors in childhood (Raitakari et 
al., 2003).  
The PDAY risk score in young people has been found to predict coronary artery 
calcium and carotid intima-media thickness into later adulthood (Gidding et al., 2006, 
McMahan et al., 2007), just as coronary artery calcium has been shown to be a reliable 
predictor of adult coronary heart disease (Pletcher et al., 2004). Jenkins et al. (1981) 
examined 35 people post-mortem who died at the average age of 18 and found that fatty 
streaks were related to total and LDL cholesterol, that coronary artery fatty streaks were 
correlated with very LDL cholesterol, and that fatty streaks were inversely related to the 
ratio of HDL to LDL and VLDL cholesterol. McGill et al. (2008) suggest that the 
prevention of risk factors will likely yield the maximum benefit in terms of 
cardiovascular disease prevention.  
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Not surprisingly, obese adolescents are at an increased risk of developing an 
NCD later in life (Reilly and Kelly, 2010). This is particularly problematic since 43 
million children globally are obese and 92 million are at risk of being overweight. 
Furthermore, the rate of childhood obesity has increased from 4.2% in 1990 to 6.7% in 
2010 (De Onis et al., 2010).  
The Middle East is one of the regions with the highest prevalence of obesity in 
the world (James, 2004, Han et al., 2010). These overweight or obese children and 
adolescents are susceptible to becoming overweight or obese adults. This is especially 
true if the child has a higher BMI or if the child had an obese parent (Guo and Chumlea, 
1999, Whitaker et al., 1997). The increase in weight among children and adolescents 
may be due to increased snack and fast food consumption (McConahy et al., 2004, 
Bowman et al., 2004). 
It has been suggested that the dietary behaviours of children are shaped by food 
preferences that are developed prenatally and post-natally, where both taste and olfaction 
are important determining factors. (Bradley and Stern, 1967) found that taste cells are 
developed before twenty weeks of gestation and fully functional by 13-15 weeks, while 
olfactory function has been found to be developed in utero (Schaal et al., 1998), 
responding to the foods eaten by the pregnant mother (Birch, 1999). Studies have 
demonstrated that premature infants have already acquired clearly defined taste 
preferences (Tatzer et al., 1985, Ventura and Worobey, 2013a).  
Children’s food preferences can also be modulated by parental restriction or 
coercion. It has been found that children who are offered contingencies for eating foods 
(reward or punishment based) may send the message to the child that a food is not 
desirable, which may actually result in a decreased preference (Birch et al., 1982). Food 
restriction in an experimental setting has also been shown to result in higher intakes and 
selection of the restricted food despite calorically equivalent free access alternatives 
(Fisher and Birch, 1999). It has also been suggested that the foods made available by 
parents, and parental intake predicts the types of foods children consume (Wardle et al., 
2005, Hanson et al., 2005, Young et al., 2004). 
An important influence on the programming phenomena is foetal nutrition, which 
is a consequence of maternal nutrition during pregnancy. An imbalance of 
macronutrients, specifically protein and carbohydrates, have been found to be associated 
with a low birth-weight and higher blood pressure in children (Shiell et al., 2001). A 
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positive association has also been found between a maternal diet that includes green 
vegetables and fruits, and higher birth-weight and better glucose tolerance in the child. 
Belizan et al. (1997), Yajnik (2004), and Rao et al. (2001) have similarly found an 
association between a maternal diet that includes higher calcium intake with lower blood 
pressure in the child. Children of mothers with diabetes have also been found to be at an 
increased risk of glucose intolerance and type 2 diabetes. These are all physiological 
conditions that may occur due to maternal nutrition and/or low birth-weight which are 
known risk factors for NCDs later in life.  
This pattern has been explained by the thrifty gene hypothesis, which suggests 
that the child’s physiology will adapt to the undernourished environment in the womb. 
The result of the child’s adaptation is a physiology unsuited to the over-nourished 
postnatal environment, thereby increasing the child's susceptibility to obesity and other 
NCDs. In the case of diabetes, it has been suggested that the foetus will direct glucose 
supply to vital organs when confronted with a glucose deficiency in the womb. As a 
result, the body adapts to low glucose environments and these children become more 
susceptible to glucose intolerance and type 2 diabetes later in life (Hales and Barker, 
2013).  
1.5.2 Nutritional Intervention at Childhood as a Method to Tackle Behavioural 
Abnormalities 
Numerous studies have shown an association between nutrition and lifestyle 
factors to cognitive functioning and mental health in children. Sjöberg et al. (2005), for 
example, found that overweight children between 15 and 18 years old had depressive 
symptoms, while children in the higher BMI groups had major depressive symptoms, as 
defined by the DSM-IV. Luppino et al. (2010) also found a relationship between 
depression and obesity in their systematic review and meta-analysis.  
 Dreyfus (1993) examined the mental health issues in obese children and found 
that 15% of obese children had a personality disorder and 2% had psychotic features 
while 58% showed no severe personality disorder. Adolescents with obesity or weight 
gain displayed more psychopathology or psychiatric morbidity and higher levels of 
depression than those with a normal weight, although the sample only included those 
who were seeking treatment for weight related issues (Hammar et al., 1972, Buddeberg-
Fischer et al., 1999). Vila et al. (2004) examined obese children who were patients at a 
nutrition outpatient centre in Paris and found that 58% had a DSM-IV psychiatric 
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diagnosis, 32% had a DSM-IV anxiety disorder, 12% had affective disorders, 16% had 
disruptive behaviour disorders; in some cases, a single individual had multiple diagnoses. 
Despite these pervasive associations, it has been demonstrated that mental health issues 
such as depression and schizophrenia in children improved with treatment of ω-3 fatty 
acids (EPA) (Nemets et al., 2006, Emsley et al., 2003).  
Cognitive functioning has also been shown to be affected by poor dietary habits. 
The main metabolic factor involved in brain function is glucose and thus the effect of 
glucose on uninterrupted brain function cannot be understated. It has been also been 
suggested that poor nutrition can affect the brain function (Bellisle, 2004). (The 
important role of fatty-acids has already been discussed above.) 
The effect of glucose ingestion on memory and cognition has been investigated 
by several researchers. It has been found that the ingestion of glucose in children 
produced beneficial effects on short-term memory, rapid information processing, 
focussed and sustained attention, arithmetic ability, long-term free and cued recall tasks. 
The rise in blood glucose after ingesting a glucose drink resulted in faster information 
processing, word recall and improvement on cognitive conflict and reaction time tasks. It 
has also been suggested that the latter phases of long and difficult mental tasks are 
improved with the ingestion of glucose, although this effect does not apply to the earlier 
phases of long and difficult mental tasks or shorter duration that are less demanding 
(Benton et al., 1987, Benton and Owens, 1993, Foster et al., 1998). This demonstrates 
the brain's sensitivity to short-term fluctuations in glucose levels (Bellisle, 2004).  
Benton et al. (2003) found that low-glycaemic index food facilitated mental 
performance hours after being ingested, since they do not severely disrupt blood glucose 
levels. Schoenthaler and Bier (1998) found that low-dose vitamin mineral supplements 
improved performance on tests of intelligence in children with poor diets; the same result 
was not found in children with adequate diets.  
1.6 The Sultanate of Oman, NCDs, Risk Factors & Epidemiology 
The Arab World, identified in the literature as the Eastern Mediterranean, 
Western Asia, North Africa and the Northern Gulf are certainly not immune to the 
effects of NCDs. In 2004, the WHO Mediterranean Region had a 47% disease burden 
due to NCDs and this number is predicted to rise to 60% by 2020 (Khatib, 2004). WHO 
also predicts that the mortality rate due to NCDs in the region will increase by 25% 
(Alwan, 2008). In some of these countries, the number of deaths below the age of 60 due 
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to NCDs is at 40% (Alwan, 2014) with more than 1.2 million Arabs dying from NCDs in 
2008, which accounted for 60% of total deaths in the region (Rahim et al., 2014b).  
The Sultanate of Oman is a WHO member state situated in the Eastern 
Mediterranean region. This developing, high-income country has a population of 3.3 
million people. Similar to other countries in the region, Oman’s population also suffers 
from NCDs and the resulting burden of disease placed on the national healthcare system 
(World Health Organization, 2014a). In 2008, NCDs accounted for 83% of deaths in 
Oman, with the under 60 mortality rate at 44.5% for men and 32.6% for women (World 
Health Organization, 2011b). In 2012, 70% of the YLL in Oman was due to NCDs or 
injuries. In Oman, the rates of death by each NCD are listed as follows:  
• CVD, 49% of total mortality 
• Diabetes, 7% 
• All Cancers, 11% and  
• CRD, 3%.  
These proportions are particularly worrying, since only 3% of the Omani population in 
2004 was aged 60 or older (World Health Organization, 2011b). 
The prevalence of overweight or obese and physically inactive is high in Arab 
region. Kim et al. (2011) found that in, in the Arabian Gulf, 66-75% of the adult 
population (above age 18) and 25-40% of children (below age 18) were either 
overweight or obese. In Oman, 30% of the population is overweight and 20%-21.5% are 
obese (Al-Lawati et al., 2008). Al-Lawati and Jousilahti (2004) found that this trend 
appears to be shifting, with more men and fewer women are becoming overweight and 
obese. 
 Rahim et al. (2014b) found that the Arab region, but particularly high-income 
GCC countries, had the highest level of physical inactivity in the world. It has been 
suggested that this is due to urbanization and its impact on recreational and lifestyle 
activities, as well as a shift to more sedentary occupations. Additionally, extreme 
climatic conditions and lack of public transport in many of these countries has created a 
reliance on personal automobiles, and people are also becoming more dependent on 
mechanization to complete household chores as well as technology for leisure activities 
(Rahim et al., 2014b).  
Between 1961 and 2007, the Arab Region experienced an increase in sugars and 
sweeteners, meats, milks and dairy products, changes that are characteristic of the 
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nutrition transition associated with an increased burden of NCDs (Golzarand et al., 
2012). The nutrition transition taking place in Oman is at stage 2, ‘Degenerative 
Diseases,’ where the intake of food has shifted to a Western diet. This usually occurs in 
societies where there is an accompanying shift in technology, especially in both work 
and leisure activities (Popkin, 1993). The other two diet types, as characterized by Jacka 
et al. (2010), are ‘Traditional’ and ‘Modern’ diets. The ‘Traditional’ dietary pattern is 
defined as consisting of vegetables and fruits, whole-grains, meats and fish. The 
‘Modern’ pattern consists of fruits, salad, and more beans, yogurt, nuts, fish and tofu. 
Rahim et al. (2014b) suggest that the Arab Region is moving away from the traditional 
diet towards the westernised diet, while the developed world is moving away from the 
western diet towards the modern diet.  
The unhealthy dietary habits resultant from rapid urbanization in the region has 
produced a largely ‘Western diet’ that is characterized by high-fat, calorie dense foods, 
refined sugars and salt, as well as high intakes of fast foods and carbonated drinks 
(Musaiger et al., 2011b, Mahmood et al., 2008). Undoubtedly, this shift partly accounts 
for the fact that, in GCC countries, 25–40% of children below 18 years of age are 
overweight or obese (Kim et al., 2011). When examining overweight and obesity in 
children aged 0–5 years old, De Onis et al. (2010) found that 14.7% of preschool 
children were overweight or obese in the Western Asia region (the Arabian Peninsula). 
Using the data trends, the researchers suggested that this rate could increase to 21.5% by 
2015 and predicted that 29.1% of children would be overweight or obese in 2020.  
Similarly, Osman et al. (2004) tracked a cohort of 550 Omani students, both male 
and female, and found that the incidence of overweight and obesity was 7.3% at 6–7 
years, and increased to 16% at 12–13 years and increased yet again to 23.3% at 15–16 
years. The authors concluded that Omani school children tend to become increasingly 
overweight and obese as they age, may be largely due to the more sedentary activities 
and socialized more by eating energy-dense nutrient poor foods as they grew older.  
1.7 Aim and Objective of the Study 
Like many other developed countries, Oman is facing a rapidly escalating burden 
of non-communicable diseases (NCDs), i.e., obesity, diabetes, high blood pressure, heart 
disease, strokes, cancers and some chronic respiratory disease .The NCD rates are high 
and markedly amplified because many, if not most, adults 30–60 years ago were born to 
relatively poorly fed mothers and frequently experience mild to moderate malnutrition in 
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childhood. It is now recognised that malnourished children are highly susceptible to 
NCDs when confronted with a high fat, sugar and salty diet in later life. As a result, the 
adult Omani population already displays greater rates of abdominal obesity and its 
associated NCDs, particularly diabetes, than adults in Western Europe. Therefore, a 
much more incisive and radical public health approach is needed to produce a better 
environment conducive to routine physical activity and higher quality food choices, and 
it is especially important to target earlier stages of school-aged children. 
In addition, behavioural disorders including attention deficit hyperactivity 
disorders (ADHD) are also on the rise. In a cross-sectional study of Omani school 
children, hyperactivity was found in 7.8% of boys (Al-Sharbati et al., 2008) and 5.1% 
girls (Al-Sharbati et al., 2004). Furthermore, a study on 5,409 Omani adolescents found 
17% (boys 14.7%, girls 19.4%) of them suffer from some sort of mild depressive 
symptoms (Afifi, 2006). The link between omega-3 fatty acids, mainly DHA and 
psychiatric disorder was proposed from several studies (Antalis et al., 2006, Burgess et 
al., 2000, Colquhoun and Bunday, 1981, Colter et al., 2008, Mitchell et al., 1987, 
Stevens et al., 1996); a similar link has been found with depression (Pottala et al., 2012).  
It has been suggested that increased long-chain omega-3 fatty acids intake might 
help pupils to study more effectively and potentially help to tackle ADHD and 
depression. In 2008, Aberg et al. (2009) reported a positive association between the 
number of times having fish meals per week at age 15 and cognitive performance 
measured 3 years later. Fish consumption of more than once per week compared to less 
than once per week was associated with higher Stanine scores in combined intelligence 
(0.58 units; 95% C.I. 0.39, 0.76), verbal (0.45; 0.27, 0.63) and visuospatial performance 
(0.50; C.I. 0.31, 0.69). The association between fish consumption and the three 
intelligence scores was the same in lowly and highly educated groups.  
 Despite growing interest in role of omega-3 fatty acid in human health and 
development worldwide, very little research has been carried out in Oman. Oman is a 
marine nation and fish has been a part of the traditional diet. Yet, more people are 
adapting a so-called “Western style diet” (high in sugar and fat) and fast food, making 
them vulnerable to chronic diseases such as obesity, diabetes and cardio-vascular 
disease. However, these are preventable diseases - through changes in diet and lifestyle - 
and this can be achieved by educating people. In order to establish guidelines and policy, 
it is important to carry out scientifically sound basic research which will provide 
informative data. Since no data is currently available on the omega-3 fatty acids status of 
62 
 
Omani school children, the current study, the first of its type to be conducted in Oman, 
was planned to fill this gap. 
A lot of studies have been conducted on the beneficial effects of omega-3 fatty 
acids in complicated and uncomplicated pregnancy, preterm and term babies (Martinez 
et al., 1993, Crawford et al., 2003), children with behavioural abnormalities acid (Richardson and Puri, 2002, Sinn and Bryan, 2007, Bloch and Qawasmi, 2011), adults with 
symptoms of mental health disorders (Gamoh et al., 1999, Hashimoto et al., 2002), adults 
with non-communicable chronic disorders (type 2 diabetes, hypertension and 
cardiovascular and cerebrovascular disease) (Shubair et al., 2005, Schulze et al., 2006, 
Norris et al., 2007, He and Daviglus, 2005). In contrast, there is a paucity of studies on 
the beneficial impact of omega-3 fatty acids in healthy school children. Indeed, because 
of the scarcity of data in this age group, the International Society for the Study of Lipids 
and Fatty Acids in its 9th Congress which was held in Maastricht (The Netherlands) in 
2010 has called for more research in healthy children. The proposed investigation, which 
we believe is the first of its kind in the Middle East, will contribute significantly to 
knowledge because it is well-powered, involves homogenous groups of children and 
compares efficacy of fish and capsule-derived omega-3 fatty acids. 
There is very limited published data on the nutritional status, body composition, 
blood lipids, fat-soluble vitamins, red blood cell fatty acid profile and behavioural status 
of Omani school children. Moreover, the effect of regular fish consumption or fish oil 
supplementation on red blood cell omega 3 fatty acid index have never been investigated 
for this population. Therefore, the current study was necessary to generate original data 
which could be vital for nutritional and health policy and management in Oman.  
There is little knowledge - and certain discrepancies - in the literature regarding 
the possible impact of fish consumption on health, especially as it is applicable to Oman. 
There has been no research designed to investigate the effect of the fatty acid profile of 
local Omani fish, nor the effect of Omani marine foods on local population health. Thus, 
this study aims to examine local fish consumption and fatty acids supplementation 
impact on school children’s nutritional status and biochemical parameters. The results of 
this study will contribute to the promotion of healthy school feeding and a 
reconsideration of the relevance of Omani Fish products. 
In the short term, this intervention will establish whether the consumption of fish 
has a beneficial effect on the health of school children. If positive effects of fish on the 
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children’s health parameters are found, then guidelines may be developed in conjunction 
with the Ministry of Health and Ministry of Education to encourage increased 
consumption of fish and/or fish oils in the population’s diet. 
 
1.7.1 Hypotheses 
• Healthy Oman school children do not have nutritional deficiency, blood lipid 
disorder or abnormal body composition. 
• Healthy Omani school children display no behavioural abnormalities in the 
classroom that would be classified as evidence of ADHD 
• Healthy Omani school children have normal plasma vitamin A, D , E, and B- 
carotene concentrations, and these levels are not influenced by omega 3 fatty acid 
supplementation  
• Healthy Omani school children have an optimal level of red blood cell omega 3 fatty 
acid, and this level does not change by increased oily fish consumption or with fish 
oil supplementation. 
The genesis of NCDs starts from the uterine stage if the pregnant mother is underfed: 
undernutrition at early life determines disease in later life (Barker, 1995b). Numerous 
animal experiments have shown that undernutrition in utero leads to persisting changes 
in blood pressure, cholesterol metabolism, insulin response to glucose, and a range of 
other metabolic, endocrine and immune functions (Barker, 1998, Lucas, 1994). An 
undernourished foetus consumes its own substrates to provide energy (Harding and 
Johnston, 1995), whereas prolonged undernutrition slows growth, resulting in 
disproportionate organ size since organs and tissues grow rapidly at this stage. 
Undernutrition in late gestation may reduce the growth of the kidney which develops 
rapidly at that time (Hinchliffe et al., 1992, Widdowson et al., 1974). Likewise, foetal 
insulin, IGF and glucose concentrations fall, probably the effect of decreased maternal 
IGF in an under nourished mother. This leads to reduced transfer of amino acids and 
glucose from mother to foetus, and eventually reduced rates of foetal growth (Oliver et 
al., 1993). Foetal insulin and the insulin-like growth factors (IGFs) are thought to have a 
central role in the regulation of growth and respond rapidly to changes in foetal nutrition 
(Fowden, 1989), which leads to a rise in cortisol, which affects cell differentiation 
(Fowden, 1995).  
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Great progress has been made in preventing and managing communicable 
diseases worldwide. Risk factors such as high blood pressure, raised cholesterol, tobacco 
use, alcohol consumption, and overweight, coupled with poor economic and social 
conditions, create the perfect storm for many of the world’s chronic diseases. If left 
unchecked, NCDs will continue to reduce global productivity, threaten quality of life, 
and cost trillions of dollars. Thankfully, systematic efforts to prevent NCDs, and 
ameliorate their burden, have now become part of a global health strategy (World Health 
Organization, 2008). 
The development of atherosclerosis, which is an important risk factor in the 
development of cardiovascular disease, has also been found to begin in childhood and 
adolescence (McGill et al., 2000b), as do fatty streaks, although this progression is 
affected by several local mechanical forces on the blood vessel wall (Stary et al., 1994). 
As noted previously, these fatty streaks can become fibrous plaque as lipids accumulate 
into the streak. The fibrous plaque can then rupture, which causes thrombosis and 
cardiovascular disease or mortality. It has been found that all children have aortic fatty 
streaks, although fatty streaks themselves are not a clinical event (Holman et al., 1958b). 
McGill et al. (2008b) have argued that no level of risk factor control in adults will 
contribute to a 90% overall eradication of coronary heart disease, and this may be 
possible only by managing risk factors from childhood. Tejada et al. (1968) showed that 
the fatty streaks that developed in childhood became fibrous plaques and complicated 
lesions during the third and fourth decades of life. Another issue that is of particular 
importance to NCD risk factors in childhood is low birth weight. The Barker Hypothesis 
posits that children born with low birth-weight are at a greater risk for developing CHD 
(Barker and Osmond, 1986). More recent research has found that low birth-weight is a 
risk factor not only for CHD, but also for hypertension, increased insulin resistance, high 
fasting insulin levels and type 2 diabetes (Curhan et al., 1996a, Curhan et al., 1996b, 
Barker and Osmond, 1986). Researchers suggest this is due to ‘programming’ whereby a 
stimulus that occurs at critical developmental periods has permanent effects on the foetus 
throughout its postnatal life (De Boo and Harding, 2006).  
 
1.7.2 Aim of the study 
• To assess at baseline the omega-3 fatty acid, blood biochemistry and nutritional 
status of Omani school children and, whether supplementation of either fish or fish 
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oil capsules improves the omega-3 fatty acid status of children and their blood 
biochemistry. 
 
1.7.3 Specific objectives  
To test the above stated hypotheses:  
a) Macro- and micro-nutrient intake, body weight, height, body mass index, fat and 
muscle mass, fat-free mass, plasma triglycerides, plasma total cholesterol, LDL 
Cholesterol, HDL Cholesterol, blood pressure will be assessed. 
b) Behavioural abnormalities, specifically attention deficit hyperactivity disorder 
and its subtypes (predominantly inattentive, predominantly hyperactive/impulsive 
and/or ADHD combined inattention/hyperactivity) and associated risk factors 
such as birth weight, gestational age, parental consanguinity, age, educational 
level, occupation, income and will be examined.  
c) Plasma vitamin A, E and D and B- carotene concentrations will be determined 
before and after intervention with oily fish or docosahexaenoic acid enriched fish 
oil capsules for 12 weeks.  
d) Levels of red blood fatty acids, particularly omega-3 fatty acid index 
(docosahexaenoic and eicopentaenoic acids), will be analysed before and after 
intervention with oily fish or docosahexaenoic acid enriched fish oil capsules for 
12 weeks.  
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CHAPTER 2: 
Methods 
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2.1 Subjects and Recruitment  
2.1.1 Subjects and Sampling Strategy 
Study area: The study was carried out in Muscat Governorate, Sultanate of 
Oman. The data were collected in the period from December 2012 till May 2013. 
Target population: Male and female children aged 9-10 years in Grade 4. 
Sampling frame: Following consultation with a statistician, a three stage sampling 
procedure was used to ensure representative samples of 9 and 10 year old children in 
Muscat Governorate. In the first stage, three (n=3) schools were randomly selected from 
the 39 schools in the Governorate. Next, the three schools were then randomly assigned 
to ‘Fish Meal’, ‘Omega-3 capsule’ or control group. Finally, in each of the selected 
schools, three classes of 9 and 10 year old children were randomly selected to receive the 
assigned intervention.  
The three schools randomly selected for participation in this study were Waha 
School, Mashareq School and Ula School, which were randomly assigned interventions 
as follows: 
• Students from Waha School were randomly assigned to receive the fish meal.  
• Students from Mashareq School received the omega-3 fish oil capsule.  
• The Ula School children did not receive fish meal or omega-3 fish oil 
capsule. 
Of the population of 6,855 children aged 9 and 10 enrolled in the 39 schools in the 
Muscat Governorate, 354 (5.2%) were included in the study. 
 
Figure 2-1: Subjects and Methodological Framework 
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2.1.2 Sample Size Calculation 
Since there is no established data on the blood (red cell or plasma) fatty acids of Omani 
children, our calculation uses the red cell DHA of UK children which is 2.0±0.70 
(Matsudaira, 2010, Gow, 2012). We anticipate that: 
• The consumption of fish or the provision of omega-3 fatty acid capsules four 
times a week for 12 weeks will enhance the DHA status of the children. 
• The increase will vary due to absorption and metabolic differences between 
individual children. 
• The mean DHA values of both groups (omega-3 supplement and fish meals) to 
increase to 2.4±0.70. 
Based on these expectations, the sample size required to detect the increase with 80% 
power and a 95% (two-sided) confidence interval is forty-nine (n=49). However, since 
there is an indication that boys and girls metabolise fatty acids differently, it was 
necessary to enrol 49 boys and 49 girls. This raised the total number of children required 
to assess the effect of fish feeding on DHA status to ninety-eight (n=98). Similarly, 
another 49 boys and 49 girls (n=98) was required to test the efficacy of the omega-3 fatty 
acid capsules on the DHA status of the school children. With the addition of another 49 
boys and 49 girls for the control group, the total required sample size was 294. 
The research literature indicates that the rate of compliance of school children in 
nutritional studies is low. There is also evidence that some children may develop a strong 
aversion to fish after a few weeks of exposure to fishy foods. To compensate for these 
possibilities, we increased the number of subjects by 20% (n=60). Hence, the total 
number of children needed for the study was raised to three hundred and fifty four 
(n=354).  
• Inclusion criteria: Male and female children aged 9-10 years who do not have 
any known hereditary or chronic medical conditions. 
• Exclusion criteria: Children with a known hereditary or chronic medical 
condition that requires medication or who suffer from a fish or shell fish allergy. 
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2.2 Ethical Approval and Consent 
Ethical approval was obtained from the Ministry of Health of Oman (Ref. 
MH/DGP/R&S/Proposal_Approved/8/2012) (Appendix 4), UK National Health Service 
Ethics Committee and London Metropolitan University Ethics Committee. 
A written informed consent was obtained from the parents or guardians of all the 
children who participated in the study. Participating children and their parents were also 
assured that withdrawal at any stage of the study was permissible and would not carry 
any negative consequence. The consent forms explained the details of the study, as 
directed by the Ethical Committee of the Ministry of Health in Oman (see Annex 3). 
Each eligible and willing child was then invited by the author and school nurse to the 
school's clinic – to be accompanied by at least one parent – where the author explained 
the study in more detail, including the mode and duration of the intervention. A thorough 
history and clinical examination, for the collection of baseline measurements, were also 
made at this time (see Annex 4).  
 
2.3 Intervention  
Fish or fish oil capsule was given to the children at lunch time in school. 
1. Fish lunch: Fish were selected from the local markets depending upon their 
availability and popularity among Omanis, such as Emperor, Grouper, King Fish, 
Red Snapper and Yellowfin Tuna. Fish meals were prepared by various methods, 
either grilled or steamed to enhance compliance and were provided to the pupils 
at school once daily (mid-day break) four days a week for 3 months (12 weeks). 
Food was prepared by one of the selected caterers in Muscat and in accordance 
with the Muscat Municipality or Consumer Protection Agency regulations and 
HACCP standards. Each serving consisted of 100-150g of fish. This amount was 
estimated to provide 200-250 mg omega-3 fatty acids, depending on the species 
of fish. 
2. Omega-3 oil capsule: One omega-3 oil capsule containing 200-250mg omega-3 
fatty acid (docosahexaenoic acid) was given to the school children once daily, 
four days a week for 12 weeks. 
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2.3.1 Determination of DHA Content in the Fish 
Fish were selected from the local markets depending upon their availability and 
popularity among Omanis. The quantity of DHA in the fish was then determined in order 
to select fish best suited for the study. These were Emperor, Red Sea Bream, Striped 
Bonito, Grouper, Mackerel, Sardine, King Fish and Long Tail Tuna, which are all 
commonly found in local markets and consumed in Oman.  
 
Figure 2-2: Quantity of DHA (mg) in 100 gram of uncooked fish  
with and without skin 
The concentration of DHA ranged between 135 mg and 572 mg per 100 grams of 
uncooked fish without skin (Figure 2-3). Of the eight fish analysed, the varieties found to 
contain the most significant levels of DHA were Striped Bonito, Mackerel, Long Tail 
Tuna and particularly King Fish. The amount of DHA in skinned fish (raw) was slightly 
higher than in un-skinned fish (raw), which suggests that eating fish with skin would 
provide more DHA.  
Similarly, 100 gram of grilled fish would provide 200–1200 mg of DHA 
depending on the type of fish, due to the loss of water (Figure 2-3).  
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Figure 2-3: Quantity of DHA (mg) in 100 gram of grilled fish with and without skin 
 
 
2.3.2 Preparation of the Fish Meals 
The fish were filleted and grilled with a minimal use of salt, cooking oil and other 
condiments. 100 mg of grilled fish fillet was used in each meal. Trial recipes were tested 
by fifty children from the three schools.  
Emperor 
 
Grouper 
 
King Fish 
 
Red Snapper 
 
Yellowfin 
Tuna 
 
Figure 2-4: Fish used in the study 
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2.3.3 Omega-3 Fish Oil Capsule 
The omega-3 fish oil capsules used for study were provided 
by Efamol Limited (14 The Mole Business Park, Leatherhead, 
Surrey KT22 7BA, UK). One capsule contained 403 mg of DHA 
and 53 mg of EPA.  
Company website: www.efamol.com 
2.4 Assessment of Habitual Diet, Blood Profile, Anthropometric and Body 
Composition, and Cognitive Function  
Before the intervention, baseline measures were assessed for dietary intake, body 
composition, cognitive, and behavioural function of the participating children. In 
addition, fasting blood samples were obtained for various biochemical analyses.  
2.4.1 Habitual Diet 
A food frequency questionnaire and a 24-hour dietary recall was developed in 
close coordination with the Ministry of Health and London Metropolitan University to 
measure fish consumption and other food items commonly used in the Omani diet. 
Children or their parents were asked to recall detailed information about everything they 
had to eat and drink over the past 24-hour period. Quantities consumed were estimated 
using calibrated cups and other standard units of weight or volume (e.g., 1 apple, a 
packet of biscuits, a can of soda). Questionnaires were completed during work days to 
avoid including data from the weekends. The Food Processor software version 10.2 
(ESHA Research, Salem, OR, USA) was used to calculate the means of daily nutrient 
intakes (carbohydrates, protein, fats and total energy intake).  
2.4.2 Anthropometric and Body Composition 
Measurements of weight, height, waist circumference and percentage body fat 
were taken by the author and two dieticians from the Ministry of Health. The standard 
operating procedure of the Ministry of Health was followed for all measurements.  
Weight was measured to the nearest 100g using a UNISCALE, with the subject 
in light clothing without shoes. Height was measured using Shorr measuring boards 
(C.M.S. Weighing Equipments Ltd. London). The subject was measured with socks and 
shoes removed, standing upright with feet together in the centre of the base plate.  
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Height (m) was measured to the nearest 0.1 cm. Values of weight and height 
were then used to calculate BMI (Kg/m2) values. BMI z-scores were extracted using 
BMI, decimal age, and gender, allowing for a comparison of BMI with WHO's 2007 
standard (overweight: z score >1 SD, and obesity : z-score >2 SD) (de Onis et al., 2007). 
Waist circumference was measured using a flexible, inelastic tape measure on the 
horizontal plane 4 cm above the umbilicus with the abdominal muscle relaxed and the 
subject breathing shallowly (Rudolf et al., 2007). Waist circumference is a measurement 
of central fat mass which contributes to the development of impaired lipid profile, high 
blood pressure, and metabolic complications (Reilly et al., 2010, Reilly and Kelly, 2010, 
McCarthy et al., 2005).  
Skin-fold thickness was measured in triplicate at the left side of the body to the 
nearest 0.1 mm with Harpenden skin-fold calliper.  
Body composition (fat-, muscle-, and bone-mass) was measured by using a Body 
Composition Analyser (Tanita, SC-331S) with subjects in light clothing without shoes.  
2.4.3 Socio-Demographic Characteristics 
Socio-demographic characteristics including age, gender, residential status, 
medical family history, vitamins or nutritional supplements, monthly income, parental 
occupation, and parental educational level were collected during personal interviews 
with the children’s parent. In addition, birth weight, length, gestational age and medical 
history for all enrolled children were compiled from their health cards. 
2.5 Collection of Biological Samples  
For each school, the nearest Primary Health Centre or Polyclinic was identified as 
responsible for sample processing.  
2.5.1 Blood sampling  
The author was responsible for collecting all blood samples, and also responsible 
for ensuring their proper transport to the processing laboratory within 2-3 hours. The 
supplies needed for field collection of biological specimens were assembled and 
prepared in advance. For each field day, a total of 23-25 kits were prepared in advance. 
School children of 9-10 years of age (grade 4) were asked to come after fasting 
overnight (about 10 hours). 
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A paediatric tourniquet was applied and a vacutainer device was used to collect 
about 17 ml blood from each student: 5 ml on a 5ml red capped plain gel-separating tube, 
and 12 ml whole anti-coagulated blood divided in 3 EDTA tubes (purple-capped) each 
having 4 ml blood. The EDTA blood was immediately mixed by repeated inversion to 
prevent clotting by mixture with the anticoagulant; blood in the plain tube was left to clot 
for about 10 minutes, then centrifuged for 5 min at a speed of 3,000 rpm until the gel 
separated the serum (above) from the clotted blood (below). 
The data for each student was entered into the computer system including Full 
name, age, date of birth, sex, nationality, and any relevant past medical history. Blood 
samples of each student were labelled with a sticker that included all relevant personal 
data and then put into a single collection bag.  
All collection bags for blood were then placed in an envelope which was then put 
in a cool box with an ice pack and immediately delivered to Royal Hospital Lab for 
further processing. 
The blood collection took place on a clean absorbent pad, and standard laboratory 
safety and hygiene procedures were followed. The blood was collected and transferred 
into vacutainer tubes and immediately labelled.  
2.5.2 Transport and Storage of Samples 
To ensure the proper transport of human biological products, the following cold 
chain was maintained (Table 2-1): 
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Table 2-1: Cold Chain to ensure the proper transport of human biological products 
 Venues in the Cold Chain 
 Polyclinic/ 
Health Centre Vehicle 
Royal 
Hospital Laboratories 
Shipment via 
DHL 
Procedures Blood 
drawing; 
centrifuge to 
separate serum 
Storage until 
shipped to Lab 
Transport to 
Royal 
Hospital 
 Analyses Some 
samples sent 
to London 
Metropolitan 
University 
Laboratory 
Packaging Cool boxes or 
Styrofoam, 
with frozen 
cool packs 
Styrofoam 
boxes with 
frozen cool 
packs 
Freezer Freezers Cool boxes 
and dry ice 
Temp. Less or equal 
to 10°C 
Less than or 
equal to 10°C 
-20°C to-
40°C 
-20 to -40°C Less than or 
equal 
to -20°C 
Duration 2-3 hours 20 minutes 3 months Until all 
analyses 
completed 
24-48 hours 
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2.5.3 The Royal Hospital Laboratories 
 The blood samples were processed at the Royal Hospital laboratories as follows 
(Table 2-2) by the author who was supervised by a specialised lab technician : 
 
 
 
 
 
Table 2-2: Procedure for Blood Sample Processing 
 Procedure for Separating Red Blood Cells and Plasma 
Step 1 Spin whole blood as follows; 
 Speed:  1500 g 
 Duration: 10 min 
 Temp.:  4°C 
Step 2 Transfer 1.0 ml supernatant (Plasma) into 1.5 ml (or 2 ml) Eppendorf tubes 
(labelled). Prepare as many aliquots as possible without discarding any 
sample.  
Step 3 Add equal volume of normal saline (0.9%) into the remaining red blood 
cells and repeat STEP 1. 
Step 4 Discard supernatant and repeat STEP 3.  
Step 5 Discard supernatant and then transfer 1.0ml of red blood cells into 1.5 ml 
(or 2 ml) Eppendorf tubes (labelled). Prepare as many aliquots as possible 
without discarding any sample.  
Step 6 Store the samples at -20°C freezer until transport to London Metropolitan 
University (UK). 
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2.5.4 Blood Lipid Profile and Vitamins 
A validated method approved by the Ministry of Health was used to determine 
triacylglycerol, total-, HDL, LDL and VLDL-cholesterol, and vitamin D. The analysis 
was carried out at the Royal Hospital. 
Plasma vitamin A and vitamin E and beta carotene analyses – An aliquot of 
200 μL of plasma in duplicate was used for analysis. The plasma was deproteinised with 
4 ml of absolute ethanol and vortexing thoroughly for three minutes. Subsequently, 10 
ml of hexane was added to the plasma-ethanol mixture, vortexed for three minutes and 
then centrifuged at 1200 g, 4ºC, for ten minutes. The top organic layer containing the 
required analytes was carefully transferred to another tube, dried at 30º C under a gentle 
stream of nitrogen, suspended in 1000 μL of methanol containing 0.01% butylated 
hydroxytoluene. An aliquot of 50 μL was then taken for analysis. The target analytes 
(retinol, alpha-tocopherol and beta-carotene) were separated by an Agilent 1100 high 
performance liquid chromatography (HPLC) system (Agilent Technologies, Waldbronn, 
Germany) with the use of a 5 micron C18 reverse-phase column, 150 X 4.6 mm 
(HiChrom Limited UK). The analytes were eluted with 100% HPLC grade methanol at a 
flow rate of 2 ml/min and detected with a diode array UV/Vis detector (Agilent 
Technologies, Waldbronn, Germany). Vitamin A, vitamin E and beta-carotene were 
detected at 325 nm (1.5 min), 292 nm (4.8 min) and 453 nm (30 min). Concentrations 
were determined from a standard curve computed with the use of ChemStation (Agilent 
Technologies, Waldbronn, Germany).  
Plasma triglycerides – Concentration of plasma triglycerides was determined 
enzymatically (Glycerol phosphate oxidase assay ) based on the method described by 
Fossati and Prencipe (1982) and McGowan et al. (1983) with the use of a reagent kit 
supplied by Abbot Laboratories (Ref: 7D74-21, 304350/R1, Abbott, Max-Planck-Ring 2, 
65205 Wiesbaden, Germany).  
Plasma cholesterol – The enzymatic method (cholesterol esterase-cholesterol 
oxidase-eroxidase) described by Roeschlau and Allain (Roeschlau et al., 1974, Allain et 
al., 1974) with a reagent kit obtained from Abbott Laboratories (Ref: 7D62-21, 
304342/R1, Abbott, Max-Planck-Ring 2, 65205 Wiesbaden, Germany) was used to 
analyse total cholesterol.  
Vitamin D (25-hydroxy vitamin D) - Plasma total vitamin D, 25-hydroxylated 
cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2) was determined with a 
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competitive electrochemiluminescence (ecl) protein binding assay (Abdel-Wareth et al., 
2013) using the Cobas e 601 immunoassay auto-analyser and reagents obtained from 
Roche Diagnostics (Sandhoferstrasse, Mannheim, Germany).  
Parathyroid Hormone (PTH) – Intact plasma PTH was quantified by Architect 
Intact PTH assay, a two-step chemiluminescent microparticle immunoassay (cmia) using 
the automatic immunoassay analyser ARCHITECT i2000SR (Abbott, Abbott Park, IL, 
USA) and reagents from Abbott Diagnostics (Ref: 8K25, 84-6434/R5, Abbott, Max-
Planck-Ring 2, 65205 Wiesbaden, Germany). 
Alkaline Phosphatase (ALP) – ALP was measured on an Architect c8000 
analyser (Abbot Diagnostics, Abbot Park, Il, USA) with a reagent kit supplied by Abbott 
Diagnostics (Ref: 7D61-20, 30-3979/RS, Abbott, Max-Planck-Ring 2, 65205 Wiesbaden, 
Germany). 
Calcium - Plasma total calcium was determined with the use of an Architect 
c8000 analyser (Abbot Diagnostics, Abbot Park, Il, USA) with the Arsenazo III dye 
binding method and a reagent kit from Abbott Diagnostics (Ref: 7D61-20, 30-3979/RS, 
Abbott, Max-Planck-Ring 2, 65205 Wiesbaden, Germany). 
Phosphate – Plasma inorganic phosphate was analysed based on the 
Molybdenum blue colorimetric method with a reagent kit obtained from Abbott 
Laboratories (Ref: 7D71-20 and 7D71-30, 30-3926//R5, Abbott, Max-Planck-Ring 2, 
65205 Wiesbaden, Germany) using the ARCHITECT c8000 auto-analyser (Abbott, 
Abbot Park, IL. USA). 
2.5.5 Red Blood Cell Fatty Acid 
Blood samples were separated into plasma and red blood cells by cold (4°C) 
centrifugation at 1500g for 10 min. After removing supernatant (plasma) to a 1.5 ml 
eppendorf tube, the remaining red cells were washed with saline (0.9%) twice and 
transferred to another tube. This initial stage of sample preparation was carried out at the 
Royal Hospital, Oman. The prepared plasma and red blood cells were then transported to 
the LNRC laboratory and kept in a -70°C freezer until analysis. 
For the analysis at LNRC, the total red cell lipid was extracted by the method of 
Folch et al. (1957a) and fatty acid methyl esters were separated using a gas-liquid 
chromatograph (HRGC MEGA 2 Series; Fisons Instruments, Milan, Italy) fitted with a 
BP20 capillary column (25m x 0.32 mm i.d., 0.25μm film). Hydrogen was used as a 
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carrier gas and the injector, oven, and detector temperatures were maintained at 250, 200, 
and 280°C, respectively. The fatty acid methyl esters were identified by comparing 
retention time with authentic standards. Peak areas were quantified by a computer 
chromatography data system (EZChrom Chromatography Data System; Scientific 
Software, Inc., San Ramon, CA). 
2.6 Cognitive, Emotional, and Behavioural Assessment Methods 
2.6.1 The Vanderbilt Test 
An Arabic version of the National Initiative for Children’s Health Quality 
Vanderbilt Assessment Scales-Teacher Assessment Scale (NICHQ Vanderbilt 
Assessment Scales) was used (American Academy of Pediatrics, 2008, Pliszka and 
AACAP Work Group on Quality Issues, 2007). The Teacher Assessment Scale of the 
NICHQ Vanderbilt Assessment Scales has 55 questions divided into two sections 
soliciting information about ‘symptoms’ and ‘performance’. The SYMPTOMS section 
contains 47 items divided into various sub-sections: items 1-18 tap into the symptoms of 
ADHD, items 19-26 tap into symptoms of oppositional defiant disorder, items 27-40 
quantify the presence of Oppositional-Defiant/Conduct disorders and items 41-47 solicit 
the presence of Anxiety/Depression. Symptoms scales are rated as follows: never = 0, 
occasionally = 1, often = 2, very often = 3. The teacher is instructed to circle only one of 
the numbers on the scale. 
The PERFORMANCE section measures the level of impairment regarding 
Academic Performance (reading, mathematics and written expression) and Classroom 
Behavioural Performance (relationships with peers, following directions/rules, disrupting 
class, assignment completion and organizational skills). Performance scales are rated as: 
excellent = 1, above average = 2, average = 3, somewhat of a problem = 4, 
problematic = 5. The formula for  scoring NICHQ Vanderbilt Assessment Scales has 
been detailed elsewhere (Wamithi et al., 2015). 
The following symptoms were the focus of the present study:  the predominantly 
inattentive subtype of ADHD (PIS), Predominantly Hyperactive/Impulsive subtype 
(PHIS), ADHD Combined Inattention/Hyperactivity (ADHDCIH), Oppositional-
Defiant/Conduct Disorders and Anxiety/Depression. The research team explained to 
teachers how to complete the NICHQ Vanderbilt Assessment Scales, and were explicitly 
instructed to base their answers in reference to the child’s behaviour over a six month 
period (see Appendix 2). 
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2.7 Quality Assurance Methods and Procedures  To ensure the quality of the data and resulting analysis, the data were checked 
during the process of data collection; during the data entry phase, a double entry 
verification process was followed; and once entered, the data were managed and cleaned 
by the author. The questionnaires were validated during the pilot phase of this research. 
2.7.1 Quality Assurance and Data Management after the data analysis 
To ensure the quality of data collection, team members were provided with the 
field manual, and were advised to follow it strictly. The field supervisor of each team 
was responsible for reviewing the questionnaires immediately after the interview in the 
school. All questionnaires were checked for consistency and accuracy by the author.  
Data entry files that included consistency checks were prepared on EPI6, and the 
data of all questionnaires were entered twice by two separate data entry personnel. The 
duplicate files were run on the validate module of EPI6 software and the errors as well as 
the missing values were corrected by referring back to the hardcopy questionnaires. 
The frequencies and cross tabulations of all relevant variables were then run, in 
order to detect any inconsistencies and corrected from the initial interview 
questionnaires. 
2.8 Data Analyses 
All statistical analyses were performed using SPSSS version 21 by the author 
with assistance of a statistician. Data were checked for normality, and all data were 
expressed as “mean and standard deviation” or “median and range”.  
Continuous variable data collected at baseline and at the end of the intervention 
period (for all three groups: Fish meal, Omega 3 and Control) were evaluated using 
analysis of variance (ANOVA) followed by a post hoc analysis. Chi-square (χ2) tests was 
used for comparing categorical variables, while non-parametric variables was assessed 
with the Kruskal-Wallis test or Fisher’s exact test. P < 0.05 was used as a measure of 
statistical significance. 
Intervention effects was investigated with the Analysis of Covariance Model 
(ANCOVA). Associations between red blood cell DHA and the other assessed 
(measured) variables including cognitive function and learning scores will be evaluated 
using Pearson or Spearman correlations, depending on the normality of the variables. 
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Variable that are not normally distributed was transformed before statistical analysis is 
undertaken, and corrections will be made for multiple testing except when it is 
inappropriate to do so. The analyses was conducted on intention-to-treat basis and 
multiple imputation was used to correct for missing data.  
The data are expressed as mean and standard deviation (S.D.). Independent 
(unpaired) and paired t-tests, respectively, were used to determine statistical significance 
between the genders at baseline and between pre- and post-intervention within gender. 
Group comparison was performed with a one-way ANOVA, and Boneferroni post hoc 
test when a significant difference is indicated. Differences were considered significant if 
the p value was less than 0.05. All analyses were carried out with SPSS version 21 (IBM 
SPSS, IBM Corporation, Armonk, NY, USA). 
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CHAPTER 3:  
Dietary Intake and Body 
Composition of Preadolescent 
Children in Oman  
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3.1 Introduction 
Over the last four decades, the Gulf Countries have undergone a drastic socio-
economic transformation. In Oman, the per-capita GDP rose 30-fold between 1970 and 
2005, from 158 Omani Rials (OMR) to 4,712 OMR, bringing with it all the promises of 
modern civilization. This 35-year span marked a period of remarkable growth and 
changes in Omani society accompanied by transitions in demography, epidemiology, and 
nutrition. 
The demographic changes have been profound. The population more than 
quadrupled, increasing from 732,000 in 1970 to 3.2 million in 2013. During the same 
period, the Total Fertility Rate (by UN Estimates) dropped from 7.41 to 2.52, while life 
expectancy at birth rose from 51 years in 1970 to 73 years in 2011. These massive 
changes were due in large part to a significant reduction in the mortality rates of under 
five year old children (U5MR) from 48 deaths of under-five year olds per 1000 live 
births in 1990, to 22 in 2000, and 9 in 2011. Predictably, with this change in life 
expectancy, the demographic profile of Oman has changed, as well: in 1970, 46.4% of 
the population was under the age of 15 years; in 2010 only 27.2% was in this young age 
group. 
This dramatic shift has led to the emergence of a double burden of disease: 
diarrheal disease, maternal complications, and several communicable diseases still 
remain a problem, but cardiovascular disease, hypertension, diabetes, cancers and 
chronic kidney disease are all on the rise. The burden of non-communicable diseases has 
now become quite substantial as shown in Figure 3-1: among the most affluent Arab 
Countries, Oman has the second highest disease burden and a significant problem with 
diabetes. Infectious diseases are no longer dominant. Increasingly, chronic NCDs 
characterize Oman’s major health problems as the population now lives long enough to 
contract them (Rahim et al., 2014a). 
The double burden of disease that characterizes this epidemiological transition is 
mirrored in the double burden of malnutrition that is key to the nutritional transition: 
during this period of development, evidence of undernutrition (in the form of stunting, 
underweight, wasting or micronutrient deficiency) now coexists with measures of over-
nutrition (in the form of overweight or obesity). 
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Figure 3-1: Death Rates from NCDs in Arab Countries 
In other words, the drastic socio-economic changes, accompanied by rapid 
urbanization, have also witnessed an increase in a sedentary lifestyle and the adoption of 
a Western diet. Regrettably, this pattern of physical inactivity and the adoption of a 
Western diet, and perhaps genetic susceptibility, is in large part responsible for the 
exponential increase in the prevalence of non-communicable diseases (NCDs), such as 
coronary heart disease, stroke and type-2 diabetes in adults, as well as obesity in 
children, adolescents and adults (Rahim et al., 2014a, Kilpi et al., 2014, Al-Lawati et al., 
2012). Consistent with the aforementioned reports, a comprehensive Oman-wide 
community household survey conducted in 2008 (Al Riyami et al., 2012) found a 
prevalence of 40.3% hypertension, 12.3% diabetes, 21.4% obesity and 33.6% elevated 
blood cholesterol. 
The factors behind the rapid globalisation of the Western diet are diverse and 
complex (Pingali, 2007). However, in the case of Oman, the liberalisation of food 
imports from developed countries to meet the rising demand associated with the 
spectacular increase in income and wealth, the proliferation of hypermarkets and fast 
food restaurants, creative food product marketing and promotional strategies, and a 
general lack of awareness of the health problems associated with a high calorie density 
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with elevated levels of saturated fats and refined sugars seems to have contributed 
significantly to the widespread consumption of Western foods. Although a 
comprehensive study has not yet been conducted to evaluate the frequency of fast food 
consumption by Omani children and adolescents, anecdotal evidence and casual 
observations and consistent with the reports from other parts of the Arab world and other 
countries (Musaiger, 1987a, Chakar and Salameh, 2006, Al-Hazzaa et al., 2011, 
Musaiger et al., 2011a, Allafi et al., 2014, Al-Haifi et al., 2013). Pingali (2007) suggests 
that fast food meals are more popular among younger age groups than in adults, and 
there is evidence that childhood dietary habits persist into adult life (Mikkilä et al., 2004, 
Ventura and Worobey, 2013b); furthermore, non-communicable chronic diseases have 
also been demonstrated to originate in early life (Holman, 1961, McNamara et al., 1971, 
Newman et al., 1986, Barker, 1995a, McGill et al., 2009a). 
The typical Western diet is composed of calorie dense foods that are high in 
glycaemic index carbohydrates, total fat and saturated, trans- and omega-6 fatty acids, 
and low in omega-3 fatty acids and essential vitamins and trace elements (Cordain et al., 
2005a, Hintze et al., 2012, Myles, 2014, USDA, 2002). Hence, the propensity of Omani 
children to develop Western food habits should be of concern due to the potential 
negative impact of such habits should be of concern due to the potential negative impact 
of such foods on growth and development, cognitive ability and behavioural competence 
(Nyaradi et al., 2013, Nyaradi et al., 2014) and the manifestation of NCDs in later life 
(Popkin, 2006, Cordain et al., 2005a, Moghaddam et al., 2007, Misra et al., 2010, 
Carrera-Bastos et al., 2011b). Numerous studies have also assessed the relationship 
between energy and nutrient intake and adiposity in children (Jennings et al., 2012, 
Kovalskys et al., 2013, Campbell et al., 2006, Walton et al., 2015, Tsiountsioura et al., 
2014, Maffeis et al., 2000); a number of such studies have also been conducted in the 
region (bin Zaal et al., 2009, Musaiger et al., 2011a, Washi and Ageib, 2010). 
Until recently, the focus of nutritional research in Oman has been the prevention 
of maternal and infant undernutrition, malnutrition and the deficiency of nutrients - such 
as protein, calcium, iron vitamin A, iodine and folate - which were once prevalent in the 
Country. As such, there are no comprehensive published data pertaining to the critical 
role of a balanced diet for optimal cognitive, emotional and physical growth of children 
and the prevention of NCDs in adults. Also, there is no comprehensive data assessed the 
dietary habits and intake of the pre-school children. As such, the current study was 
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conducted to assess the dietary intake, body composition and blood lipid profile of 
preadolescent children. 
 
3.2 The Current Nutritional Situation in Oman  
Oman has experienced remarkable improvements in health and nutrition 
indicators, especially for women and children, such that WHO ranked it among the top 
10 member countries in its 2000 World Health Report (WHO, 2000). UNICEF has also 
reported on the significance of Oman’s progress, noting that the under-five mortality rate 
(U5MR) has decreased from 48 (1990), to 22 (2000) and 9 (2011), representing a 
reduction of 82% since 1990 and 60% since 2000. The progress marked by these 
indicators are matched by a rise in life expectancy rates from 51 years (1970) to 76 years 
(2012) (Ministry of Health, 2012). Despite these signs of remarkable progress, however, 
there are other markers that suggest that these improvements are far from uniform or 
complete. Rates of anaemia illustrate this, although reportedly only in a mild form: 
42.7% in pregnant women, 34% in non-pregnant women, and 50.5% in preschool 
children (DoN-DGHA, 2009). 
In light of the radical and abrupt demographic and nutritional transitions in Oman 
during the past thirty-five years, and these measures of uneven progress, it is especially 
important to maintain an up-to-date and comprehensive portrait of the population’s 
current nutritional status, particularly as it relates to the increased disease burden 
associated with NCDs. The following provides an overview of the most important 
features of such a portrait. 
Monitoring of malnutrition among Omani school children was first initiated in 
2002 (Abdou et al., 2010). Since then, students in Grades 1, 7 and 10 have been screened 
as part of the annual school health examination. The proportion of underweight children 
in grade 1 has shown a steady decline from 16.5% in 2002 to 10.8% in 2007, which is 
consistent with data from health centres for younger children (ages 0-5 years old). The 
proportion of underweight children in grade 7 follows the same pattern. Adolescents in 
grade 10 seem to have less underweight children, although there was also a counter-trend 
towards an increasing proportion of students who are overweight or obese (Abdou et al., 
2010). 
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3.2.1 Non-Communicable Diseases (NCDs) 
The same conditions of an improved socio-economic status, and accompanying 
changes in lifestyle to a more sedentary existence, the importation of high caloric density 
processed foods, an urban environment with poor access to parks or other areas for 
exercise that contribute to a lack of physical activity, etc., are conditions found in many 
of the Arab countries, particularly member states of the Gulf Cooperation Council 
(UNICEF, 2010). The recent Lancet series on the health of Arab countries places Oman 
as second only to the United Arab Emirates in deaths from non-communicable diseases. 
The planning section of the Ministry of Health has produced evidence which 
confirms that Oman now has one of the highest rates of death from cardiac disease 
among the more affluent Middle East countries, and indeed the world. This problem is 
predicted to escalate along with an increase in diabetes and other co-morbidities of the 
metabolic syndrome (Mokdad et al., 2014). Cancer rates are also predicted to increase, as 
highlighted by the International Agency in their report for World Cancer Day (Falkner et 
al., 1994). In addition, the societal burden associated with NCDs will continue to grow as 
the demographic transition continues, and as life expectancy increases. Other countries 
facing similar trends have experienced a decline in work efficiency from absenteeism 
due to disease, while premature deaths from coronary heart disease and diabetes 
contribute to greater DALYs. This increasing trend is a major concern in Oman where 
cardiovascular diseases and cancer are the two leading causes of hospital deaths, totalling 
32.5% and 9.9%, respectively. The prevalence of diabetes among adults has increased by 
nearly 50% since 1991 and now stands at 12.3% (World Health Organization, 2011b). 
3.2.2 Physical Activity and Dietary Behaviours 
A large portion of NCDs are preventable through the reduction of four key 
behavioural risk factors, namely: unhealthy diet, physical inactivity, tobacco use, and 
alcohol abuse. The prevalence of the first three of these key risks is of primary concern. 
Nearly 70% (69.8%) of Omani adults eat less than 5 servings of fruit and vegetables per 
day and 40% are physically inactive; in addition, 14.7% of men smoke. Low daily fruit 
and vegetable intake and physical inactivity are also a concern for younger populations: 
75.3% and 84.3%, respectively, among 13-15 year-old students and 87.6% and 50%, 
respectively, among college students. In addition, tobacco use among male college 
students is higher than among men in general; 17.3% smoke cigarettes and 13.2% use 
shisha.  
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The Oman Global School Based Student Health Survey (2010) showed that 
41.6% of the sample usually ate fruit two or more times per day, while 17.9% usually ate 
vegetables three or more times per day. Nearly half of the sample ate breakfast most of 
the time, while nearly one half of students consumed carbonated soft drinks one or more 
times per day. Almost one quarter of surveyed students (24.1%) ate fast food. As for 
physical activity, 22.7% of the students in the sample were physically active five or more 
days per week for a total of 60 minutes. This behaviour was more predominant in males 
than females (Abdou et al., 2010). 
Along similar lines, a health survey of adolescents, conducted by the government 
in 2004, found that only 45% of 13-15 year olds had breakfast on a regular basis. 
Furthermore, the Global Health Survey (2004) identified a number of additional 
behaviours among this age group that could lead to overweight and obesity: the 
consumption of fast foods, sugary drinks, high consumption of crisps and carbonated 
drinks. The 2010 Global School-Health Student Survey reported similar findings: of the 
students included in the sample, 45.1% ate breakfast most of the time, with a significant 
difference between boys (55.8%) and girls (35.8%). The survey also found that 18.2% 
ate vegetables  three or more times a day (boys 19.6%; girls 16.5%), and 42% ate fruit 
two or more times a day (boys 46.6%, girls 38.5%) (Abdou et al., 2010). 
The Global School-Health Student Survey, in both 2005 and 2010, identified the 
importance of physical activity throughout the lifespan to maintain normal weight and to 
prevent the onset of chronic disease, also noting that habits formed in youth continue 
through to adulthood. In 2010, however, only 22.7% of all students were physically 
active for a total of at least 60 minutes per day on five or more days in a week. This 
represented a significant decrease from the survey’s 2005 results, where that measure 
was 75.5%. According to the same survey, girls (15.9%) were half as active as boys 
(29.0%). The survey also found that two-thirds of the students did not walk or ride a 
bicycle to school the previous week (Abdou et al., 2010). 
Preliminary results of a 2009 Knowledge, Attitudes and Practices (KAP) study 
conducted among students in Universities, College and Higher Institutes showed a 
noticeable gap between knowledge and behaviour related to diet: knowledge about the 
importance of breakfast, and about increasing the proportion of vegetables and fruits in 
the diet, was quite high, while behaviour consistent with that knowledge was very low. 
Furthermore, 45% of the sample mentioned eating fast food 3 or more days during the 
previous week and 66% ate fast food 1-2 times per day (MOH, 2009). The reasons 
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underlying this gap between knowledge and healthy dietary behaviour were as follows: 
lack of time (44%); unavailability of healthy food (32%); insufficient knowledge (31%); 
social pressure (27.6%); insufficient skills to buy and prepare healthy foods (24%); do 
not enjoy healthy food (19.2%) and high cost of health foods (17.8%). 
The same gap between knowledge and practice was found in regard to the 
importance of physical activity, with the percentage of females who demonstrated 
adequate levels of physical activity being half of that found in males. On the other hand, 
it was found that the percentage of students who walk was high (83.5%) when compared 
with the proportion that is sedentary for more than two hours a day (28.7%). The main 
challenges and difficulties for not practicing physical activity were: lack of time (53.5%), 
accessibility of places to practice (48.7%), weather conditions (46.8%) and social 
network support (34.2%).  
3.3 Methods and Analysis 
Sample: A total of 354 school children aged 9 and 10 in the Muscat Governorate 
were included in the study’s sample using a three-stage sampling procedure, and only 
222 of them were completed their dietary intake data.  
Measurements: baseline measures were assessed for dietary intake, body 
composition, and cognitive/behavioural function of the participating children. In 
addition, fasting blood samples were obtained for various biochemical analyses. Dietary 
intake was assessed using a food frequency and a 24-hour dietary recall questionnaire. 
Both the instrument and procedure is described in Chapter 2 section 2.4.1. The 
procedures used to assess and analyse the blood profile, anthropometric and body 
composition of students is described in Chapter 2 sections 2.4.2 - 2.7.1. 
Analysis: Continuous variable data collected at baseline and at the end of the 
intervention period (for all three groups) were evaluated using analysis of variance 
(ANOVA) followed by a post hoc analysis. Chi-square (χ2) tests were used for 
categorical variables, while non-parametric variables were assessed with the Kruskal-
Wallis test or Fisher’s exact test. Statistical significance was established using P < 0.05. 
The procedures used are described more fully in Chapter 2 section 2.8. 
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3.4 Research Findings  
3.4.1 Birth Characteristics of Children and their Families 
The foetal birth measures of the children and the socio-demographic 
characteristics of their parents are presented in Table 3-1. Of the total sample of children, 
11% were delivered by caesarean section and 3% and 1% of them were low birth weight 
and pre-term delivery children, respectively. Among these measures, there is no 
appreciable difference by gender, either clinically or epidemiologically. With respect to 
antenatal history of the mothers, 11% were diagnosed with gestational diabetes while 
0.6%, 7% and 5% were diagnosed with Type 2 Diabetes, hypertension and iron 
deficiency anaemia, respectively. In all, 70% of the mothers were absent of any illness 
during their antenatal period. 
On average, the children’s birth weight was 3.1 (±0.5) kg and their birth length 
was 50 (±5) cm. Of all the children, 58% had parents who were unrelated, 28% were of 
first degree consanguineous marriage, while the rest (15%) were of second degree 
consanguineous marriage. In terms of education, 42% of the mothers were high school 
graduates while 23% studied up to primary school; among the fathers, 55% were high 
school graduates and 16% studied up to primary school. In terms of employment, 55% of 
the mothers were housewives, while 29% and 10% worked in the public and private 
sectors, respectively. Among the fathers, 34% and 31% worked in the public and private 
sectors, respectively. Overall, 40% of the children were from low income families while 
20% were from high income families.  
3.4.2 Macronutrients 
Table 3-2 presents the mean (sd) of baseline daily macronutrient intake as 
compared to the daily recommended intake (DRI) (Institute of Medicine of the National 
Academies, 2005). In terms of daily caloric intake, both boys and girls fall below the 
DRI, although their intake levels remain within one standard deviation of the mean. The 
daily consumption of calories from fat, however, falls well below the recommended 
range of 25-35% of total recommended calories (550-750 Kcal), with a sample average 
of 389.5 ± 157.9. Daily Recommended Intake levels for unsaturated and saturated fats, 
trans fatty acid and other fats were not available for purposes of comparison. 
In contrast, data for the intake of protein and carbohydrates indicate that students 
in the sample consumed more than the minimal daily recommended levels. For protein, 
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the DRI is 136 Kcals, which is significantly lower than found in our study sample (231.0 
± 68.5). Similarly, the DRI for carbohydrates is 520 Kcals, which is also significantly 
lower than the level of daily carbohydrate intake found in our sample (790.4 ± 327.4). 
Total sugar intake was much lower than the recommended maximum, which should be 
no more than 25% of the total recommended number of calories consumed per day (540 
Kcal). In our sample, the mean intake of sugar was measured at 313.5 ± 197.0 Kcal. 
The most important measures for this study, however, relate to the intake of 
omega-3 and omega-6 fatty acids. The DRI for omega-3 fatty acids is between 108-207 
Kcal or 5-10% of total recommended calories consumed per day. In our study’s sample, 
the average daily intake of omega-3 fatty acids was 4.2 ± 0.2 Kcal. The DRI for omega-6 
fatty acids, on the other hand, is between 13-26 Kcal, or 0.6-1.2% of total calories, 
significantly lower than the recommended level. In our study’s sample, the average daily 
intake of omega-6 fatty acids was 27.0 ± 1.4 Kcal. In other words, the consumption of 
fatty acids by the students in our sample was more adequate for omega-6 than for omega-
3 fatty acids.  
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Table 3-1: Foetal birth dimension and parental socioeconomic characteristics 
    Male 
(86) 
Female 
(136) 
Total 
(222) 
     
Natal history (%) Caesarean Section 13 9 11 
Low Birth Weight 5 2 3 
Preterm Baby 0.00 2 1 
Normal 78 85 82 
Antenatal history (%) Gestational Diabetes 10 12 11 
Diabetes type 2 0.00 1.00 0.60 
Hypertension 12 4 7 
Iron Defeciency Anemia 5 5 5 
Other 5 8 7 
Normal 67 71 70 
Birth weight (kg)  3.1±0.5 3.1±0.5 3.1±0.5 
Birth length (cm)  50±5 50±5 50±5 
Consanguinity  (%) First degree 33 25 28 
Second degree 15 14 15 
No relationship 52 61 58 
Mother Education(%) Primary  27 20 23 
Secondary  29 39 35 
Graduate 44 41 42 
Father Education(%) Primary 16 16 16 
Secondary 34 26 29 
Graduate 50 58 55 
Mother Occupation (%) Public sector 31 27 29 
Private sector 12 8 10 
Military sector 1 4 3 
Freelancers 1 0.70 0.90 
Retired 0.00 4 3 
Housewife 55 55 55 
Father  Occupation (%) Public sector 30 36 34 
Private sector 37 27 31 
Military sector 17 19 18 
Freelancers 2 5 4 
Retired 11 11 11 
Do not work 2 3 3 
Family Income(%) Low Income 39 40 40 
Medium Income 44 38 40 
High Income 17 22 20 
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Table 3-2: Sample Mean (sd) of Macronutrient Intake 
and Recommended Daily Intake (DRI) 
 
Variables Mean ±  SD 
DRI 
(9- 13 Years) 
Calories (kcal) 1761.4 ± 401.5 (B) 1709.0 ± 380.4 (G) 
2279 (B*) 2071 (G*) 
Calories from Fat (kcal) 389.5 ± 157.9 550-750 Kcal (25- 35% of total) 
 Fat (Kcal) 315.3 ± 131.2 ND 
Saturated Fat (kcal) 129.0 ± 62.5 
As low as possible while 
consuming a nutritionally 
adequate diet 
Unsaturated Fat (Kcal) 184.6 ± 87.5 - 
Trans Fatty Acid (kcal) 1.8 ± 2.8 As low as possible 
Other Fat (Kcal) 4.3 ± 3.9 - 
Protein (kcal) 231.0 ± 68.5 136 
Carbohydrates (Kcal) 790.4 ± 327.4 520 
Total Sugars (Kcal) 313.5 ± 197.0 < 540 Kcal  (no more than 25% of total) 
Monosaccharides (Kcal) 20.5 ± 65.6 - 
Disaccharides (Kcal) 36.3 ± 34.2 - 
Other Carbs (Kcal) 420.1 ± 201.0 - 
Dietary Fiber (g) 19.6 ± 9.4 31(B), 26 (G) 
Soluble Fiber (g) 1.4 ± 1.3 - 
Cholesterol kcal  11.9 ± 0.6 As low as possible 
Poly fat kcal 78.3 ± 2.8  
Omega-3 Fatty Acid (Kcal) 4.2 ± 0.2 108 - 217 Kcal) (5- 10% of total Kcal) 
Omega-6 Fatty Acid (Kcal) 27.0 ± 1.4 13 - 26 Kcal (0.6- 1.2 % of total Kcal) 
 
Table 3-3 presents the mean (sd) of macronutrients by gender. For all 
macronutrients except Omega-3 fatty acid and Omega-6 fatty acid, the means are nearly 
identical for boys and girls. However, the mean (sd) of saturated fat (kcal) intake was 
134.5 (65.7) in girls, which was higher than the mean (sd) in boys 120.2 (56.3); the 
difference was tending towards significance (p=.085). The mean (sd) of Omega-3 fatty 
acid intake was 4.8 (2.9) for boys, significantly higher than for girls 3.9 (2.0) (p=.012). 
Similarly, the mean (sd) of Omega-6 fatty acid was significantly higher in boys as 
compared to girls (p=.044). 
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Table 3-3: Sample Mean of Macronutrient Intake by Gender 
 
Variables 
Boys n= 86 
mean ±  SD 
Girls n=136 
mean ±  SD 
Total N=222 
mean ±  SD P value 
Calories (kcal) 1761.4 ± 401.5 1709.0 ± 380.4 1729.3 ± 388.7 0.335 
Calories from Fat (kcal) 391.2 ± 156.5 388.4 ± 159.3 389.5 ± 157.9 0.897 
 Fat (Kcal) 309.6 ± 129.1 318.9 ± 132.9 315.3 ± 131.2 0.605 
Saturated Fat (kcal) 120.2 ± 56.3 134.5 ± 65.7 129.0 ± 62.5 0.012 
Unsaturated Fat (Kcal) 187.5 ± 88.0 182.7 ± 87.4 184.6 ± 87.5 0.691 
Trans Fatty Acid (kcal) 1.9 ± 3.8 1.7 ± 1.9 1.8 ± 2.8 0.651 
Other Fat (Kcal) 4.6 ± 4.3 4.1 ± 3.5 4.3 ± 3.9 0.366 
Protein (kcal) 235.2 ± 70.0 228.3 ± 67.7 231.0 ± 68.5 0.469 
Carbohydrates (Kcal) 811.0 ± 356.2 777.3 ± 308.5 790.4 ± 327.4 0.471 
Total Sugars (Kcal) 333.4 ± 215.1 300.9 ± 184.4 313.5 ± 197.0 0.248 
Monosaccharides (Kcal) 21.7 ± 74.6 19.8 ± 59.4 20.5 ± 65.6 0.842 
Disaccharides (Kcal) 31.9 ± 30.5 39.0 ± 36.2 36.3 ± 34.2 0.118 
Other Carbs (Kcal) 424.0 ± 210.9 417.7 ± 195.2 420.1 ± 201.0 0.823 
Dietary Fibre (g) 20.3 ± 9.3 19.2 ± 9.5 19.6 ± 9.4 0.395 
Soluble Fibre (g) 1.5 ± 1.3 1.4 ± 1.2 1.4 ± 1.3 0.566 
Cholesterol kcal  12.6 ± 10.2 11.6 ± 8.3 11.9 ± 0.6 0.446 
Poly fat kcal 78.9 ± 40.9 77.7 ± 42.1 78.3 ± 2.8 0.833 
Omega-3 Fatty Acid Kcal 4.8 ± 2.9 3.9 ± 2.0 4.2 ± 0.2 0.012 
Omega-6 Fatty Acid Kcal 30.3 ± 21.6 24.6 ± 18.4 27.0 ± 1.4 0.044 
 
Table 3-4 presents the observed distribution of nutrient intake according to 
Omani recommended intake levels for various nutrients by gender (Department of 
Nutrition, 2007). The Omani Ministry of Health, specifically, its Nutrition Department, 
developed the Omani Guide to Healthy Eating in 2009 (Department of Nutrition, 2009). 
The guidelines target the general population above the age of 2 years and focus on 
adequate nutrition (see Appendix 5); and the prevention of obesity and chronic diseases 
such as diabetes, hypertension, and hyper-lipidemia through diet and physical activity. 
Patients with special dietary requirements and complicated cases are advised to consult 
professional dietitians. Emerging issues were taken into consideration in the 
development of these guidelines; the most important among these were issues related to 
trans fats and omega-3 and omega-6 fatty acids. 
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The recommended cut-offs vary by nutrient, presented as a range, such as the 
total energy (Kcal) intake for boys (2000-2300) and girls (1900-2200). In our sample, the 
mean intake of total energy for both boys (1761) and girls (1709) fell below the 
recommended range. In terms of percentages, 65.1% of boys and 64.7% of girls fell 
below the Omani DRI for total energy consumption. The mean daily intake of 
carbohydrates for both boys (202.8g) and girls (194.3g) also fell below the recommended 
levels (for boys, 275-175g; for girls, 261-356g). In terms of our sample, 88.4% of boys 
and 83.8% of girls fell below the DRI for daily carbohydrate consumption. 
Table 3-4: Distribution of Sample Macronutrient intake versus Omani Recommended 
Daily Intake (DRI) by gender 
 DRIs (9-13 y) Boys Girls 
Nutrients Boys  (n=86) Girls (n=136) % (n) % (n) 
Energy (Kcal) <2000 
2000-2300 
>2300 
<1900 
1900-2200 
>2200 
65.1% (56) 
20.9% (18) 
14.0% (12) 
[m = 1761] 
64.7% (88) 
25.0% (34) 
10.3% (14) 
[m = 1709] 
Protein (g) <40 
40-50 
>50 
<38 
38-47.5 
>47.5 
15.1% (13) 
18.6% (16) 
66.3% (57) 
[m = 58.8] 
12.5% (17) 
19.9% (27) 
67.6% (92) 
[m = 57.1] 
CHO (g) <275 
275-375 
>375 
<261 
261-356 
>356 
88.4% (76) 
8.1% (7) 
3.5% (3)  
[m = 202.8] 
83.8% (114) 
11.8% (16) 
4.4% (6) 
[m = 194.3] 
Fat (g) <33.3 
33.3-66.7 
>66.7 
<31.7 
31.7-63.3 
>63.3 
52.3% (45) 
45.3% (39) 
2.3% (2) 
[m = 34.4] 
41.2% (56) 
54.4% (74) 
4.4% (6) 
[m = 35.4] 
Saturated Fat (g) <22 
≥22 
<20.9 
≥20.9 
93.0% (80) 
7.0% (6) 
[m = 13.4] 
80.9% (110) 
19.1% (26) 
[m = 14.9] 
Trans Fatty Acid (g) <0.04 
≥0.04 
<0.04 
≥0.04 
40.7% (35) 
59.3% (51) 
[m = 0.21] 
36.0% (36) 
64.0% (87) 
[m = 0.19] 
Fibre (g) < 16 
16-40 
>40 
<15 
15-38 
>38 
34.9% (30) 
65.1% (56) 
0% (0) 
[m = 20.3] 
37.5% (51) 
59.6% (81) 
2.9% (4) 
[m = 19.2]  
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On the other hand, as already noted above, the sample’s average daily intake of 
protein exceeded the daily recommended level. For boys, the DRI is 40-50g, while the 
mean intake of protein for the boys in the sample was 58.8g; for girls, the DRI is 38-
47.5g, while the mean actual intake for the girls in the sample was 57.1g. In terms of the 
study’s sample, 66.3% of boys and 67.6% of girls exceeded the DRI, while 15.1% of 
boys and 12.5% of girls fell below the DRI level. 
With regard to dietary fibre, both boys (20.3g) and girls (19.2g) in the sample fell 
within the DRI range defined by the Department of Nutrition, but only marginally so, 
since both means fell at the lower end of range (16-40g, for boys; 15-38g, for girls). 
More than a third of students fell below the recommended range (34.9% for boys, 37.5% 
for girls). The average daily intake of fat was also at the lower end of the DRI range for 
both boys and girls, with 52.3% of boys and 41.2% of girls falling below the lower cut-
off for the daily intake of fat.  
The average intake of saturated fat also fell below the recommended range, with 
93% of boys and 80.9% of girls falling below the lower cut-off point. On the other hand, 
the level of consumption of trans fatty acids in the sample far exceeded the 
recommended levels of 0.04g per day: while the average intake of trans fatty acids for 
boys was 0.21g and for girls was 0.19g. 
Figure 3-3 depicts the distribution of macronutrient consumption across and 
between meals; complete summary measures are provided in Table 3-5. The overall 
distribution indicates that the two largest sources of calories comes from the morning 
snack (m=501.93) and from dinner (m=486.18). In terms of total energy, breakfast and 
lunch are next, each providing approximately 300 Kcal intake, with the afternoon snack 
coming next (246.17), and finally the evening snack (173.46). In general, the distribution 
of energy, protein, carbohydrate and fat intake for boys and girls was not significantly 
different, except for the following: 
The mean (sd) intake of energy at the morning snack was significantly higher in 
boys 542.9 (251.2) as compared to girls 475.8 (212.7) (p=.036). The mean (sd) intake of 
energy for dinner, on the other hand, was not significantly different between boys and 
girls. The difference in the consumption of carbohydrates was significant, however: the 
boys consumed significantly more carbohydrate 53.61 (60.88) when compared to girls 
38.95 (38.79). For the morning snack, carbohydrate intake was significantly higher in 
boys 55.65 as compared to girls 47.74 (p=.057). 
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Similarly, the mean (sd) consumption of fat during the evening snack was 
significantly higher in boys than girls (p=.068). In sum, the boys consumed significantly 
more carbohydrate and fat when compared to girls. 
 
 
 
 
Figure 3-2: Distribution of Macronutrient Consumption between Meals 
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Table 3-5: Distribution of Energy between Meals by Gender 
 Total (n=222) 
Males (n=86) 
(38.7%) 
Females (n=136) 
(61.3%) P-value
b 
 Mean ± SD  
Breakfast       
Energy  305.71±210.60 291.97±222.18 314.27±203.52 0.47 
Fat 7.26±5.90 7.61±7.32 7.05±4.85 0.524 
Carbohydrate 37.3±30.55 34.39±23.60 39.11±34.14 0.291 
Protein  10.63±8.00 10.78±9.54 10.55±6.94 0.845 
Morning Snack      
Energy  501.93±230.27 542.97±251.25 475.82±212.75 0.036* 
Fat 10.92±8.82 11.51±9.61 10.54±8.29 0.429 
Carbohydrate 50.74±28.58 55.65±33.81 47.74±24.50 0.057 
Protein  16.19±10.11 17.31±10.15 15.48±10.05 0.196 
Lunch     
Energy  304.51±202.69 297.62±191.73 308.87±209.95 0.693 
Fat 5.38±6.32 5.16±6.38 5.52±6.30 0.685 
Carbohydrate 45.27±38.12 44.39±27.88 45.82±43.47 0.789 
Protein  12.12±7.33 11.72±7.80 12.38±7.04 0.527 
Afternoon snack     
Energy  246.17±168.57 241.51±159.97 248.83±173.94 0.782 
Fat 7.18±6.80 6.91±6.74 7.34±6.87 0.691 
Carbohydrate 41.26±31.46 39.35±28.70 42.37±33.03 0.543 
Protein  4.45±4.39 4.09±4.26 4.68±4.46 0.399 
Dinner 
    Energy  486.18±311.43 516.52±322.30 467.50±304.30 0.269 
Fat 11.36±10.33 11.08±9.84 11.53±10.66 0.76 
Carbohydrate 44.54±48.79 53.61±60.88 38.95±38.79 0.038* 
Protein  18.11±12.86 19.24±13.99 17.42±12.13 0.323 
Evening snack      
Energy  173.46±131.64 181.80±129.80 167.04±137.95 0.797 
Fat 7.01±5.13 9.60±6.20 5.42±3.78 0.068 
Carbohydrate 20.46±17.18 24.08±17.05 17.95±17.50 0.424 
Protein  5.81±3.53 5.78±2.86 5.82±3.99 0.979 
a Selected population: Energy: 1000-2500 Kcal 
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3.4.3 Micronutrients 
Table 3-6 presents the mean (m±sd) of daily micronutrient intake as compared to 
the daily recommended intake (DRI) (Institute of Medicine of the National Academies, 
2005), from which it becomes clear that the students in our sample fall far short of 
recommended levels for a number of micronutrients. For calcium, the DRI for children in 
this age group is 1300mg, while the mean for our sample was only 465.4mg (sd=263.3). 
Similarly, the DRI for potassium for this age group is 4500 mg, while the mean intake in 
our sample was only 2068mg (sd=634.3). 
The daily intake levels of other micronutrients also fell short of the DRI, but not 
to the same extreme. Among these was phosphorous, with a DRI of 1250mg, compared 
with the sample mean daily intake of 845.2mg (sd=316.7). Also in this category was 
Vitamin A, with a DRI of 600µg, as compared with the mean daily intake in our sample 
of 348.8µg (sd=232.7). Also notable is the level of intake for Vitamin D, with a DRI of 
15µg, compared with the intake level in our sample at 4.9µg; a standard deviation of 23.1 
suggests a large variability among students for this measure. The daily intake of the 
remaining micronutrients in the study sample all appear to conform to the DRI levels 
recommended for this age group. 
Table 3-7 presents the observed distribution of micronutrient intake and the 
Omani recommended intake levels for various nutrients by gender (Department of 
Nutrition, 2007). The recommended cut-offs vary by nutrient and, for the most part, are 
presented as a range rather than a single number. Thus, the recommended daily intake of 
Calcium is 500-800mg for boys and 475-760mg for girls. In our sample, however, 64% 
of boys and 56% of girls fell below this recommended range, while 36.1% of boys and 
44.1% girls met or exceeded it. Similarly, 52.3% of boys and 76.5% of girls fell below 
the recommended intake level for Folate, while only 22.1% of boys and 22.8% of girls 
exceeded the recommended range. A similar pattern was found in terms of the intake of 
Iodine, where 80.2% of boys and 76.5% of girls failed to meet the minimal daily intake 
level recommended by the Omani Department of Nutrition. 
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Table 3-6: Sample Mean of Micronutrient Intake 
and Recommended Daily Intake (DRI) 
Nutrients Total (N=222) Mean ± SD 
DRI 
(9-13 years) 
Calcium (mg) 465.4 ± 263.3 1300 
Copper (mg) 0.8 ± 0.3 0.7 
Folate (mcg) 297.7 ± 151.1 250 
Iodine (mcg) 97.3 ± 65.1 73 
Iron (mg) 12.0 ± 6.6 8 
Magnesium (mg) 206.6 ± 89.7 240 
Manganese (mg) 3.9 ± 2.5 1.9 (B) 1.6 (G) 
Phosphorus (mg) 845.2 ± 316.7 1250 
Potassium (mg) 2068. ± 634.3 4500 
Selenium (mcg) 51.9 ± 26.1 40 
Sodium (mg) 1532. ± 638.7 1500 
Vitamin A (µg RE) 348.8±232.7 600 
Vitamin D (µg) 4.9±23.1 15 
Zinc (mg) 6.7 ± 2.9 8 
A more extreme pattern is evident with Sodium and Zinc, where 100% of both 
boys and girls consumed less than the recommended daily amount: for sodium, 5g for 
boys and 4.8g for girls; for zinc, 20mg for boys and 19mg for girls. The daily intake 
levels of Vitamins A and D were also deficient: in the case of Vitamin A, 89.5% of boys 
and 83.1% of girls did not consume sufficient quantities to meet the minimal daily 
requirement; in the case of Vitamin D, 91.9% of boys and 89.7% of girls consumed less 
than the lower end of the recommended range. 
In the case of Iron, approximately half of the sample fell below the recommended 
daily intake (11mg for boys, 10.5mg for girls), while the other half of the sample met or 
exceeded the minimum requirement.  
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Table 3-7: Distribution of Micronutrient Intake versus Omani Recommended Daily 
Intake (DRI) by gender 
 DRIs (9-13 y) Boys Girls 
P value 
Nutrients Boys  (n=86) 
Girls 
(n=136) % (n) % (n) 
Ca (mg) 
<500 
500-800 
>800 
<475 
475-760 
>760 
64.0% (55) 
29.1% (25) 
7.0 % (6) 
55.9% (76) 
30.9% (42) 
13.2% (18) 
0.28 
Folate (µg) 
<300 
300-400 
>400 
<285 
285-380 
>380 
52.3% (45) 
25.6% (22) 
22.1% (19) 
76.5% (104) 
0.7% (1) 
22.8% (31) 
0.000 
Iodine (mcg) 
<150 
≥150 
<142 
≥142 
80.2% (69) 
19.8% (17) 
76.5% (104) 
23.5% (32) 0.51 
Iron (mg) 
<11 
≥11 
<10.5 
≥10.5 
53.5% (46) 
46.5% (40) 
50.7% (69) 
49.3% (67) 0.0689 
Sodium (g) 
<5.0 
≥5.0 
<4.8 
≥4.8 
100% (86) 0.0% 100% (136) 0.0% NA 
Vitamin A (µg 
RE) 
<700 
700-1000 
>1000 
<665 
665-950 
>950 
89.5% (77) 
10.5% (9) 
0% (0) 
83.1% (113) 
11.8% (16) 
5.1% (7) 
0.092 
Vitamin D (µg) 
<5 
5.0-10.0 
>10 
<4.8 
4.8-9.5 
>9.5 
91.9% (79) 
7.0% (6) 
1.2% (1) 
89.7% (122) 
9.6% (13) 
0.7% (1) 
0.762 
Zinc (mg) 
<20 
≥20 
<19 
≥19 
100% (86) 
0.0% 
100% (136) 
0.0% NA 
  
 
 
Table 3-7 also provides evidence of the gender differences in the intake of these 
micronutrients which, overall, point to the significance of folate, iron and vitamin A. As 
for the gender differences, for Vitamin A intake, 89.5% of the boys consumed less than 
the recommended level compared to girls (83.1%), although the difference was 
marginally significant (p=.09). Iron intake was significantly higher for boys (53.5%) as 
compared with girls (50.7%) (p<0.068), although both fell short of the recommended 
daily level. In contrast, Folate intake was significantly higher in girls (76.5%) when 
compared to boys (52.3%) (p<.001), although both were also lower than the 
102 
 
recommended level. The rates of consumption of the other remaining nutrients did not 
vary by gender. 
The following Table 3-8 presents the mean (sd) intake of micronutrients by 
gender. Overall, the mean (sd) level of micronutrient intake was nearly identical by 
gender; there was no statistically significant difference between boys and girls on these 
measures. 
Table 3-8: Mean (sd) Micronutrient Intake by gender 
Nutrients Total (N=222) Mean ± SD 
Boys (n= 86) 
Mean ± SD 
Girls (n=136) 
Mean ± SD P value 
Calcium (mg) 465.4 ± 263.3 450.1 ± 252.1 475.1 ± 270.7 0.485 
Copper (mg) 0.8 ± 0.3 0.8 ± 0.3 0.8 ± 0.3 1.000 
Folate (mcg) 297.7 ± 151.1 300.4 ± 138.3 296.0 ± 159.1 0.827 
Iodine (mcg) 97.3 ± 65.1 93.0 ± 66.3 99.9 ± 64.4 0.446 
Iron (mg) 12.0 ± 6.6 11.9 ± 5.6 12.0 ± 7.1 0.907 
Magnesium (mg) 206.6 ± 89.7 208.8 ± 86.5 205.2 ± 92.0 0.768 
Manganese (mg) 3.9 ± 2.5 3.9 ± 2.5 3.9 ± 2.4 1.000 
Phosphorus (mg) 845.2 ± 316.7 844.2 ± 325.8 845.8 ± 312.1 0.971 
Potassium (mg) 2068. ± 634.3 2072.0± 619.2 2065. ± 645.9 0.935 
Selenium (mcg) 51.9 ± 26.1 53.8 ± 27.6 50.6 ± 25.2 0.385 
Sodium (mg) 1532. ± 638.7 1538.2± 667.6 1528.9 ± 622.2 0.917 
Vitamin A (µg RE) 348.8±232.7 382.3±278.1 369.3±261.4 0.334 
Vitamin D (µg) 4.9±23.1 2.4±2.1 3.4±14.3 0.319 
Zinc (mg) 6.7 ± 2.9 6.8 ± 3.0 6.7 ± 2.9 0.806 
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3.4.4 Anthropometric, Body Composition, Blood Pressure & Blood Sugar Profile 
Table 3-9 presents the anthropometric, body composition, blood pressure and 
blood sugar levels of the children included in the study by gender. 
The mean weight of the students in the sample was 30.2kg (sd=8.0), with girls 
weighing slightly more (30.2±8.0) than boys (30.1±7.6). The mean height was 133.6cm, 
with girls measuring slightly taller (133.7±6.6) than boys (133.6±5.0). The differential 
for waist circumference was slightly larger, with boys measuring at 60.9cm (sd=8.8) and 
girls at 60.2 (sd=8.8). The measures for mean body mass index, on the other hand, were 
virtually identical (m=16.8±3.4), with boys at 16.8 (sd=3.3) and girls at 16.8 (sd=3.4). 
No statistically significant difference was obtained for any of these measures. 
However, the mean (sd) body fat (%) for girls was significantly higher at 19.5 
(7.8) when compared to the boys’ measure at 17.3 (7.8) (p=.048), although there was no 
significant difference in body fat (Kg), with boys average (5.9±4.6) slightly lower than 
girls (6.4±4.6). Inversely, the mean (sd) of muscle mass (kg) was significantly higher for 
boys than girls: 23.6 (3.9) versus 22.5 (3.7) (p=0.038). The difference in muscle mass 
(%) was marginally significant (p=0.061), with the boys’ average slightly higher 
(78.2±7.3) than the average for girls (76.3±7.4). The mean (sd) of impedance for boys 
was 598.99 (67.1), significantly lower when compared to the mean impedance for girls 
649.8 (72.7) (p<.001).  
The fasting glucose was higher in boys 5.1 (0.4) as compared to girls 5.0 (0.4) 
(p=.071), as was the mean (sd) of HbA1, which was also significantly higher in boys 5.2 
(0.6) than girls 4.98 (0.6) (p=.008). Measures of systolic (m=109, sd=10) and diastolic 
(m=65, sd=10) were not significantly different between boys and girls. 
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Table 3-9: Anthropometric, Body composition, Blood Pressure and 
Blood Sugar Profile by Gender 
 Variables  
Male 
N=86 
Female 
N=136 
Total 
N=222 p-
value 
Mean ± sd Mean ± sd Mean ± sd 
Weight (kg) 30.1 ± 7.6 30.2 ± 8 30.2 ± 8 0.925 
Height (cm) 133.6 ± 5 133.7 ± 6.6 133.6 ± 6.0 0.893 
Waist circumference (cm) 60.9 ± 8.8 60.2 ± 8.8 60.5 ± 8.7 0.564 
Mean Body Mass Index  (Wt/Ht2) 16.8 ± 3.3 16.8 ± 3.4 16.8 ± 3.4 1.000 
Body Fat (%)  ٭  17.3 ± 7.8 19.5 ± 7.8 18.60 ± 7.9 0.042 
Body Fat (Kg) 5.9 ± 4.6 6.4 ± 4.6 6.20 ± 4.6 0.431 
Muscular Mass (%) 78.2 ± 7.3 76.3 ± 7.4 77.0 ± 7.4 0.061 
Muscle Mass (Kg) 23.6 ± 3.9 22.5 ± 3.7 22.90 ± 3.8 0.038 
Impedance٭ 598.99 ± 67.1 649.8 ± 72.7 630.1 ± 74.6 <0.001 
Systolic (mmhg) 109 ± 10 108 ± 11 109 ± 10 0.486 
Diastolic (mmhg) 65.5 ± 10 65 ± 11 65 ± 10 0.727 
HB (g/dl) 12.7 ± 1.1 12.8 ± 0.96 12.8 ± 1,00 0.489 
Fasting glucose ٭(mmol/L) 5.1 ± 0.4 5.00 ± 0.4 5.04 ± 0.4 0.071 
HbA1٭(mmol/L) 5.2 ± 0.6 4.98 ± 0.6 5.1 ± 0.6 0.008 
 
  
 
Using BMI-for-age z-scores, the prevalence of overweight or obesity in our study 
was 28.2% for boys and 22.6% for girls; obesity and overweight for the entire sample 
was 24.3% (see Figure 3-4). At the other extreme, while nearly one fourth of the 
adolescent school going children in Oman are overweight or obese, the prevalence of 
underweight from our study was about 12% and 8% in the males and females of our 
sample. In terms of sample distribution, 9.0% of the sample was thin, 7.7% of the sample 
was moderately thin, and 1.4% of the sample was severely thin. 
These data have seldom been reported from other studies.  
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Figure 3-3: Prevalence of Thinness, Overweight and Obesity among Omani 
Children  
3.4.5 Blood Lipids 
Table 3-10 summarizes the mean (sd) blood lipids levels (mmml/L) of boys and 
girls in our sample. The average HDL for the sample was 1.4 (0.33), with the boys’ 
average slightly higher 1.41 (0.36) than the girls’ 1.4 (0.30). This difference was not 
found to be significant. The mean LDL for the sample was 2.72 (0.62), with the girls’ 
average higher 2.78 (0.61) than the boys’ 2.63 (0.62). This was found to be significant at 
the 0.078 level. 
More significant than this was the difference in TGS between boys and girls. 
While the sample average was 0.63 (0.30), the average measure for girls was found to be 
higher 0.7 (0.30) than for boys 0.6 (0.30) (p=0.016). The difference in CHOL measures 
was not statistically significant: the average sample measure was 4.4 (0.7), with girls 
averaging slightly higher 4.45 (0.7) when compared to the boys 4.3 (0.8). 
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Table 3-10: Blood Lipids by Gender 
 Variables  
Male 
N=86 
Female 
N=136 
Total 
N=222 p-
value 
Mean ± sd Mean ± sd Mean ± sd 
HDL(mmol/L) 1.41 ± 0.36 1.4 ± 0.30 1.4 ± 0.33 0.830 
LDL(mmol/L) 2.63 ± 0.62 2.78 ± 0.61 2.72 ± 0.62 0.078 
TGS٭(mmol/L) 0.6 ± 0.30 0.7 ± 0.30 0.63 ± 0.30 0.016 
CHOL(mmol/L) 4.3 ± 0.8 4.45 ± 0.7 4.4 ± 0.7 0.155  
3.5 Summary and Discussion 
The sample of children included in this study were identified using a two-stage 
random sampling procedure from schools in the Muscat Governorate; it is believed that 
these children and their dietary behaviour would represent the population of similarly 
aged school children in Oman. Moreover, the instruments used to measure 
anthropometry were well calibrated. It seems reasonable to conclude, then, that the 
results from this study could be generalisable to children’s dietary behaviour in other 
Gulf countries, at the minimum. This is the first study in the region to incorporate micro- 
and macro-nutrient levels, in addition to extensive anthropometry, such as body fat and 
muscular mass, etc. in school-going children. The study’s main aim was to assess at the  
micro- and macro-nutrients intakes, anthropometry, body composition and lipid profiles 
for Omani school children. 
Compared to the Daily Recommended Intake levels, the students in our sample 
fell below established standards when it came to total calories, fat, sugar, and omega-3 
and omega-6 fatty acids (Table 3-2). Both boys and girls fell below the DRI for total 
calories, although the average level of consumption remained within one standard 
deviation of the recommended norm. The recommended intake of fat, on the other hand, 
was even lower with a sample average of 389.5kcal, compared to the recommended 
range (25-35% of total calories) of 550-750kcals. The average consumption of sugar in 
our sample (313kcal) also fell below the recommended level (540kcal). In terms of fatty 
acids, it was found that the students’ normal diet provided adequate levels of omega-6 
fatty acids while, in sharp contrast, the consumption of omega-3 fatty acids (4.2kcal) was 
woefully inadequate to meet the recommended level (108-207kcal). In terms of the 
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intake of protein and carbohydrates, the students in our sample exceeded the DRI levels: 
the DRI for protein is 136kcal, compared to the sample average of 231kcal, while the 
DRI for carbohydrates is 520kcal, compared to the sample average of 790kcal. 
Similar but slightly different patterns were found when comparing intake levels 
in our sample with the Omani DRI levels (Table 3-4). Here, too, both boys (1761kcal) 
and girls (1709kcal) fell below the DRI for total energy consumption. The mean level of 
calories from fat also fell below the Omani DRI, with 93% of boys and 80.9% of girls 
falling below the lower end of the recommended range. The same pattern was found for 
carbohydrates, where 88.4% of boys and 83.8% of girls fell below the recommended 
levels. In contrast, students exceeded the recommended levels of calories from protein 
and trans fatty acids: regarding the former, 66.3% of boys and 67.6% of girls exceeded 
the recommended range; with regards to calories from trans fatty acids, both boys 
(0.21g) and girls (0.19g) far exceeded the established DRI of 0.04g/day. 
There were also a number of significant differences in levels of macronutrient 
intake by gender (Table 3-3). On average, the girls in the sample were found to consume 
more calories from saturated fat (134.5kcal) as compared to boys (120.2kcal), while boys 
were found to consume more calories from omega-3 fatty acids (4.8kcal) when compared 
to girls (3.9kcal). The same pattern was found for calories from omega-6 fatty acids. 
In terms of micronutrient consumption (Table 3-6), the students’ diets were found 
to be most deficient in calcium and potassium: whereas the DRI for calcium was 
1300mg, the mean for the students in our sample was only 465mg; and compared to the 
DRI for potassium (4500mg), the mean for the students was only 2068mg. The students’ 
level of consumption of phosphorus, Vitamin A and Vitamin D were also found to fall 
short of the DRI levels, although not to the same degree as calcium and potassium. 
Consumption levels for all other micronutrients were found to fall within the 
recommended DRI range.  
Similar, but slightly different, patterns were found in relation to the Omani DRIs 
(Table 3-7). For both sodium and zinc, 100 per cent of boys and girls fell below the 
recommended levels. For Vitamin A, 89.5% of boys and 83.1% of girls fell below the 
Omani DRI levels, whereas for Vitamin D, 91.9% of boys and 89.7% of girls consumed 
less than the lower end of the range recommended by the Omani Department of 
Nutrition. Less severe shortfalls in micronutrient intake were found for Calcium, Folate, 
and Iodine. 
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In terms of gender, no significant differences were found in the levels of 
micronutrients consumed by boys and girls. However, when compared with the gender-
differentiated DRI levels set by the Omani government, significant gender differences 
were found for Folate, Iron and Vitamin A. In terms of blood lipids, the only significant 
difference was found for TGS. While the sample average was 0.63, the girls were found 
to have a significantly higher level (0.7) when compared to boys (0.6) (p=0.016). 
The mean (sd) body fat (%) and TSG measures were significantly higher among 
girls as compared to boys, while muscle mass, omega-3 and omega-6, and fasting 
glucose levels were significantly higher in boys. The prevalence of overweight or obesity 
was 28.2% and 22.6% in boys and girls, respectively. Data such as these, and on the 
above mentioned micro- and macro-nutrients, blood pressure and lipid profiles are scanty 
for Gulf countries.  
However, it has been reported that the rate of obesity among adolescents in 
Bahrain is between 12%-25% (Musaiger, 2004). Over time, the study participants 
generally showed a higher rate of obesity, ranging from 15% to 45%; and in adulthood, 
women showed a higher prevalence (35%-75%) when compared with men (30%-60%). 
The common risk factors, such as change in dietary habits, socioeconomic factors, 
inactivity and multiparity (among women) were all shown to be significantly associated 
with these trends in Bahrain. Similarly, in Saudi Arabia, the prevalence of obesity was 
reported to be 46% amongst adolescents in Jeddah (Washi and Ageib, 2010). Increased 
weight status of 13- to 18-year-old Saudi adolescents was also demonstrated to be related 
to their dietary habits.  
Thus, while the prevalence of overweight or obesity was lower in Oman 
compared to these other countries in Gulf, nearly one-fourth of the adolescent school-
going children in Oman can be said to be overweight or obese. In contrast, the 
prevalence of underweight from our study was about 12% and 8% in males and females 
adolescent children, respectively. These data have seldom been reported in other similar 
studies. 
In addition, our study found that higher calorie and protein intake was 
significantly associated with overweight or obesity. In the same vein, it has also been 
reported that changes in dietary habits and inactivity were associated with obesity in 
Bahrain (Musaiger, 2004); just as obesity in Jeddah has been reported to be associated 
with higher intake of carbohydrates, proteins and fat.  
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In 2010, an extensive school-based study covering 1606 8th to 10th standard 
Omani students from 49 schools was conducted in collaboration with WHO and the 
CDC, USA (Joshi et al., 2006, Abdou and Al-Murzahmi, 2012). According to that study, 
one in five students (18.7%) described themselves as slightly overweight or overweight, 
in contrast to our study which reported the actual prevalence of obesity as 28% and 23% 
in males and females, respectively. Thus, our study highlights an important discrepancy 
between these figures, signalling the potential inaccuracy of self-reported measures; 
there may have also been a significant increase in the prevalence of obesity among older 
Omani school children since the GSHS study was conducted. This (apparent) increase is 
of great concern.  
The authors of the Omani GSHS report also reported that nearly one third 
(35.6%) of students were trying to lose weight while only one in five students (18.7%) 
described themselves as slightly overweight or overweight. About 41.6% of students 
usually ate fruit two or more times per day while 17.9% of students usually ate 
vegetables three or more times per day during the past 30 days. About 45.1% of students 
ate breakfast most of the time or always during the past 30 days. Consistent with this 
study, many Omani students actually skip breakfast, which leaves dinner and other 
snacks as the main sources for their daily caloric intake. Traces of this pattern were 
apparent in our study, as well, since the two main sources of calories during the day were 
dinner (m=486kcal) and their morning snack (m=501kcal) (Table 3-5), and during the 
course of a single day, total snacks almost contributed the same number of calories 
(m=922kcal) as total meals (1096kcal). It was also found that there were significant 
gender differences: for morning snacks, the meaning intake of energy and carbohydrates 
was significantly higher for boys when compared to girls; the mean consumption of fat 
during the evening snack was significantly higher for boys than girls; and for the evening 
dinner, the consumption of carbohydrates was similarly higher for boys when compared 
to girls. 
Kovalskys et al. (2013) report that the mean calorie intake of 5th grade students in 
Buenos Aires (average age, 10.9 years) was 2316 kcal/day, where the most frequently 
consumed high calorie density foods were soft drinks, juices, candies, sweet cookies and 
high fat seasonings and dressings. In contrast, the average calorie intake from our study 
was 1729 (kcal)/day.  
In Buenos Aires, the prevalence of overweight and obesity was 21.3% and 
14.3%, respectively. According to our study, the prevalence of overweight or obesity in 
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Oman was 28% and 23% for boys and girls, respectively. Thus, Omani children showed 
a significantly higher prevalence of overweight and obesity as compared to school 
children in Buenos Aires (Kovalskys et al., 2013). Drawing upon the Ireland National 
Children’s Food Survey, Walton et al. (2015) reported that 16% of the total energy 
consumed in one day was provided from food eaten ‘before school’, 33% was provided 
from food eaten ‘at school’, and 53% was provided from food eaten ‘after school’. 
Relative to the overall school-day, food eaten ‘before school’ was lower in saturated fat 
and sodium, and higher in DF and many micronutrients; food eaten ‘at school’ was 
relatively high in added sugars and sodium, lower in DF and micronutrients, and similar 
in saturated fat compared to the overall school-day; food eaten ‘after school’ was 
relatively high in DF and vitamin A, similar in saturated fat, magnesium and sodium, and 
lower in added sugars and other micronutrients compared to the overall school-day. 
Though we do not have similar data from Oman, it would be useful to conduct such a 
study to identify the main sources of energy for Omani school children.  
Maffeis et al. (2000) reported the relationship between Italian children's adiposity 
and their parents' body mass index (BMI). The correlation between children’s adiposity 
and their mother’s and father’s BMI was 0.12 and 0.13 (p<.01), respectively (Samadi et 
al., 2014). The correlation (however small) becomes significant when the size is small. 
Clinically or epidemiologically, the minimum should be above 4. Because the sample 
size in this study was 503, the small correlation was considered significant, which is not 
very useful.  
3.6 Conclusion 
Our study has established standards for most micro- and macro-level nutrients by 
gender for school-going children in Oman. In terms of macronutrients, the students fell 
below established standards when it came to total calories, fat, sugar, and omega-3 and 
omega-6 fatty acids; their intake of protein and carbohydrates, on the other hand, 
exceeded DRI levels. In terms of micronutrients, students in the sample were most 
deficient in calcium and potassium; their intakes of Vitamin A and Vitamin D were also 
found to fall short of the DRI levels. No significant gender differences were found, 
except in the case of calories from saturated fat (girls > boys) and calories from omega-3 
fatty acids (boys > girls). 
This data will provide a crucial reference for future studies but also an important 
estimate of the prevalence of micro- and macro-nutrient deficiencies in Oman. As such, 
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it provides a benchmark for the country and a roadmap for future planning for school 
health programs. In summary, the prevalence of overweight or obesity is comparable to 
other countries in the Gulf region and significantly lower than in more developed 
countries. Nevertheless, the prevalence rate of approximately 25% overweight and 
obesity for boys and girls is still too high. Therefore, health education that focuses on 
nutrients should start at the school level.   
112 
 
  
CHAPTER 4: 
ADHD and Parental Factors 
in Omani School Children 
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4.1 Introduction  
The global prevalence of Attention Deficit Hyperactivity Disorder (ADHD) is 
estimated to be approximately 5% to 13% (Faraone et al., 2003). The condition is 
defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 
(American Psychiatric Association, 2013) and also by the International Classification of 
Diseases (ICD-10) (World Health Organization, 1992) as including two distinct 
behavioural dimensions - inattentive and hyperactive-impulsive - which have been 
recognized to exist across cultures and in a variety of ethnic groups (Barkley, 2003). 
Children who suffer from ADHD tend to have difficulties in following 
instructions or abiding by the rules (Taylor et al., 2004). They are also more likely to 
generally misbehave and more frequently interrupt and/or intrude on others’ 
conversations and activities (de Boo and Prins, 2007). In addition, these children are 
more prone to risk-taking and rule-violating behavior. As a consequence, they are also 
more prone to offend norms of social modesty by their disruptive behavior. The net 
outcome of such conduct are negative responses from peers, teachers and parents 
(McQuade and Hoza, 2008, Solanto et al., 2009).  
Symptoms of ADHD have been linked to higher risks of substance misuse, 
comorbid neurobehavioral disorders as well as becoming ‘social misfits’ with all the 
consequences this may entail, including a decreased quality of life (Frick and Dickens, 
2006, Tapert et al., 2002, Tercyak et al., 2002). As the bulk of literature on ADHD has 
emerged from Euro-American populations, initial studies led to the view that ADHD 
might be a ‘culture-bound syndrome’ (Canino and Alegria, 2008). Although a systematic 
review of studies from different populations and ethnicities identified drastic variations 
in the magnitude of the disorder (Polanczyk et al., 2007), it cannot be denied that ADHD 
is a global challenge.  
There is a dearth of studies from Arabian Gulf populations such as those of 
Oman, a country that lies at the tip of the Arabian Peninsula, adjacent to the continent of 
Africa and Asia. Oman has a pyramidal population structure with the bulk of the 
population consisting of children and adolescents (United Nations, 2010). Anecdotal 
evidence indicated that different regions are not immune to the vagaries of neuro-
developmental disorders such as ADHD. In the instance of Qatar (Bener et al., 2006), 
teachers using the Conner’s scale found that 16.7% males and 7.3% female students had 
a propensity to having ADHD. In the principality of Sharjah of the United Arab Emirates 
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(Bu-Haroon et al., 1999), 18.3%, of male and 11.4% of female students were also 
identified by their teachers as having symptoms of typical of ADHD. In Saudi Arabia, 
clinical notes at a tertiary care hospital indicated that 10.5% of attendees were marked by 
symptoms of ADHD (Al-Haidar, 2002). In Oman, Al-Sharbati et al. (2004) reported that 
7.8% males and 5.1% females showed characteristic symptoms of ADHD. 
Although these studies should be welcomed as useful beginnings in an emergent 
field of research, they have failed to include the risk factors or familiar aggregates for 
children with ADHD. Charting out socio-demographic factors has a potential to lay the 
groundwork for devising preventive measures and for designing relevant health 
educational programs. Furthermore, quantifying the risk factors for children with ADHD 
can help construct a theoretical model to discern whether ADHD is a global phenomenon 
or an artifact of socio-cultural factors. Thus, while genetic and neurological determinants 
have been shown to be critically associated with the development of ADHD in western 
countries, the range of social and economic indicators are seen to play an important role 
in the development of ADHD, as well (Russell et al., 2014, Pastor and Reuben, 2008, 
Akinbami et al., 2011, Froehlich et al., 2007, St Sauver et al., 2004, Ford et al., 2007, 
Boe et al., 2012, Hjern et al., 2010, Paananen et al., 2013, Hobcraft, 2004, Sciberras et 
al., 2011).  
Within this context, the present study aims to achieve the following goals: first, to 
estimate the current rate of ADHD in school children aged 9-10 years in Oman, second, 
to examine the role of parental factors such as sex, educational level, occupation, income 
and consanguinity in the cognitive functioning and symptomatology of ADHD and, 
third,  to identify the role of each subtype of ADHD (predominantly inattentive, 
predominantly hyperactive/impulsive and/or ADHD combined inattention/hyperactivity) 
in the expression of cognitive functioning. 
4.2 Methods  
4.2.1 Participants 
The study was conducted between August 2012 and February 2013 in the Muscat 
Governorate, a region in Oman including the coterminous capital city of Muscat. It lies 
in the most populated part of the country and has a population reaching slightly above 
one million (National Centre for Statistics and Information, 2014). The Governorate is 
divided into 6 administrative divisions or wilayats: Al Amerat, Bawshar, Muscat, 
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Mutrah, Qurayyat and As Seeb. All participants from the selected schools were invited to 
participate in the study during the academic year.  
4.2.2 Sampling 
According to statistics available from the Ministry of Education, in the 2012–
2013 academic year there were 101,597 pupils in the Muscat Governorate enrolled in 
public schools (run by the state under the direction of the Ministry of Education). In 
total, there were 49,783 (49%) male and 51,814 (51%) female students. For the purpose 
of this study, all participating pupils were children who were enrolled for the second 
stage sampling of the 4th grade (aged 9-10). 
There is some debate whether children younger than 9-10 years can be said to 
manifest the symptoms of ADHD as outlined in International Classification of Disease 
(ICD-10) (World Health Organization, 1992) or the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-5) (American Psychiatric Association, 2013). In these and other 
manuals, the diagnosis symptoms such as those associated with ADHD are often 
attached to a specific age and must endure for a specific period of time. If the relevant 
symptomatology has appeared by the age of 9 years, however, it would appear that the 
condition has been firmly consolidated (Treyvaud et al., 2013). In the existing research 
literature, this age group has been identified as suitable for testing with the cognitive 
measures used in this study (Goodman et al., 2016). This age group was also deemed 
appropriate in light of the dietary intervention at the heart of this study since, at this age, 
the children will have developed independent food preferences and their eating habits 
(healthy, or otherwise) will have been established. 
The participants were selected using stratified random selection. In the first stage, 
three schools in the catchment area of 39 schools were randomly selected with an equal 
representation of both genders. In the second stage, three Grade 4 classes from five were 
randomly selected, and inviting all students in those classes to participate in the study. 
All students were given letters of invitation addressed to their parents/guardians 
describing the rationale for the study. The parents/guardians were asked to sign consent 
forms indicating their consent to the study. In addition to this, the students themselves 
were also required to give consent before taking part in the study. The invitation was sent 
to 354 students, of whom 327 responded giving a response rate of 85.9%. After 
excluding those cases with missing socio-demographic data or incomplete 
questionnaires, a total of 304 students were included in the final sample, among whom 
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female students constituted 55%. These students account for 4.6% of the school children 
between 9 and 10 from the Muscat Governorate.  
4.2.3 Sample Size 
The objective of the current study is to estimate the prevalence of ADHD in 
school children and their risk factors. The prevalence of ADHD is reported in the 
literature to be about 9%. In order to estimate this with the precision of 3% with a 95% 
CI, nearly 350 children would need to be included in the study. Thus, the baseline data of 
the main study should provide enough precision to estimate the prevalence of ADHD. 
4.2.4 Inclusion and Exclusion Criteria 
 Criteria of Inclusion: Male and female children aged 9-10 years without any 
hereditary or chronic medical condition or cognitive impairment that would warrant 
diagnosis of developmental disorder. Since the present cohort was derived from schools 
designed to serve the educational mainstream, the students were deemed likely to have 
adequate intellectual functioning since children with special needs, talents, learning 
disorders and mental disability do not attend ‘mainstream’ schools (Al-Lamki, 2012).  
Criteria of Exclusion: Children receiving pharmacotherapy for behavioural, 
cognitive or emotional disorders, or with hearing or visual impairments.  
4.2.5 Participant Consent 
Informed and signed consent to participate was obtained from the parents/ 
guardians of the children. 
4.2.6 Ethical Approval 
The study was approved by the Research Ethics Committee of the Ministry of 
Health, Sultanate of Oman (Ref. MH/DGP/R&S/Proposal_Approved/8/2012), and the 
National Research Ethics Committee North West – Haydock, UK (REC reference no. 
12/NW/0760).  
4.3 Study Variables 
4.3.1 Socio-Demographic Characteristics 
Socio-demographic characteristics including age, gender, monthly income for 
socio-economic status, educational level of parents, occupational status of parents and 
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the consanguinity status of parents were collected by a trained researcher during face-
face interviews.  
4.3.2 Outcome Measures 
An Arabic version of the National Initiative for Children’s Health Quality 
Vanderbilt Assessment Scales-Teacher Assessment Scale (NICHQ Vanderbilt 
Assessment Scales) was used (American Academy of Pediatrics, 2008, Pliszka and 
AACAP Work Group on Quality Issues, 2007). The NICHQ Vanderbilt Assessment 
Scales has 55 questions divided into two sections: ‘symptoms’ and ‘performance’. The 
SYMPTOMS section contains 47 items that are divided into various sub-sections: items 
1-18 tap into the symptoms of ADHD, items 19-26 tap into oppositional defiant disorder 
symptoms, items 27-40 quantify the presence of Oppositional-Defiant/Conduct disorders 
and items 41-47 solicit the presence of Anxiety/Depression. Items are rated: never = 0, 
occasionally = 1, often = 2, very often = 3. The teacher is instructed to circle only one of 
the numbers on the scale. 
The PERFORMANCE section taps into the level of impairment in Academic 
Performance (reading, mathematics and written expression) and Classroom Behavioral 
Performance (relationships with peers, following directions/rules, disrupting class, 
assignment completion and organizational skills). Performance scales are rated as: 
excellent = 1, above average = 2, average = 3, somewhat of a problem = 4, 
problematic = 5. The formula used for scoring the NICHQ Vanderbilt Assessment Scales 
has been detailed elsewhere (Wamithi et al., 2015).  
The following symptoms were the focus of the present study: the predominantly 
inattentive subtype of ADHD (PIS), Predominantly Hyperactive/Impulsive subtype 
(PHIS), ADHD Combined Inattention/Hyperactivity (ADHDCIH), Oppositional-
Defiant/Conduct Disorders and Anxiety/Depression. The research team explained to 
teachers how to fill out NICHQ Vanderbilt Assessment Scales. The teachers were then 
explicitly informed to base their answers in reference to the child’s behaviour over a six 
month period.  
4.4 Statistical Methods 
The prevalence of PIS, PHIS and ADHD was measured using a 95% CI. In the 
unadjusted (bivariate) analysis, a chi-square test was used to measure the association 
between risk variables and the outcome variables: PIS, PHIS and ADHD (yes/no). 
118 
 
Logistic regression analysis was done as adjusted analysis to control for the effect of 
confounders and other risk variables. The odds ratio was presented with a 95% CI along 
with P value, where a P value < 0.05 was considered significant. The goodness of fit of 
the logistic regression analyses (model) was done using Hosmer-Lemeshow statistics. 
The assumptions were validated using Deviance chi-square statistics versus predicted 
probabilities graphs. Data was analysed using SPSS 21.0 software. 
4.5 Results 
A total of 328 children participated in the study. The prevalence of PIS, PHIS and 
ADHDCIH was 7.3% (95%CI: 4.5%, 10.1 %), 3% (1.2%, 4.8%) and 8.8% (5.7%, 
11.8%), respectively. The prevalence of Opposition-Defiant/Conduct disorder and 
Anxiety/ Depression was 1.5% (0.2%, 2.8%) and 1.8% (0.4%, 3.2%), respectively. Male 
children had significantly higher prevalence of PIS, PHIS and ADHD as compared to 
female children (p<0.05).  
4.5.1 Predominantly Inattentive Subtype (PIS) 
The unadjusted (bivariate) and adjusted (multivariate) analyses results for the 
scale PIS according to the socio-demographic characteristics of parents and gender of 
children is presented in Table 4-1. Though the child’s gender was statistically significant 
at the unadjusted (bivariate) analyses, after adjusting for parental characteristics it was no 
longer significant in the adjusted (multivariable) analyses. Children who had mothers 
that could not read or write had significantly higher odds for PIS as compared to children 
whose mothers were graduates (p=0.06). Similarly, fathers with occupations other than 
in public or military sectors had higher odds of their children having PIS 2.8 (0.9, 8.3) 
(p=0.07), although both of these relationships were only marginally significant. 
4.5.2 Predominantly Hyperactive/Impulsive Subtype (PHIS) 
The unadjusted and adjusted analyses results for the scale PHIS according to 
socio-demographic variables of the parents and gender of the children is presented in 
Table 4-2. The male children were 6.2 (0.9, 42.7) times more likely to have PHIS as 
compared to female children, although this relationship was only marginally significant 
(p=0.06). The children whose fathers studied up to the preparatory or secondary 
diplomas were 83% less likely to have PHIS as compared to the children of fathers who 
graduated with a degree; this relationship was also marginally significant (p=0.08). On 
the other hand, the mothers of children whose occupation was other than housewife, had 
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7.1 (1.1 , 50) times higher odds for PHIS as compared to housewives (p=03). Similarly, 
the children who came from low income families had 24 (1.7 , 341) times higher odds 
for PHIS as compared to children from medium or high income families (p=0.01). Thus, 
it appears that mother’s occupation and family income were more powerful predictors of 
PHIS than father’s education or gender of the child. 
4.5.3 ADHD Combined Inattention/Hyperactivity (ADHDCIH) 
The unadjusted and adjusted analyses results for the scale ADHDCIH according 
to socio-demographic variables of parents and the gender of children is presented in 
Table 4-3. The children of mothers who were non-literate, who could not write or who 
studied up to primary school were 9.5 (0.7, 125) times more likely to have ADHDCIH 
compared to children whose mothers who were degree holders, but this relationship was 
only marginally significant (p=0.08). The children of fathers who were employed in 
areas other than the public sector or the military had 4.2 (1.5, 12.5) times higher odds for 
ADHDCIH as compared to children of fathers who worked in those sectors; this 
relationship was highly significant (p=0.01). On the other hand, children from low 
income families had nearly 3 (0.9 , 10) times higher odds for ADHDCIH as compared to 
children from medium or higher income families, but this relationship was only 
marginally significant (p=0.08). 
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Table 4-1: Unadjusted and Adjusted analysis for Predominantly Inattentive subtype (PIS) 
with Socio demographic variables 
Variables 
Unadjusted Analysis of PIS Adjusted Analysis of PIS 
Total 
n (%) 
Yes 
n (%) 
No 
n (%) P value OR 95%CI P value 
Sex 
 Male 
 Female 
 
142(43.3) 
186(56.7) 
 
17(70.8) 
7(29.2) 
 
125(41.1) 
179(58.9) 
 
 0.005 
 
1.65 
1.00 
 
0.60– 4.58 
 
 0.334 
Mother Education 
 Unread/Unwrite/Primary 
 Preparatory/Secondary/Diploma 
 Ealorois/Graduate 
 
49(15.4) 
196(61.6) 
73(23.0) 
 
7(29.2) 
16(66.7) 
1(4.2) 
 
42(14.3) 
180(61.2) 
72(24.5) 
 
 0.017 
 
11.4 
3.49 
1.00 
 
0.87– 150.70 
0.36 – 34.29 
 
 0.064 
 0.283 
Father Education 
Unread/Unwrite/Primary 
Preparatory/Secondary/Diploma 
Ealorois/Graduate 
 
22(6.9) 
177(55.8) 
118(37.2) 
 
2(8.3) 
14(58.3) 
8(33.3) 
 
20(6.8) 
163(55.6) 
110(37.5) 
 
 0.791 
 
 
 
0.59 
0.69 
1.00 
 
0.08– 4.18 
0.19 – 2.43 
 
 0.596 
 0.568 
Mother Occupation 
House-wife 
Others 
 
180(56.6) 
138(43.4) 
 
15(62.5) 
9(37.5) 
 
165(56.1) 
129(43.9) 
 
 0.544 
 
0.75 
1.00 
0.20 – 2.83 0.672 
Father Occupation 
Public/Military Sector 
Others 
 
169(53.3) 
148(46.7) 
 
9(37.5) 
15(62.5) 
 
160(54.6) 
133(45.4) 
 
 0.106 
 
1.00 
2.80 
 
0.9 - 8.3 
 
 
 0.076 
Family Income 
Low Income 
Medium/High Income 
 
137(54.4) 
115(45.6) 
 
14(73.7) 
5(26.3) 
 
123(52.8) 
110(47.2) 
 
 0.079 
 
2.04 
1.00 
 
0.60 – 6.96 
 
 0.252 
Consanguinity: 
Yes 
No 
 
128(40.5) 
188(59.5) 
 
8(33.3) 
16(66.7) 
 
120(41.1) 
172(58.9) 
 
 0.456 
 
0.65 
1.00 
 
0.23 – 1.86 
 
 0.422 
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Table 4-2: Unadjusted and Adjusted analysis for Predominantly Hyperactive  
Impulsive subtype (PHIS) with Socio demographic variables 
Variables 
Unadjusted Analysis of PHIS Adjusted Analysis of PHIS 
Total 
n (%) 
Yes 
n (%) 
No 
n (%) P value OR 95%CI P value 
Sex 
 Male 
 Female 
 
142(43.3) 
186(56.7) 
 
8(80.0) 
2(20.0) 
 
134(42.1) 
184(57.9) 
 
0.023 
 
6.24 
1.00 
 
0.91– 42.76 
 
 0.062 
Mother Education 
 Unread/Unwrite/Primary 
 Preparatory/Secondary/Diploma 
 Ealorois/Graduate 
 
49(15.4) 
196(61.6) 
73(23.0) 
 
2(20.0) 
7(70.0) 
1(10.0) 
 
47(15.3) 
189(61.4) 
72(23.4) 
 
0.722 
 
6.89 
1.74 
1.00 
 
0.25– 193.48 
0.14 – 22.47 
 
 0.257 
 0.669 
Father Education    
 Unread/Unwrite/Primary 
 Preparatory/Secondary/Diploma 
 Ealorois/Graduate 
 
22(6.9) 
177(55.8) 
118(37.2) 
 
1(10.0) 
5(50.0) 
4(40.0) 
 
21(6.8) 
172(56.0) 
114(37.1) 
 
0.675 
 
0.29 
0.17 
1.00 
 
0.01– 5.94 
0.02 – 1.27 
 
 0.421 
 0.084 
Mother Occupation 
 House-wife 
 Others 
 
180(56.6) 
138(43.4) 
 
5(50.0) 
5(50.0) 
 
175(56.8) 
133(43.2) 
 
0.751 
 
1.00 
7.1 
 
 
1.1 – 50.0 
 
 
0.038 
Father Occupation 
 Public/Military Sector 
 Others 
 
169(53.3) 
148(46.7) 
 
1(10.0) 
9(90.0) 
 
168(54.7) 
139(45.3) 
 
0.007 
 
 
- 
 
- 
 
- 
Family Income 
 Low Income 
 Medium/High Income 
 
137(54.4) 
115(45.6) 
 
7(87.5) 
1(12.5) 
 
130(53.3) 
114(46.7) 
 
0.074 
 
24.09 
1.00 
 
1.70 –340.83 
 
 0.019 
Consanguinity: 
 Yes 
 No 
 
128(40.5) 
188(59.5) 
 
2(20.0) 
8(80.0) 
 
126(41.2) 
180(58.8) 
 
0.211 
 
0.35 
1.00 
 
0.06 – 2.06 
 
 0.246 
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Table 4-3: Unadjusted and Adjusted analysis for ADHD Combined  
Inattention Hyperactivity with Socio demographic variables 
Variables 
Unadjusted Analysis of ADHD Adjusted Analysis of ADHD 
Total 
n (%) 
Yes 
n (%) 
No 
n (%) 
P 
value OR 95%CI 
P 
value 
Sex 
Male 
Female 
 
142(43.3) 
186(56.7) 
 
21(72.4) 
8(27.6) 
 
121(40.5) 
178(59.5) 
 
0.001 
 
2.27 
1.00 
 
0.85 – 6.06 
 
0.101 
Mother Education 
Unread/Unwrite/Primary 
Preparatory/Secondary/Diploma 
Ealorois/Graduate 
 
49(15.4) 
196(61.6) 
73(23.0) 
 
7(24.1) 
21(72.4) 
1(3.4) 
 
42(14.5) 
175(60.6) 
72(24.9) 
 
 
0.009 
 
9.49 
3.61 
1.00 
 
0.72 – 124.61 
0.36 – 35.94 
 
0.087 
0.273 
Father Education 
Unread/Unwrite/Primary 
Preparatory/Secondary/Diploma 
Ealorois/Graduate 
 
22(6.9) 
177(55.8) 
118(37.2) 
 
2(6.9) 
15(51.7) 
12(41.4) 
 
20(6.9) 
162(56.2) 
106(36.8) 
 
 
0.864 
 
0.28 
0.39 
1.00 
 
0.04 – 1.92 
0.13 – 1.19 
 
0.197 
0.098 
Mother Occupation 
House-wife 
Others 
 
180(56.6) 
138(43.4) 
 
19(65.5) 
10(34.5) 
 
161(55.7) 
128(44.3) 
 
0.310 
 
0.98 
1.00 
 
0.27 – 3.55 
 
0.971 
Father Occupation 
Public/Military Sector 
Others 
 
169(53.3) 
148(46.7) 
 
10(34.5) 
19(65.5) 
 
159(55.2) 
129(44.8) 
 
0.033 
 
 
1.00 
4.2 
 
 
1.4 - 12.5 
 
 
0.012 
Family Income 
Low Income 
Medium/High Income 
 
137(54.4) 
115(45.6) 
 
18(78.3) 
5(21.7) 
 
119(52.0) 
110(48.0) 
 
0.016 
 
2.96 
1.00 
 
0.86 – 10.15 
 
0.084 
Consanguinity: 
Yes 
No 
 
128(40.5) 
188(59.5) 
 
13(44.8) 
16(55.2) 
 
115(40.1) 
172(59.9) 
 
0.619 
 
1.06 
1.00 
 
0.42 – 2.71 
 
0.899 
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4.6 Discussion 
To our knowledge, this is the first study with robust methodology to highlight the 
prevalence rate of ADHD among school children in Oman. The study indicates that 8.8% 
of the cohort exhibited symptoms of ADHD as solicited by the NICHQ Vanderbilt 
Assessment Scales. In previous studies, most reports were based on the Conner’s Scale 
(Bener et al., 2006, Bu-Haroon et al., 1999, Al-Haidar, 2002, Al-Sharbati et al., 2004). 
Unlike Conner’s Scale, the NICHQ Vanderbilt Assessment Scales used in this study are 
more protracted, and appear to reflect the nomenclature as depicted in the DSM 
(Wamithi et al., 2015, Collett et al., 2003). Furthermore, the NICHQ Vanderbilt 
Assessment Scales are better equipped to detect a spectrum of ADHD including 
inattentive symptoms and hyperactivity/impulsivity, as well as a combination of these. 
The NICHQ Vanderbilt Assessment Scales are also equipped to tap into the core 
symptoms of ADHD, but also impairment as well as comorbidity, such as Oppositional-
Defiant/Conduct Disorders and Anxiety/Depression (Wamithi et al., 2015). 
The present study has therefore identified a different and, perhaps, more complete 
spectrum of ADHD. The study results indicate that 7.3% of children in the sample were 
identified by the teacher as having inattentive symptoms while 3% were identified as 
exhibiting predominately hyperactivity/impulsivity symptoms. On the whole, the present 
rate of 8.8% appears to echo the international range noted in the research literature 
(Faraone et al., 2003), although it appears in the lower range more typical when using 
questionnaires or a symptoms checklist (Faraone et al., 2003). On the other hand, when 
studies are conducted in the community using the 'gold standard' of semi-structured 
interview, the rate has been estimated to range between 6-7% of the targeted group 
(Faraone et al., 2003). The available literature also indicates that Arab populations 
generally show a lower rate of ADHD, as compared to Euro-American populations 
(Polanczyk et al., 2007).  
On the whole, this study indicates that ADHD is relatively common among 
school-going children in Oman. As the present cohort is derived from school children 
residing in the area coterminous with the capital city of Muscat which, in essence, the 
urban region of the country where the bulk of the population in Oman is located 
(National Centre for Statistics and Information, 2013). Further studies are needed to 
render the study findings generalization to the rest of the population beyond the Muscat 
Governorate.  
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The second interrelated aim of this study was to highlight the risk factors, or 
specifically parental factors, associated with ADHD. Previous studies in the regions have 
focused only on establishing the rate of prevalence (Bener et al., 2006, Bu-Haroon et al., 
1999, Al-Haidar, 2002, Al-Sharbati et al., 2004). Establishing the risk factors would lay 
the groundwork for developing preventative measures as well as for contemplating the 
most effective remedial services. This results of this study suggest that socio-economic 
status has a direct bearing on whether the children exhibit symptoms of ADHD or 
otherwise. Specifically, this study indicates that the higher income of the parent, the 
more likely that the children will be shielded from exhibiting ADHD, especially PHIS 
(Russell et al., 2014, Larsson et al., 2014). 
This study also indicates that the parent`s place of work has strong links to 
whether a child has ADHD or not. Parents working in the government sectors, 
particularly fathers, have children with less risk for exhibiting symptoms of ADHDCIH 
compared to those working in private sectors. In Oman, government jobs tend to provide 
more holidays as well as higher salaries. In fact, studies have indicated that the most 
preferred jobs among the Omani labour force are in the government sector. Indeed, one 
study has indicated that those working in the private sector are more likely to have a 
lower level of education and are more like to suffer from an emotional disorder (Al-
Salmani et al., 2015).  
Finally, and somewhat surprisingly, the results of this study indicate that children 
of mothers who are not housewives have a significantly higher risk of showing 
symptoms of PHIS, even though the mother’s level of education had no predictive value 
for this subtype of ADHD. This suggests that the operative factor relates to the mother’s 
presence inside the home. This is consistent with socio-cultural teaching where mothers 
tend to play dominant role in socializing children (Frick and Dickens, 2006, Tercyak et 
al., 2002, Tapert et al., 2002). On the other hand, it seems to challenge previous findings 
that suggest that low parental education is predictive of ADHD (St Sauver et al., 2004). 
It should be kept in mind, however, that the variables in question demonstrate 
different predictive patterns across the different types and measures of ADHD used in 
this study (PIS, PHIS, ADHDCIH). Thus, it provides a more nuanced portrait of the 
possible contributing factors for the development of ADHD symptomatology. On the 
other hand, the possible causative or contributory role of these variables cannot be 
divorced from the specific forms of impairment captured by these measures. 
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4.6.1 Study Limitations 
The current study’s objective to establish the prevalence of ADHD in Oman and 
identify the associated risk factors were addressed using a cross-sectional study design. 
The study’s findings, therefore, rely upon a single measurement in time which is subject 
to change as the children become older. Therefore, the ideal design would be a 
longitudinal cohort study using 6 month intervals to measure ADHD. This would provide 
a more accurate measure of the incidence of ADHD as well.  
The sample children in this study were from Muscat region alone, which is not 
necessarily representative of the national population. Therefore, the generalisability of 
these findings to children in other areas of the country may be limited. Consequently, a 
multicentre study using more than a single region would be appropriate to address this 
limitation.  
In previous studies, familiar measures of ADHD have been strongly linked to IQ 
as well as parental factors. IQ levels were not explored in this study. Thus, based on the 
findings of this study, we are unable to explore the association between IQ and the 
spectrum of ADHD.  
4.7 Conclusion  
This study has measured the prevalence rate of PIS, PHIS and ADHD among 
Omani school children as 7.3% (95% CI: 4.5%, 10.1 %), 3% (1.2, 4.8%) and 8.8% 
(5.7%, 11.8%), respectively. Statistical analyses indicates that reduced family income, 
and non-government jobs were most strongly associated with an increased risk for 
ADHD: specifically, family income for PHIS (p=.019) and father’s employment sector 
for ADHDCIH (p=.012). Childhood symptoms of PHIS were also significantly 
correlated with mother’s occupations outside the home (p=.038). These associations 
remain the same even after controlling for other factors.  
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CHAPTER 5: 
 
Vitamin D Deficiency  
Is Prevalent in Healthy Omani 
School Children: Omega-3 Fatty 
Acids Have a Mitigating Effect 
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5.1 Introduction 
Oman has made a remarkable progress in socio-economic development in the last 
four decades (Musaiger, 1998, IBPUS, 2013). This advancement is reflected in dramatic 
reductions in maternal, child and infant mortality rates, common infectious diseases, 
extreme poverty, and a significant increase in life expectancy (UNICEF, 2009, Al-
Lamki, 2010, UNDP, 2010). Conversely, the prevalence of obesity in adults and 
children, and non-communicable diseases, such as vascular and respiratory diseases, 
diabetes and cancer has reached epidemic proportions (Musaiger, 2002, Badran and 
Laher, 2011, Rahim et al., 2014a). The Oman World Health Survey, a country-wide 
community-based household survey involving about 5000 subjects conducted in 2008, 
revealed that 40.3% of those surveyed had hypertension, 12.3% diabetes, 21.4% obesity 
and 33.6% elevated blood cholesterol (Al Riyami et al., 2012).  
It is plausible that genetic predisposition may be a factor for the rise in non-
communicable diseases in Oman and the other Gulf countries. However, the fact that the 
rise occurred in a short time and coincided with a period of economic prosperity suggests 
that modifiable lifestyle factors, such as physical inactivity, smoking and unhealthy diets 
could be the main culprits. Indeed, it has been reported that the traditional diet of the 
Gulf Countries which comprises primarily of dates, milk, rice, brown bread, fish and 
vegetables (Musaiger, 1998, Galal, 2002) has changed to resemble a more Western diet 
which is high in vegetable oils and animal fat (~30% daily calorie), refined sugar (~51% 
daily calorie) and low fibre cereals (mainly highly extracted wheat flour and polished 
rice, 35-42% of daily energy) (Musaiger, 1998, Badran and Laher, 2011). The Western 
diet is high in calorie, high glycaemic index carbohydrates, total fat and saturated, trans 
and omega-6 fatty acids, and low in omega-3 fatty acids and essential vitamins and trace 
elements.  
Childhood dietary habits tend to track to adult life (Mikkilä et al., 2004, Ventura 
and Worobey, 2013b) and some of the non-communicable chronic diseases are thought 
to begin in early life and progress to become clinical diseases in adulthood (Holman et 
al., 1958a, Holman, 1961, McNamara et al., 1971, Newman et al., 1986, Barker, 1995a, 
McGill et al., 2000a, McGill et al., 2008a, McGill et al., 2009a). Moreover, perhaps 
because of the impact of marketing strategy (Robinson et al., 2007, Andreyeva et al., 
2011), fast food meals have become very popular among children and adolescents in the 
Arab countries (Musaiger, 1987b, Chakar and Salameh, 2006) and elsewhere. Therefore, 
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children and young adults must be an integral part of programmes for prevention and 
control of non-communicable diseases.  
Recently, we conducted a comprehensive study designed to define health, 
physical fitness and cognitive ability of school children within the context of the rapid 
nutrition transition in Oman. This communication reports plasma fat-soluble 
micronutrient status at baseline and after intervention with fish-based menu or 
docosahexaenoic acid (DHA) enriched fish oil supplement.  
It should be noted that there is conflicting evidence about the bioavailability of 
EPA and DHA from various forms of fish oil (el Boustani et al., 1987, Lawson and 
Hughes, 1988, Luley et al., 1990, Nordoy et al., 1991, Krokan et al., 1993, Hansen et al., 
1993). El Boustani et al. (el Boustani et al., 1987) have reported a delayed and reduced 
incorporation of EPA into plasma triglycerides when administered as an ethyl ester, 
compared to the incorporation of EPA administered as natural triglycerides or as a free 
fatty acid. When Lawson and Hughes (Lawson and Hughes, 1988) compared the time 
course for the increase in concentration of EPA in plasma triglycerides relative to the 
maximal rise in a-linolenic acid, they found a nearly 100% absorption of EPA and DHA 
as free fatty acids, in contrast to the absorption of EPA as natural triglycerides (68%) or 
ethyl esters (20%).  
Other research suggests an equal absorption of n-3 FA, either as triglycerides or 
ethyl esters (Luley et al., 1990, Nordoy et al., 1991). In comparing the absorption of EPA 
and DHA from natural fish oil triglycerides with that from ethyl esters at two different 
levels of EPA and DHA (54% and 35%), Luley et al. (1990) found no difference in 
absorption. Nordoy et al. (1991) compared the content of n-3 FA in chylomicron 
triglycerides and the increase in chylomicron triglycerides after a test meal with a large 
dose of n-3 FA, either as re-esterified triglycerides or as ethyl esters; they found a similar 
absorption of n-3 FA irrespective of whether the supplement was re-esterified 
triglycerides or ethyl esters, despite a lower rate of hydrolyses by intestinal lipase of fatty 
acids from ethyl esters than from triacylglycerols in vitro. The same pattern was found 
by Krokan et al. (1993), who demonstrated that the absorption of EPA and DHA from 
synthetic ethyl esters rich in EPA and DHA were fully comparable to that of natural 
triacylglycerols containing smaller amounts of these fatty acids.  
Hansen et al. (1993) gave volunteers EPA and DHA, either as natural 
triglycerides or as ethyl esters, of approximately 3.5 g/day for 7 weeks. They found equal 
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incorporations of EPA and DHA into plasma phospholipids from their two formulations. 
The incorporation of EPA into plasma cholesterol esters from ethyl esters, on the other 
hand, was significantly lower than that from natural triglycerides. 
5.2 Subjects and Methods 
5.2.1 Subjects and Recruitment 
Three hundred fourteen children (boys, n=139, girls, n=175) accounting for a 
4.6% of the school pupils aged between 9 and 10 years from the Muscat Governorate 
were recruited using a two stage sampling procedure. In the first stage, three (n=3) of 
thirty nine (n=39) schools in the Governorate and in the second stage, three Grade 4 
classes from five were randomly selected. The three schools were assigned to fish, fish 
oil or control group and the children were given for lunch a 100 gram lightly grilled fish 
sandwich with some vegetables (fish group), their habitual food or omega-3 fatty capsule 
containing 403 mg docosahexaenoic (DHA) and 53 mg eicosapentaenoic (EPA) acids. 
One hundred gram (100g) of the fish used in the study (Grouper, Sea bream, Kingfish, 
Emperor and Snapper) provided 150 to 200 mg omega-3 fatty acids and the dishes were 
prepared tastefully to enhance compliance by professional chefs at the Intercontinental 
City Hotel, Muscat. Body weight, height and body mass index were assessed baseline 
and a non-fasting blood sample, about 8 ml, obtained in EDTA at baseline and after 12 
weeks of intervention.  
The study was approved by the Research Ethics Committee of the Ministry of 
Health, Sultanate of Oman (Ref. MH/DGP/R&S/Proposal_Approved/8/2012), and the 
National Research Ethics Committee North West – Haydock, UK (REC reference no. 
12/NW/0760) and registered with ISRCTN Register (Reg. No. ISRCTN93233285). 
Informed and signed consent was obtained from the parents/guardians of the children 
and the study was conducted in accordance with the provisions of the ethical approval of 
the two ethics committees and the principles of Helsinki Declaration. 
5.2.2 Methods  
Sample processing – Plasma and red blood cells were separated from whole 
blood specimen by centrifugation at 1200 g, 4ºC, for 10 minutes. The plasma was 
siphoned out carefully and transferred to another tube. The buffy coat was discarded and 
the red cell pellet washed three times by suspension in physiological saline (0.85% 
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NaCl) and cold centrifugation. The plasma and red blood cells were stored at -70ºC until 
analysis. 
Anthropometry - Weight in kilogram and height in centimetre were assessed with 
a Seca Electronic Scale 890 (UNISCALE, Seca, Birmingham B5 5QB, UK) and a 
measuring board (Schorr, Weight and Measure, LLC, Olney, Maryland, USA) 
respectively.  
The specific procedures used for each micronutrient included in this analysis are 
described in section 2.4.2 Blood Lipid Profile and Vitamins. 
5.3 Results  
5.3.1 Pre-intervention (baseline) gender comparison  
Body weight, height, body max index and plasma vitamin A (all-trans retinol), 
beta carotene, vitamin E (alpha-tocopherol), total lipid (triglycerides and cholesterol), 
alpha-tocopherol and total lipid ratio, total vitamin D, parathryroid hormone, alkaline 
phosphatase, calcium and inorganic phosphate levels of the children are shown in Table 
5-1. The male compared with the female students had higher vitamin D (p<0.0001) and 
lower parathyroid hormone (p<0.0001) and alkaline phosphatase (p<0.01) levels.  
5.3.2 Post-intervention group comparison  
Compared with the control group, the children (both male and female students) 
who were given fish oil supplement for twelve weeks had increased concentrations of B- 
carotene and vitamin D (p<0.001). Similarly, both carotene (p<0.001) and vitamin D 
(p<0.05) levels were higher in those who received fish meals (Table 5-2).  
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Table 5-1: Baseline weight, height, body mass index and plasma A, D and E, beta 
carotene, total lipid, parathyroid hormone, calcium and phosphate levels of Omani 
school children 
Variables Total students (n=314) 
Male students 
(n=139) 
Female 
students 
(n=175) 
Weight (kg)  30.1 ± 7.8 29.9 ± 8.2 
Height (cm)  133.1 ± 6.4 133.1 ± 6.6 
Body mass index (kg/m2)  16.8 ± 3.4 16.7 ± 3.5 
Retinol (μmol/L) 2.7 ± 0.9 2.7 ± 0.8 2.6 ± 0.9 
Beta carotene (μmol/L) 0.7 ± 0.5 0.7 ± 0.5 0.7 ± 0.5 
α-tocopherol (μmol/L) 21.1 ± 4.8 20.9 ± 4.9 21.3 ± 4.7 
Total lipid (mmol/L) 5.0 ± 0.8 4.9 ± 0.8 5.1 ± 0.8 
α-tocopherol (μmol) / total lipid 
(mmol) ratio 
4.3 ± 0.9 4.3 ± 0.9 4.3 ± 0.9 
Vitamin D (25-hydroxy vitamin D) 
(nmol/L) 
43.1 ± 17.1 49.3 ± 17.5 38.5 ± 15.3٭٭ 
Parathyroid hormone (pmol/L) 5.5 ± 1.9 5.0 ± 1.7 5.8 ± 2.1٭٭ 
Alkaline phosphatase (U/L) 237.2 ± 73.5 225.2 ± 66.6 247.8 ± 73.7٭ 
Calcium (mmol/L) 2.5 ± 0.1 2.5 ± 0.1 2.5 ± 0.1 
Phosphate (mmol/L) 1.6 ± 0.2 1.6 ± 0.2 1.6 ± 0.2 
٭٭p<0.0001, *p<0.01 - Male students vs. Female students   
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Table 5-2: Plasma vitamin A, D and E, beta carotene, total lipid, parathyroid 
hormone, calcium and phosphate levels of male and female school children after 
intervention with DHA-rich fish oil formulation or fish meal for 12 weeks 
Variables  
Control group 
(n=116) 
Fish oil group 
(n=86) 
Fish meal 
group 
(n=108) 
Retinol  (μmol/L) 2.2 ± 0.7 2.3 ± 0.8 2.3 ± 0.8 
Beta carotene (μmol/L) 0.9 ± 0.4 1.2 ± 0.7٭٭ 1.2 ± 0.7٭٭ 
α-tocopherol (μmol/L) 20.0 ± 4.8 20.5 ± 4.5 20.5 ± 4.7 
Total lipid (mmol/L) 5.1 ± 0.8 5.1 ± 0.8 5.2 ± 0.8 
α-tocopherol (μmol) / total lipid (mmol) ratio 4.2 ± 0.9 4.6 ± 1.0$ 4.2 ± 0.8 
Vitamin D (nmol/L) 42.3 ± 17.5 54.1 ± 17.5٭٭ 49.2 ± 17.4٭ 
Parathyroid hormone (pmol/L) 5.8 ± 2.1 5.8 ± 2.1 6.4 ± 2.4 
Alkaline phosphatase (U/L) 250.4 ± 72.8 245.9 ± 65.7 253.6 ± 85.0 
Calcium (mmol/L) 2.5 ± 0.1 2.5 ± 0.1 2.5 ± 0.1 Phosphate (mmol/L) 1.9 ± 0.4 1.6 ± 0.1 1.6 ± 0.1 
** P<0.001 Control group vs. Fish oil group;  ٭p<0.05 Control group vs. Fish meal group  
$ P<0.001 Fish oil group vs. Fish meal and Control Groups    
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5.3.3 Gender-stratified post-intervention group comparison 
In the male students, beta carotene and vitamin D concentrations in the fish oil 
(p<0.001) and in the fish (p<0.05) groups were higher than in their counterparts who did 
not receive fish oil or fish meals (Table 5-4). Likewise, in the female students who were 
given fish oil and fish meals had elevated level of vitamin D (p<0.001 and p<0.05) 
compared with the control group students (Table 5-5). 
 
 
 
  
Table 5-3: Plasma vitamin A, D and E, beta carotene, total lipid, parathyroid 
hormone, calcium and phosphate levels of male and female school children after 
intervention with DHA-rich fish oil formulation or fish meal for 12 weeks. 
Variables  
Control group 
(n=116) 
Fish oil group 
(n=86) 
Fish meal 
group 
(n=108) 
Retinol (μmol/L) 2.2 ± 0.7 2.3 ± 0.8 2.3 ± 0.8 
Beta carotene (μmol/L) 0.9 ± 0.4 1.2 ± 0.7٭٭ 1.2 ± 0.7٭٭ 
α-tocopherol (μmol/L) 20.0 ± 4.8 20.5 ± 4.5 20.5 ± 4.7 
Total lipid (mmol/L) 5.1 ± 0.8 5.1 ± 0.8 5.2 ± 0.8 
α-tocopherol (μmol) / total lipid 
(mmol) ratio 
4.2 ± 0.9 4.6 ± 1.0$ 4.2 ± 0.8 
Vitamin D (nmol/L) 42.3 ± 17.5 54.1 ± 17.5٭٭ 49.2 ± 17.4٭ 
Parathyroid hormone (pmol/L) 5.8 ± 2.1 5.8 ± 2.1 6.4 ± 2.4 
Alkaline phosphatase (U/L) 250.4 ± 72.8 245.9 ± 65.7 253.6 ± 85.0 
Calcium (mmol/L) 2.5 ± 0.1 2.5 ± 0.1 2.5 ± 0.1 
Phosphate (mmol/L) 1.9 ± 0.4 1.6 ± 0.1 1.6 ± 0.1 
** p<0.001 Control group vs. Fish oil group;  ٭p<0.05 Control group vs. Fish meal group  
$ p<0.001 Fish oil group vs. Fish meal and Control Groups   
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Table 5-4: Plasma vitamin A, D and E, beta carotene, total lipid, parathyroid 
hormone, calcium and phosphate levels of the male school children after 
intervention with DHA-rich fish oil formulation or fish meal for 12 weeks 
Variables  Control group (n=51) 
Fish oil group 
(n=37) 
Fish meal group 
(n=48) 
Retinol (μmol/L) 2.2 ± 0.7 2.1 ± 0.7 2.4 ± 0.6 
Beta carotene (μmol/L) 0.9 ± 0.4 1.4 ± 0.8٭٭ 1.2 ± 0.8٭ 
α-tocopherol (μmol/L) 20.2 ± 5.6 21.1 ± 4.0 20.5 ± 3.6 
Total lipid (mmol/L) 5.1 ± 0.8 5.0 ± 0.7 5.3 ± 0.8 
α-tocopherol (μmol) / total 
lipid (mmol) ratio 
4.2 ± 0.9 4.6 ± 0.8$ 4.1 ± 0.8 
Vitamin D (nmol/L) 50.6 ± 18.9 63.1 ± 17.3٭٭ 58.0 ± 16.5٭ 
Parathyroid hormone 
(pmol/L) 
5.5 ± 1.9 4.9 ± 1.4 5.9 ± 2.1 
Alkaline phosphatase (U/L) 237.2 ± 61.8 226.6 ± 39.2 256.7 ± 82.6 
Calcium (mmol/L) 2.5 ± 0.1 2.5 ± 0.1 2.5 ± 0.1 
Phosphate (mmol/L) 2.4 ± 0.4 1.6 ± 0.1 1.6 ± 0.1 
**p<0.001 Control group vs. Fish oil group; ٭p<0.05 Control group vs. Fish meal group +p<0.05 Fish 
oil group vs. Fish meal and Control groups; $p<0.05 Fish oil group vs. Control and Fish meal groups  
 
Table 5-5: Plasma vitamin A, D and E, beta carotene, total lipid, parathyroid 
hormone, calcium and phosphate levels of the female school children after 
intervention with DHA-rich fish oil formulation or fish meal for 12 weeks 
Variables Control group (n=65) 
Fish oil group 
(n=49) 
Fish meal group 
(n=60) 
Retinol (μmol/L) 2.2 ± 0.7 2.2 ± 0.9 2.3 ± 0.8 
Beta carotene (μmol/L) 0.8 ± 0.5 1.1 ± 0.7 0.9 ± 0.8 
α-tocopherol (μmol/L) 19.9 ± 4.2 20.1 ± 4.9 20.6 ± 5.5 
Total lipid (mmol/L) 5.1 ± 0.8 5.2 ± 0.8 5.2 ± 0.8 
α-tocopherol (μmol) / total 
lipid (mmol) ratio 
4.2 ± 0.8 4.6 ± 1.0$ 4.2 ± 0.8 
Vitamin D (nmol/L) 36.1 ± 13.5 47.3 ± 14.6٭٭ 41.8 ± 14.6٭ 
Parathyroid hormone 
(pmol/L) 
6.0 ± 2.2 6.5 ± 2.3 6.8 ± 2.6 
Alkaline phosphatase (U/L) 261.2 ± 79.6 260.8 ± 77.6 251.2 ± 87.5 
Calcium (mmol/L) 2.5 ± 0.1 2.5 ± 0.1 2.5 ± 0.1 
Phosphate (mmol/L) 1.6 ± 0.2 1.7 ± 0.2 1.6 ± 0.1 
٭٭p<0.001 Control group vs. Fish oil group; ٭p<0.05 Control group vs. Fish meal group  
$p<0.05 Fish oil group vs. Control and Fish meal groups  
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5.3.4 Pre- and post-intervention comparison 
Post-intervention plasma vitamin D (Fig. 5-1) and parathyroid hormone (Fig. 5-2) 
concentrations compared with pre-intervention (baseline) were higher in the children 
who received fish oil and fish meals (p<0.0001). There was no difference between the 
pre- and post-intervention concentrations of the two analytes in the control group.  
 
 
Figure 5-1: Plasma vitamin D concentrations before (baseline) and after 
intervention with fish oil and fish meal for 12 weeks 
 
 
 
Figure 5-2: Plasma parathyroid hormone levels before (baseline) and after 
intervention with fish oil and fish meal for 12 weeks 
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5.4 Discussion 
Urbanisation, heavy reliance on imported foods (primarily beef, dairy and poultry 
products and refined cereals, vegetable oils and sugar) and sweetened beverages and the 
proliferation of food supermarkets and convenience fast-food restaurants have led to a 
drastic change in dietary habits in Oman. The impact of the change, which is 
characterised mainly by intakes of calorie-rich and essential micronutrient-poor foods, on 
lipid-soluble nutrient (vitamin A, D and E, and beta carotene) status of Omani children 
has not been fully investigated. Accumulating evidence demonstrates, these 
micronutrients, in addition to their well-characterised classical functions (Goodman et 
al., 1966, Bonet et al., 2003, DeLuca, 2004, Black et al., 2008, Sathe and Patel, 2010, 
Niki and Traber, 2012) play a role in gene expression (Zhang et al., 1992, Azzi et al., 
2004, Bastien and Rochette-Egly, 2004, Hossein-nezhad et al., 2013), cognitive function 
(Grodstein et al., 2007, Olson and Mello, 2010, Soni et al., 2012, Ulatowski et al., 2014) 
and antioxidant defence (Burton and Ingold, 1984, Lin et al., 2005). Moreover, 
deficiency/insufficiency of these nutrients is thought to be associated with increased risks 
of non-communicable diseases. 
A biannual supplementation programme with a high dose vitamin A in infants 
and children aged six to fifty-nine months (UNICEF, 2007, WHO, 2011a) is effective in 
reducing morbidity, mortality and vision impairment (Beaton et al., 1993, Fawzi et al., 
1993, Imdad et al., 2010). Regardless, vitamin A deficiency is still the foremost cause of 
these preventable problems, particularly in South East Asia and Africa. Based on the 
prevalence of night blindness and biochemical vitamin A deficiency based estimates, 45 
and 122 countries respectively have vitamin A deficiency of public health significance 
(WHO, 2009). A 0.70 μmol/l serum/plasma vitamin A concentration is the cut-off point 
of deficiency (WHO, 1996, de Pee and Dary, 2002) which is used as a marker for 
assessing severity and public health significance in most age groups (WHO, 2011b). A 
cross-sectional survey (Ministry of Health of the Sultanate of Oman, 2006) on food 
fortification and micronutrient deficiencies conducted in Oman in 2004 found vitamin A 
deficiency in children aged 6-59 (5.5%), 6-23 (18%) and 24-59 (3%) months, and in non-
pregnant women of reproductive age (0.5%). In the current study, deficiency (≤ 0.70 
μmol/l) was not detected in any of the children and only three of them had a marginal 
status (<1.05 μmol/l). Some of the milk and dairy products in the Omani market are 
fortified with vitamin A (Alasfoor et al., 2007) and it is mandatory for edible vegetable 
oils sold in the country to incorporate 60 IU/g of the vitamin. It appears that the children 
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were able to maintain adequate status by consuming foods fortified with preformed 
vitamin A as well as vegetables containing provitamin A.  
There is a wide variability in blood beta carotene concentration among healthy 
individuals (Winklhofer-Roob et al., 1997). The variations are primarily a reflection of 
intake, vitamin A status and genetic make-up (Lacher et al., 2005, Tourniaire et al., 2009, 
Borel, 2012). Gender-related differences in concentration have also been reported 
(Hercberg et al., 1994, Olmedilla et al., 1994). Nevertheless, depending on the amount of 
fruits and vegetables consumed, blood beta carotene levels generally fall between 0.2 
and 1.5 μmol/l (Burri, 1997). The present study did not detect gender-related effect on 
plasma beta carotene, and the values were within the aforementioned range in 87% 
(0.63±0.31 μmol/l), below in 7% (0.16±0.04 μmol/l) and above in 6% (1.87±0.28 
μmol/l) of the children. Fresh fruits, which are an important component of the Omani 
foods, are eaten three or more times a week (Opara et al., 2007). This Omani dietary 
habit may provide and an explanation for the ‘adequate’ beta carotene status in most of 
the children in the current study.  
In contrast to vitamin A, the concentration of plasma beta carotene increased 
significantly in the fish diet and fish oil groups after intervention for 12 weeks  (P<0.001) 
(Table 5-2). This finding, which is consistent with the report that fish oil 
supplementation enhances the absorption of beta carotene in human (Nair et al., 1993) 
and rats (Blakely et al., 1992), is rather intriguing since dietary fat is thought to facilitate 
fat-soluble vitamin uptake and transport.  
As is the case with the other fat-soluble vitamins, the blood level of vitamin E 
(alph-tocopherol) varies considerably between individuals and population groups 
(Winklhofer-Roob et al., 1997, Valtuena et al., 2011, Peter et al., 2013, Traber, 2014). 
Nevertheless, a concentration of less than 12 μmol/l in plasma is defined as the cut-off 
point of vitamin E inadequacy (Institute of Medicine et al., 2000), and the minimum 
concentration required to help prevent cardiovascular diseases and cancer is thought to 
be 30 μmol/l (Gey, 1995). 96.6% of the children in this study had concentrations higher 
and 3.4% lower than the cut-off point (12 μmol/l). Two children had levels (7.38 and 
7.89 μmol/l) less than 8 μmol/l, a value which is associated with neurological disease. 
Since vitamin E is intimately associated with circulating lipids, the ratio of the two 
nutrients was used to evaluate vitamin E status. All of the children had vitamin E/total 
lipid ratio higher than the cut-off point 1.11 μmol/mmol suggesting that the ‘deficiency’ 
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in the 3.4% of the children indicated by plasma vitamin E concentration may not be 
related to a low intake.  
There was no difference in the post-intervention plasma vitamin E concentration 
between the three groups (Table 5-2, 5-3 and 5-4). In contrast, the post-intervention 
vitamin E/total lipid ratio was significantly higher in the children who received the fish 
oil supplement compared with the fish diet and control groups. This difference was most 
likely due to the combined effect of omega-3 fatty acids which reduces blood lipid 
content and the vitamin E incorporated in the supplement to prevent lipid peroxidation.  
Consistent with the previous reports of Omani non-pregnant (Al-Kindi, 2011) and 
pregnant (Al Kalbani et al., 2011) women, school children aged 9 to 12 years (Kilani et 
al., 2013) and adults aged 18 to 55 (Abiaka et al., 2013), most of the children in the 
current study were severely deficient (<27.5 nmol/L; 10.5% boys and 28.5% girls), 
deficient (27.5-44.9 nmol/L; 47.6% boys and 49.4% girls) or insufficient (50 – 74.9 
nmol/L; 34.6% boys and 21.5% girls) in vitamin D. Only 7.3% boys and 0.6% girls had a 
sufficient level (≥ 75 nmol/L) level. As it is borne out by the elevated levels of 
parathyroid hormone and alkaline phosphatase (Table 5-1) the insufficiency was more 
pronounced in the female children. The high prevalence of vitamin D deficiency in the 
children should be a major public health concern because childhood is a period of 
skeletal mineral acquisition and bone modelling and there is evidence that vitamin D 
plays a critical role in muscle growth and development, cognitive function and 
modulation of innate and adaptive immunity.  
Omega-3 fatty acids have been shown to enhance bone mineralisation in human 
and experimental animals but their effect on blood vitamin D has not been investigated. 
The children who were given oily fishes, which are thought to contain variable amounts 
of vitamin D, and DHA-enriched fish oil supplement, which was stripped out of vitamin 
D, had elevated plasma 25-hydroxy vitamin D concentration compared with the control 
group (Tables 5-2, 5-3, 5-4). It is not obvious how fish oil increases plasma vitamin D. 
However, since it did not have any effect on PTH or alkaline phosphatase the action may 
be mediated by the facilitation of vitamin D transport across the intestinal mucosa. 
Indeed, there is evidence that dietary fat promotes vitamin D absorption (Dawson-
Hughes et al., 2015).  
Bone mineral density of the children and vitamin D status of rural children with 
limited access to school transport were not assessed. These limitations will be addressed 
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in future investigations. This study demonstrates that vitamin D insufficiency is highly 
prevalent in Omani young school children and it could be mitigated with omega-3 fatty 
acid supplementation. Various studies have reported vitamin D deficiency/insufficiency 
in non-pregnant and pregnant Omani women. It is conceivable that Omani children may 
be at risk of developmental and health problems caused by prenatal and postnatal vitamin 
D deficiency. Vitamin D plays a crucial role in skeletal and extra-skeletal systems. 
Therefore, there is an urgent need for a well-thought-out programme which incorporates 
a fortification of foods and drinks favoured by children and outdoor activities to help 
tackle this major public health problem.  
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CHAPTER 6: 
Red Blood Cell Fatty Acid Profile 
of Healthy Omani School Children 
Before and After Intervention  
with Omega 3 Fish Fatty Acids 
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6.1 Introduction  
The traditional Omani economy was based on subsistence farming, herding, 
fishing and trading (The Bank Group, 1972, College of Agriculture, 1995, Al-Mashakhi 
and Koll, 2007) and the diet of the population consisted mainly of whole grain, legumes, 
fruits, vegetables and fish (UNICEF, 1973, Musaiger, 1998). However, following the 
discovery and exploitation of oil five decades ago, the country has undergone a major 
economic transformation (Musaiger, 1998) and registered a significant progress in health 
and social care, education and reduction in poverty and mal-nutrition (Al-Lamki, 2010). 
In the same period of time, the prevalence of non-communicable chronic diseases, such 
as obesity, diabetes, cancer, high blood pressure and cardiovascular disease (Al Riyami 
et al., 2012, Rahim et al., 2014a) and the consumption of imported energy-dense foods, 
vegetable oils, milled and polished grains and carbonated beverages (Musaiger, 1998, 
US Commercial Service, 2005, Mohammed, 2009) have increased considerably. The 
numerous fast food outlets and restaurants dotted across towns and the supermarket 
ready meals have and are contributing to the transformation of the traditional dietary 
pattern. This change in food culture is likely to be enduring as there is evidence that 
children and adolescents in Oman and other Arab countries have adopted readily 
Western eating habits (Chakar and Salameh, 2006, Braithwaite et al., 2014).  
Injudicious consumption of contemporary Western pattern diets - high protein 
and fat of intensively reared land animals, refined sugar, vegetable fat and oils (mainly 
sunflower, safflower and corn) and low fresh fruits and vegetables and marine foods 
(Cordain et al., 2005a, Patterson et al., 2012, Misra et al., 2010, Carrera-Bastos et al., 
2011a) – have played a critical role in the rise of non-communicable chronic diseases 
(Carrera-Bastos et al., 2011a, Meyerhardt et al., 2007, Torfadottir et al., 2012) in the last 
six decades. This deleterious effect is attributed primarily to an excessive amount of 
saturated, trans and omega 6 fatty acid and an insufficient omega 3 fatty acid and 
essential micro-nutrient content of the consumed diet (Cordain et al., 2005a, Litin and 
Sacks, 1993, Simopoulos, 2011).  
Cell line, experimental animal and human epidemiological and intervention 
studies demonstrate that the long chain omega 3 polyunsaturated fatty acids directly, or 
indirectly via their metabolites, play a pivotal role in neuro-visual development, function 
and rehabilitation (Martinez, 2001, Helland et al., 2008a, Ryan et al., 2010, Pu et al., 
2013), cardioprotection (Nestel et al., 2015, Costanzo et al., 2013), modulation of 
inflammatory and immune responses (Calder, 2013, Maskrey et al., 2013, Fritsche, 2015) 
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signal transduction and gene expression (Gdula-Argasinska et al., 2015, Nakamoto et al., 
2015, Zaree et al., 2015).  
In light of the rapidly shifting nutrition transition in Oman, this study investigated 
fatty acid status of preadolescence school children before and after intervention with fish 
oil or oily fish. 
6.2 Materials and Methods  
6.2.1 Subjects and recruitment 
Female (n=160) and Male (n=125) healthy school children aged 9 and 10 years 
were recruited from three schools in Muscat, Sultanate of Oman. Subsequently, the 
schools were assigned at random to one to three groups and the children given a 100 
gram oily fish sandwich, lightly grilled (Fish Group), fish oil capsule, 403 mg DHA and 
53 mg EPA (Fish Oil Group) or their habitual diet (Control Group) during lunch time, on 
schools days, for twelve weeks. The fish used for the sandwich, which were grouper, sea 
bream, kingfish, emperor and snapper, supplied between 150 and 200 mg omega-3 fatty 
acids (EPA, DPA and DHA). To help improve consistency, taste and flavour and 
consequently compliance the sandwich was prepared by professional chefs of the 
Intercontinental City Hotel, Muscat. About 8 ml of non-fasting blood specimen was 
collected from each child before and at the end of the intervention period and stored in a 
freezer at - 80° C and subsequently transported in dry ice to London for analysis. Ethical 
approval was obtained from the Ethics Committee of the Ministry of Health, Sultanate of 
Oman (Ref. MH/DGP/R&S/8/2012), and the National Research Ethics Committee North 
West – Haydock, UK (REC reference no. 12/NW/0760). Informed and signed consent 
was obtained from the parents/guardians of the children. Study registration 
ISRCTN93233285.  
6.2.2 Analysis of red blood cell fatty acids  
Red blood cell lipids were extracted based on the method of Folch et al. (1957b) 
by homogenising 0.5 ml of sample in chloroform/methanol (2:1 v/v) containing the 
antioxidant butylated hydroxytoluene (BHT, 0.01% w/v) under nitrogen. Fatty acid 
methyl esters (FAMEs) were prepared by acid-catalysed transesterfication reaction by 
heating the extracted lipids in 4 ml methanolic acetyl chloride (15% v/v) in a tightly 
sealed vial at 70C° for 3 hours after degassing with nitrogen. The FAMEs were extracted 
with petroleum spirit, dried and then re-dissolved in heptane for separation by a gas 
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chromatograph (HRGC MEGA 2 series, Fisons Instruments, Italy) fitted with a BPX 70 
capillary column (60m x 0.25mm ID, 0.25µ film). Hydrogen was used as carrier gas at a 
flow rate of 2.3 ml/min and the injector and detector temperatures were set at 250 and 
280°C, respectively. The initial oven temperature which was 60°C increased at 5ºC/min 
to 160°C, maintained for 5 min, and then increased at 3ºC/min to 205°C and kept 
constant for 12 minutes. The eluted peaks were identified with fatty acid methyl ester 
standard mixture certified for quality (Supelco® 37 Component FAME Mix. U47885-U, 
Sigma-Aldrich, Dorset, UK), GC-MS authenticated fatty acid methyl esters prepared 
from lipid extract of vegetable seed oils containing alpha-linolenic, gamma-linolenic and 
stearidonic acids, and bovine brain L-A-phosphatidylethanolamine Type 1 (Sigma-
Aldrich, Dorset, UK ). Peak areas were computed with EZChrom Ellite, version 3.2 
(Scientific software, Pleasant, CA, USA).  
6.3 Data Analyses  
The continuous variables are expressed as mean and standard deviation (mean± 
sd). Statistical differences between the data of the female and male students at baseline, 
and between the three groups at post-intervention were evaluated with an independent 
(unpaired) t-test and a one-way analysis of variance (ANOVA), respectively. The 
Bonferroni pairwise multiple comparison post-hoc test was performed when the 
ANOVA F-test indicated significance. A univariate regression analysis was used to 
assess relationships between the major fatty acids. P values of less than 0.05 were 
deemed statistically significant. Analyses were conducted with IBM SPSS statistics, 
version 22 (IBM Corporation, New Orchard Road, Armonk, New York 10504-1722, 
USA)  
6.4 Results  
6.4.1 Demographics and baseline blood pressure and lipids  
Age, height, weight, systolic and diastolic blood pressure, plasma triglycerides 
and HDL, LDL and total cholesterol levels of the children prior to the intervention are 
presented in Table 6-1. There was no difference in any of the aforementioned variables 
between the genders (p>0.05).  
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Table 6-1: Baseline characteristics of the children 
Characteristics Boys & Girls 
(n=285) 
Boys  
(n=125) 
Girls 
(n=160) Age (year) 9/10 9/10 9/10 Weight (kg) 29.6±7.5 29.3±6.6 29.9±8.2 Height (cm) 133.3±6.6 133.3±6.3 133.3±6.8 Systolic BP (mmHg) 107.2±10.4 107.5±9.5 106.9±10.6 Diastolic BP (mmHg) 63.8±10.3 63.8±9.9 63.8±10.6 
Triglycerides (mmol/L) 0.61±0.3 0.59±0.30 0.63±0.26 Total Cholesterol 
(mmol/L) 4.32±0.68 4.28±0.71 4.35±0.65 
HDL- Cholesterol (mmol/L) 1.38±0.32 1.41±0.34 1.36±0.31 
LDL-Cholesterol (mmol/L) 2.66±0.55 2.61±0.58 2.71±0.53  
 
 
6.4.2 Baseline red blood cell fatty acids  
The male students had a higher level of myristic (C14:0), palmetic (C16:0) 
(p<0.05) and oleic (C18:1n-9, p<0.01) and lower adrenic (22:4n-6, p<0.05) acids 
compared with their female counterparts. The percentages of the other saturated, mono-
unsaturated, n-6 and n-3 fatty acids and DHA sufficiency index (DHA/N-6 DPA) were 
not different between the two groups (p>0.05, Table 6-2). The n-3 index correlated 
positively with arachidonic (r=0.258, p=0.004) and total n-6 (r=0.504, p=0.0001) and 
inversely with total saturated (r= - 0.765, p=0.0001) and mono-unsaturated (r= - 0.684, 
p=0.0001) fatty acids in the male children. Similarly, in the girls, arachidonic (r= 0.169, 
p=0.030), total n-6 (r=0.340, p=0.0001), total saturated (r= - 0.677, p=0.0001) and mono-
unsaturated (r= - 0.484, p=0.0001) fatty acids and diastolic blood pressure (r= - 0.207, 
p=0.049) and body weight (r= - 0.224, p=0.005) were associated with n-3 index. 
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Table 6-2: Baseline percent red blood cell lipid acid composition of  
Omani preadolescent school children aged 9 and 10 years 
Fatty acids Boys & Girls (n=290) 
Boys 
(n=126) 
Girls 
(n=164) 14:0 0.17±0.10 0.18±0.10* 0.16±0.09 16:0 23.5±4.3 24.2±4.5* 22.9±4.1 18:0 15.9±1.4 15.9±1.5 15.9±1.3 20:0 0.36±0.11 0.35±0.11 0.36±0.10 22:0 1.58±0.49 1.56±0.52 1.59±0.48 24:0 3.42±.1.1 3.44±1.1 3.40±0.99 
∑ Saturates 44.9±5.9 45.6±6.5 44.3±5.3     16:1n-7 0.17±0.07 0.17±0.07 0.17±0.07 18:1n-7 0.63±0.10 0.62±0.11 0.64±0.10 18:1n-9 11.6±1.5 11.9±1.6** 11.4±1.3 20:1n-9 0.16±0.05 0.15±0.06 0.16±0.05 24:1n-9 2.39±0.72 2.33±0.69 2.44±0.74 
∑ Monoenes 15.0±1.9 15.2±2.1 14.8±1.7     18:2n-6 9.31±1.5 9.23±1.5 9.36±1.5 18:3n-6 0.10±0.03 0.10±0.03 0.09±0.03 20:2n-6 0.18±0.06 0.18±0.06 0.19±0.05 20:3n-6 1.33±0.37 1.33±0.41 1.34±0.33 20:4n-6 14.7±1.8 14.6±1.9 14.9±1.8 22:4n-6 2.84±0.87 2.71±0.90* 2.94±0.83 22:5n-6 0.67±0.24 0.66±0.25 0.68±0.22 N-6 Metabolites 19.9±2.7 19.5±2.70 20.1±2.7 
∑ N-6 29.2±3.5 28.8±3.8 29.5±3.3     18:3n-3 0.05±0.07 0.05±0.06 0.05±0.08 20:5n-3 0.36±0.14 0.39±0.13 0.35±0.14 22:5n-3 0.99±0.33 0.97±0.37 1.00±0.30 22:6n-3 3.63±1.45 3.50±1.57 3.78±1.35 N-3 Index 4.10±1.32 3.89±1.65 4.20±1.41 N-3 Metabolites 4.98±1.79 4.86±1.95 5.07±1.64 
∑ N-3 5.00±1.80 4.84±1.96 5.12±1.67     
16:0 DMA 2.45±0.49 2.49±0.52 2.41±0.47 
18:0 DMA 3.33±0.56 3.26±0.56 3.38±0.55 
18:1 DMA 0.43±0.11 0.42±0.12 0.44±0.10 
Male vs. Female * p<0.05, **p<0.01 
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6.4.3 Post-intervention red blood cell fatty acids, blood pressure and plasma lipids  
Red blood cell total lipid fatty acid composition of the children after intervention 
with fish oil or oily fish for twelve weeks is shown in Table 6-3. The control group 
compared with those who received oily fish and fish oil capsules had higher levels of 
lignoceric (24:0), nervonic (24:1n-9), docosapentaenoic (DPA, 22:5n-6) (p<0.05) and 
lower eicosapentaenoic (EPA, 20:5n-3), decosapentaenoic (DPA, 22:5n-3), 
docosahexaenoic (DHA, 22:6n-3) and total n-3 fatty acids, n-3 metabolites, n-3 index 
and 18:1 dimethyl acetals (p= 0.0001). Palmitic and total saturated fatty acids, DHA, 
DHA sufficiency index and n-3 index were lower (p<0.05) and AA, n-6 metabolites and 
n-3 DPA higher (p=0.0001) in the oily fish group than in the children supplemented with 
fish oil capsules. 
In the fish oil group, n-3 index correlated positively with arachidonic (r=0.394, 
p=0.0001), adrenic (r=0.394, p=0.0001), n-6 DPA (r=0.562, p=0.0001) and total n-6 
(r=0.414, p=0.0001) and negatively with palmitic (r= -0.762, p=0.0001), total saturated 
(r= -0.816, p=0.0001), palmitoleic (r= -0.384, p=0.001), oleic (r= -0.347, p=0.002) and 
total mono-unsaturated (r= - 0.431, p= 0.0001) fatty acids. Similarly, there was a 
correlation between n-3 index and arachidonic (r=0.231, p=0.038), oleic (r= -0.271, 
p=0.008) and total saturated (r= -0.439, p= 0.0001) and mono-unsaturated (r= -0.213, 
p=0.037) fatty acids in the children who received oily fish. 
Post-intervention blood pressure, plasma triglycerides and LDL, HDL and total 
cholesterol values of the children are presented in Table 6-4. Systolic and diastolic blood 
pressure (p=0.0001) and plasma triglycerides (p<0.05) but not HDL, LDL and total 
cholesterol (p>0.05) were lower in the children supplemented with fish oil compared 
with those who were fed oily fish. There was no gender-related difference in any of the 
aforementioned variables between the control and oily fish children (p>0.05). The boys 
in the fish oil group had lower triglyceride and higher HDL cholesterol levels than their 
female counterparts (p<0.05). 
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Table 6-3: Percent red blood cell lipid acid composition of Omani preadolescent 
school children aged 9 and 10 years after intervention with oily fish or fish capsule 
for 12 weeks 
Fatty acids Control (n=102) Oily Fish (n=77) Fish oil (n=96) 
14:0 0.10±0.07 0.11±0.10 0.12±0.08 
16:0 21.1±3.6 19.8±3.6a 21.5±3.8 
18:0 16.2±0.99 16.2±1.1 16.4±1.1 
20:0 0.32±0.09 0.33±0.07 0.32±0.06 
22:0 1.57±0.24 1.53±0.27 1.53±0.29 
24:0 3.71±0.54g 3.45±0.58 3.46±0.73 
∑ Saturates 42.9±3.4 41.4±2.9 a 43.3±4.0 
    
16:1n-7 0.13±0.06 0.13±0.08 0.12±0.05 
18:1n-7 0.63±0.11 0.61±0.09 0.59±0.09 
18:1n-9 11.5±1.1 11.3±1.2 11.4±1.2 
20:1n-9 0.14±0.09 0.15±0.04 0.14±0.04 
24:1n-9 2.65±0.47g 2.53±0.51 2.46±0.51 
∑ Monoenes 15.0±1.3 14.7±1.4 14.8±1.4 
    
18:2n-6 9.77±1.3 9.64±1.3 10.0±1.2 
18:3n-6 0.04±0.03 0.04±0.02 0.03±0.02 
20:2n-6 0.15±0.05 0.17±0.05b 0.16±0.04 
20:3n-6 1.44±0.27 1.45±0.31 1.35±0.25 
20:4n-6  14.8±2.1 15.2±1.8 c 13.7±2.0 e 
22:4n-6 3.00±0.57 2.87±0.59 2.42±0.53f 
22:5n-6 (N-6 DPA) 0.74±0.19g 0.67±0.17 0.65±0.14 
N-6 Metabolites 20.1±2.7 20.3±2.4 18.3±2.5f 
∑ N-6 29.9±3.1 30.0±2.7 c 28.3±3.0 e 
    
18:3n-3 0.03±0.02 0.04±0.02 0.03±0.02 
20:5n-3 0.25±0.13h 0.41±0.19 0.36±0.12 
22:5n-3 1.17±0.29h 1.40±0.27 c 1.07±0.22 
22:6n-3 4.49±1.43h 5.63±1.24 d 6.25±1.53 
N-3 Index 4.74±1.53h 6.03±1.39 d 6.60±1.63 
N-3 Metabolites 5.91±1.69h 7.42±1.57 7.59±1.82 
∑ N-3 5.95±1.70h 7.46±1.58 7.62±1.82 
    
16:0 DMA    1.97±0.31 2.00±0.31 1.90±0.29 
18:0 DMA 3.26±0.41 3.46±0.46 b 3.37±0.49 
18:1 DMA 0.41±0.09h 0.48±0.09 0.48±0.08 
DHA/N-6 DPA 6.49±2.71 8.77±2.79 b 9.86±2.12f 
          Oily Fish vs. Control & Fish oil (a p< 0.05), vs. Control (b p< 0.05) and vs. Fish Oil (c p<0.0001, d 
p<0.05) 
          Fish Oil vs. Control (e p<0.001) and vs. Oily Fish & Control (f p<0.0001) 
     Control vs. Oily Fish & Fish Oil (g p<0.05, h p< 0.0001) 
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Table 6-4: Blood pressure, plasma triglycerides and HDL, LDL and total cholesterol of 
the children after intervention for 12 weeks with fish oil or oily fish  Control Oily Fish Fish Oil 
Characteristics All (n=102) Male (n=46) Female (n=56) All (n=95) Male (n=42) Female (n=50) All (n=78) Male (n=34) Female (n=44) Systolic BP (mmHg) ─ ─ ─ 111.9 ±9.6 111.9 ±9.1 111.8 ±10.0 101.7 ±7.5** 102.1 ±6.7 101.4 ±7.9 Diastolic BP (mmHg) ─ ─ ─ 67.0 ±11.7 66.6 ±11.6 67.0 ±11.9 60.1 ±7.9** 60. 0±5.5 60.0 ±7.3 Triglycerides 
(mmol/L) 0.64 ±0.35 0.59 ±0.37 0.67 ±0.33 0.65 ±0.23 0.64 ±0.24 0.65 ±0.22 0.55 ±0.28* 0.48 ±0.27$ 0.60 ±0.28 Total Cholesterol  
(mmol/L) 4.47 ±0.65 4.52 ±0.65 4.44 ±0.65 4.49 ±0.71 4.57 ±0.80 4.43 ±0.63 4.50 ±0.64 4.49 ±0.57 4.52 ±0.70 
HDL  
(mmol/L) 1.39 ±0.29 1.41 ±0.28 1.38 ±0.31 1.41 ±0.33 1.46 ±0.33 1.37 ±0.32 1.44 ±0.32 1.55 ±0.35$ 1.36 ±0.28 
LDL  
(mmol/L) 2.80 ±0.54 2.83 ±0.56 2.75 ±0.52 2.79 ±0.54 2.81 ±0.66 2.76 ±0.44 2.81 ±0.55 2.71 ±0.49 2.89 ±0.59 
* p<0.05 Fish oil vs. Fish and vs. Control (All), ** p< 0.0001 Fish oil vs. Fish (All); $ p<0.05 Male vs. Female (Fish oil 
group) 
 
 
6.5 Discussion  
The primary focus of this study was the n-3 long chain polyunsaturated fatty acids 
which are thought to be limiting nutrients in Westernised dietary patterns. The sum of red 
blood cell DHA and EPA percentages, n-3 fatty acid index, was used to assess status.  
Previous studies have reported higher levels n-3 long chain polyunsaturated fatty 
acids in women than in men (Lohner et al., 2013) this distinction is attributed to hormonal 
effect (Childs et al., 2008) the current study, although the female children had slightly 
elevated levels of DHA, n-3 metabolites (EPA, n-3 DPA and DHA) and n-3 fatty acid index 
compared with their male counterparts, the differences were not statistically significant. 
This was predicable since the children were prepubescent aged 9 and 10 years and the 
gender-related variation in oestrogen concentration would not be high enough to have a 
measurable influence on the activity of delta 6 and 5 desaturases.  
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Consistent with the country’s long maritime history and coastline fish is an integral 
part of the Omani traditional diet. Therefore, the low mean baseline red cell n-3 fatty acid 
index of the children, which is broadly comparable to those of healthy Guatemalan 
(Solomons et al., 2015) Danish (Damsgaard et al., 2013) and American (Harris et al., 2013) 
children of a similar age group, suggests the consumption of fish might have declined 
among the preadolescent Omani perhaps in favour of the widely available subsidised 
processed foods (Mohammed, 2009) which are high in saturated and n-6 fatty acids.. The 
most striking and indeed puzzling finding was the very low n-3 fatty acid index (<2%), 
which was unrelated to improper specimen collection and processing, in a small number of 
seemingly healthy children with no history of mental or neurological disorders (Figure 5-
1).The short and long-term implications of this finding is not apparent; nevertheless, it is of 
concern because of the critical role of n-3 long chain fatty acids, particularly in visual and 
neuronal development, function and brain protection (Ryan et al., 2010, Martinez et al., 
2000, Baumgartner, 2016, Farooqui and Farooqui, 2016, Bauer et al., 2014). In addition, in 
adults, there is evidence that patients with psychiatric conditions and individuals at a higher 
risk of unexpected death from a heart disease have red blood cell n-3 fatty acid index of less 
than 4% (Messamore and McNamara, 2016). These observations are pertinent for children 
since early life is thought to be the genesis of a number of non-communicable chronic 
diseases (psychiatric and cardiovascular) (Stein, 2003, Abbott et al., 1998, Brown and 
Susser, 2008, Hollis, 2000, Holman, 1961, McGill et al., 2009b). Indeed, O'Sullivan and 
colleagues have reported that n-3 fatty acid index correlates with reduced cardiovascular 
disease risk factors in adolescent boys (O'Sullivan et al., 2011). 
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Figure 6-1: Baseline Percent N-3 Fatty Acid Index Distribution 
After 12 weeks supplementation, compared with the controls, red blood cell n-3 fatty 
acid index increased by 27.2% and 39.2% in the oily fish and fish oil groups, respectively. 
The observed differential increase was a reflection of intake which was 150 to 200 mg/day 
n-3 long chain polyunsaturated fatty acids in the oily fish and 456 mg/day in the fish oil 
children. A pilot test conducted on a small number of children prior to the start of 
supplementation revealed the maximum amount of oily fish that they can consume in a 
single meal was 100 grams containing the aforementioned amount of n-3 long chain pufa. 
Although red blood cell n-3 fatty acid index of the children increased with both oily fish 
(6.03±1.39%) and fish oil (6.60±1.63%) supplementation it did not reach the 
cardioprotective high value target (≥8%) for adults proposed by Harris and von Schacky 
(2004). The reason for this is not evident; however, it could be the 12 week supplementation 
period was short, the 456 mg/day given to the children was insufficient or both. Consistent 
with our findings, Block and colleagues (2008) have reported 2/3 servings of oily fish a 
week, 2/3 standard fish oil capsules a day or 2 or more servings of oily fish a week plus 
standard fish oil capsules did not raise the level of red blood cell n-3 fatty acid index to 
≥8%. The American Heart Association (AHA) guidelines have suggested adults need to 
consume 500 to 1000 mg of docosahexaenoic and eicosapentaenoic acids from oily fish to 
help reduce the risk of coronary heart disease (Harris and Von Schacky, 2004, Kris-Etherton 
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et al., 2002b). It is plausible children and adults may respond differently to n-3 fatty acid 
supplementation; however, from the current study, it appears the lower intake, 500 mg/day, 
suggested by AHA is unlikely to increase n-3 fatty acid index to the proposed optimal target 
(Harris and Von Schacky, 2004) in adults.  
The fish oil group compared with their counterparts who received oily fish and with 
baseline had significantly lower levels of systolic (─9.1% and ─5.1%) and diastolic 
(─10.3% and ─5.8%) blood pressure and plasma triglycerides (─15.4% and ─8.3%). 
Conversely, in contrast to previous findings (Julian-Almarcegui et al., 2016, Dallongeville 
et al., 2003), oily fish did not seem to have beneficial effects on any of the above blood 
parameters in the current study. A plausible explanation for the discrepancy might be that 
the dose of omega 3 fatty acids, 150 to 200 mg/day, given to the group was too low to have 
a discernible impact. There is a strong association between childhood and adulthood blood 
pressure (Chen and Wang, 2008, Magnussen and Smith, 2016); therefore, early 
supplementation of children with n-3 long chain polyunsaturated fatty acids might help to 
reduce the risk of development of essential hypertension later in life.  
With the exception of palmitolic acid which was lower in the children who were 
given oily fish there was no difference in any of the other saturated and mono-unsaturated 
fatty acids between the three groups. This finding was not unexpected as the oily fish and 
fish oil supplement used in the study contained saturated and unsaturated fatty acids. N-3 
fatty acid index correlated inversely with total saturated (Figure 6-2) and mono-unsaturated 
(Figure 6-3) fatty acids in the oily fish and fish oil groups. This perhaps to be expected since 
these fatty acids are displaced from membrane by both eiocosapentaenoic and 
docosahexaenoic acids (Walker et al., 2015, Ye et al., 2010).   
152 
 
 
Figure 6-2: Post-intervention Relationship between Total Saturated Fatty Acids and N-
3 Fatty Acid Index (Fish oil group r = - 0.816, p<0.0001; Fish group r = - 0.439, 
p<0.0001) 
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Figure 6-3: Post-intervention Relationship between Total Monounsaturated Fatty 
Acids and N-3 Fatty Acid Index (Fish Oil Group r = - 0.431, p<0.0001;  
Fish Group r = - 0.231, p <0.05) 
154 
 
In agreement with previous studies fish oil supplementation increased n-3 
metabolites and n-3 fatty acid index and concomitantly reduced arachidonic (Walker et al., 
2015, Simopoulos, 2002b, Metcalf et al., 2007, Rajamoorthi et al., 2005), dihomo gamma 
linolenic and n-6 docosatetraenoic acids. In contrast, oily fish did not decrease the level of 
the aforementioned n-6 fatty acids. Fish species from the warm-water of Gulf of Oman and 
Indian Ocean contain appreciable amounts of linoleic, dihomo gamma linolenic and 
arachidonic acids and this may have counterbalanced the n-6-reducing effect of 
docosahexaenoic and eicosapentaenoic acids. Paradoxically, although arachidonic, dihomo 
gamma linolenic acid and n-6 docosatetraenoic acids were displaced by fish oil 
supplementation, n-3 fatty acid index correlated positively with total n-6 fatty acids (Figure 
6-4) and arachidonic acid (Figure 6-5). This finding corresponds with the result of our 
previous study which indicated significant direct relationships between docosahexaenoic 
and arachidonic acids in red cell phosphoglycerides of British and Korean pregnant women 
and their offspring at birth, cord blood (Ghebremeskel et al., 2000). Similarly, Payet and 
others have reported that the consumption of docosahexaenoic acid acid-enriched egg 
induces accretion of arachidonic acid in erythrocytes of elderly patients (Payet et al., 2004). 
Luxwolda et al. (2011) have found a bell curve relationship between erythrocyte n-3 fatty 
acid index and arachidonic acid level. It appears the incorporation of n-3 and n-5 long chain 
polyunsaturated fatty acids into cell membrane is highly regulated and the balance between 
the two fatty acid families is critical for orderly structural organisation and function of 
cellular and subcellular membranes. Indeed, there is evidence that the relative composition 
of the major fatty acid classes (SFA, MUFA and PUFA) in membrane lipids of all tissues is 
strongly regulated over very large variation in diet composition (Abbott et al., 2012).  
Ethnic homogeneity, narrow age range and compliance monitoring by teachers were 
some of the strengths of the study. Learning ability and health-related behaviour of the 
children with the very low n-3 fatty acid index, and dietary fatty acid intake of the whole 
group because of the incompleteness of the food composition database were not assessed. In 
addition, in a sub-group of children, it would have been important to assess if a longer 
period of supplementation increases the level of n-3 fatty acid index. These limitations must 
be taken in account in future research. 
This study provides evidence that Omani pre-adolescents have a low level n-3 fatty 
acid index that can be ameliorated by fish oil supplementation or consumption of oily fish. 
Epidemiological and intervention studies indicate these fatty acids are critical for visual and 
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neurological development and function, reduction of cardiovascular and inflammatory 
disease risk factors and healthy ageing. There is a need to tackle this problem through 
school feeding programme, targeted intervention with n-3 fatty acid enriched food products 
and/or family nutrition education programme. 
    
 
Figure 6-4: Post-intervention Relationship between Total N-6 Fatty Acids and N-3 
Fatty Acid Index (Fish Oil Group r = 0.414, p<0.0001; Fish Group r = - 0.032, p>0.05) 
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Figure 6-5: Post-intervention Relationship between Arachidonic Acid and N-3 Fatty 
Acid Index (Fish Oil Group r = 0.394, p<0.0001; Fish Group r = 0.213, p<0.05) 
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CHAPTER 7:  
Overview and Future Research  
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7.1 Overview 
Non-communicable diseases (NCDs) – cardiovascular diseases, diabetes, cancer and 
respiratory diseases – account for more than 60% of the global disease burden and mortality 
rate. In the Arabian countries, including Oman, over 50% of annual deaths are due to NCDs. 
Moreover, obesity, an antecedent of NCDs, has reached epidemic proportions in the region. 
Childhood NCDs are also on the rise globally: 1.2 million children and youth under the age 
20 died of NCDs in 2002 (Mathers, 2009); more than 25% of obese adolescents have signs 
of diabetes by age 15 (Goran et al., 2003), which accounts for approximately 486,000 
children under 15 years of age (Mathers (2009); and of the 497,100 children between 0-14 
years found with Type 1 diabetes globally, approximately 64,000 of these are from the 
Middle East/North Africa region alone, with an additional 10,700 new cases each year. 
In light of recent studies identifying the childhood antecedents of adult disease, various 
national and international committees on NCDs have recommended that children and young 
adults be the primary focus of any action plan aimed at preventing and controlling non-
communicable diseases. Overweight and obesity is a key risk factor to be considered since it 
is related to other metabolic risk factors for the development of a CVD, such as raised blood 
pressure, raised blood sugar, raised blood lipids (cholesterol and triglycerides) and 
dyslipidaemia (National Heart Lung and Blood Institute, 2002, Grundy, 2004). As an 
individual’s BMI increases, so does the risk for coronary heart disease, stroke and diabetes 
(World Health Organization, 2000).  
There is growing evidence on the efficacy of omega-3 fatty acids in the fight against 
obesity, although in some ways the research is still limited. It has been found that obese 
individuals have lower ω-3 in their blood when compared to healthy, non-obese controls 
(Micallef et al., 2009), while Couet et al. (1997) have found that a fish oil diet corresponded 
to a 0.88 kg reduction of body fat when compared to a control diet. Epidemiological studies 
have also shown that fish consumption within a healthy eating pattern is associated with 
lower body weight (Shubair et al., 2005, Schulze et al., 2006). However, less is known about 
the health impact of fish consumption and fish oil supplementation, when paired with 
physical activity, on the nutritional status of school children, body composition, blood 
biochemistry and mental and physical abilities. Dietary intervention studies which that 
include fish and fish oil in a weight loss diet are also limited (Mori et al., 1999, Thorsdottir 
et al., 2009).  
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This research study sought to assess: 
1. The nutritional status, body composition, blood biochemistry, mental ability and 
cognitive function in Omani children aged 9 and 10 years, and 
2. The effect of fish consumption, and supplementation with fish oil, on body 
composition, blood biochemistry, mental ability and cognitive function of these 
children.  
7.2 Conclusion  
7.2.1 Study 1 (Chapter 3: dietary analysis)   
Both boys and girls in the study sample fell below the DRI for total calories, fat, sugar, and 
omega-3 and omega-6 fatty acids, while exceeding the DRI for proteins and carbohydrates. 
The most severe deficiency was found in relation to omega-3 fatty acids: compared to the 
DRI of 208-207 kcal/day, the students’ average consumption level was only 4.2 kcal/day. 
There was also a significant difference between boys and girls on this measure, with boys 
consuming 4.8 kcal/day as compared to girls consuming 3.9 kcal.day (p=0.012). 
In terms of micronutrients, the students’ diets were found to be most deficient in calcium 
and potassium, their daily consumption levels on these micronutrients less than half of the 
daily recommended intake. While the mean DRI for calcium was 1300 mg/day, the student 
average was only 465 mg/day; and while the mean DRI for potassium 4500 mg/day, the 
student average was only 2068 mg/day. The students’ consumption of phosphorus, Vitamin 
A and Vitamin D were also found to fall short of the DRI levels, although to a lesser degree. 
The mean body fat and TGS measures were significantly higher among girls as compared to 
boys, while muscle mass, omega-3 and omega-6, and fasting glucose levels were 
significantly higher in boys. Our study also found that higher calorie and protein intake was 
significantly associated with overweight or obesity, which was 28.2% and 22.6% in boys 
and girls, respectively. These rates are comparable to other countries in the Gulf region and 
significantly lower than in more developed countries, although there is evidence that these 
rates are on the rise.  
7.2.2 Study 2 (Chapter 4: cognitive assessment)   
While the global prevalence of ADHD is estimated to be between 5% to 13% (Faraone et 
al., 2003), there are few studies that involve Arabian Gulf populations. Anecdotal evidence 
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suggests that children in the region are not immune, which is confirms by our study which 
identifies the prevalence rate of PIS, PHIS and ADHD among Omani school children as 
7.3% (95% CI: 4.5%, 10.1 %), 3% (1.2, 4.8%) and 8.8% (5.7%, 11.8%), respectively. To 
our knowledge, this is the first study with a robust methodology to identify the prevalence 
rate of ADHD among school children in Oman. Compared to other studies, the inclusion of 
the different ADHD subtypes provides a more complete spectrum of the relevant 
symptomatology associated with ADHD. 
The second goal of this study was to examine the possible role of parental factors (such as 
sex, educational level, occupation, income and consanguinity) in the development of 
ADHD, which would provide a vital foundation for devising preventive measures and 
relevant health educational programs. Statistical analyses indicate that the most significant 
factors were: reduced family income and non-government jobs were most strongly 
associated with an increased risk: specifically, family income for PHIS (p=.019) and father’s 
employment sector for ADHDCIH (p=.012). Childhood symptoms of PHIS were also 
significantly correlated with mother’s occupations outside the home (p=.038).  
7.2.3 Study 3 (Chapter 5: fat soluble vitamins)   
This study demonstrated that vitamin D insufficiency is highly prevalent among Omani 
school children , they were severely deficient (<27.5 nmol/L; 10.5% boys and 28.5% girls), 
deficient (27.5- 44.9 nmol/L; 47.6% boys and 49.4% girls) or insufficient (50 – 74.9 
nmol/L; 34.6% boys and 21.5% girls) in vitamin , and the effectiveness of omega-3 fatty 
acid supplementation in counteracting this. The high prevalence of vitamin D deficiency in 
the children should be a major public health concern because childhood is a period of 
skeletal mineral acquisition and bone modelling and there is evidence that vitamin D plays a 
critical role in muscle growth and development, cognitive function and modulation of innate 
and adaptive immunity. 
Compared with the control group, both boys and girls who were given fish meals or fish oil 
supplement for twelve weeks had increased concentrations of beta carotene and vitamin D 
(p<0.001). Post-intervention plasma vitamin D and parathyroid hormone concentrations 
compared with pre-intervention (baseline) were higher in the children who received fish oil 
and fish meals (p<0.0001). The concentration of plasma beta carotene also increased 
significantly in the fish diet and fish oil groups after intervention for 12 weeks. 
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If the prevalence rates reported here reflect trends in the larger population, Omani children 
may be at risk of developmental and health problems caused by vitamin D deficiency. As 
such, there is an urgent need for a fortification programme that targets the foods and drinks 
favoured by children and outdoor activities to help tackle this public health problem. 
7.2.4 Study 4 (Chapter 6: red blood fatty acids status) 
The spread of contemporary Western pattern diets during the past four decades have played 
a critical role in the rise of non-communicable chronic diseases. Such diets are typically 
high in the protein and fat of intensively reared land animals, refined sugar, vegetable fat 
and oils, and low fresh fruits and vegetables and marine foods. The negative health effects 
of this dietary pattern is associated with an excessive amount of saturated, trans and omega 
6 fatty acids, paired with an insufficient omega 3 fatty acid and essential micro-nutrient 
content. This study investigated fatty acid status of preadolescence school children before 
and after intervention with fish oil or oily fish to assess the efficacy of such a diet in 
counteracting nutritional deficiencies. The primary focus was the n-3 long chain 
polyunsaturated fatty acids which are thought to limit nutrient assimilation in Westernised 
dietary patterns. 
The mean baseline red cell n-3 fatty acid index of the children was low, comparable to other 
populations of similarly aged and healthy children reared on a Westernized diet. This 
suggests that traditional dietary patterns - including the consumption of fish - may have 
declined in favour of the more widely available processed foods which are high in saturated 
and n-6 fatty acids. Most surprising was the very low n-3 fatty acid index (<2%).  
After 12 weeks supplementation, compared with the controls, the red blood cell n-3 fatty 
acid index increased by 27.2% and 39.2% in the oily fish and fish oil groups, respectively. 
The fish oil group compared with their counterparts who received oily fish and with baseline 
had significantly lower levels of systolic and diastolic blood pressure and plasma 
triglycerides. In contrast, oily fish did not seem to have beneficial effects on any of the 
above blood parameters in the current study. 
7.3 Limitations of the study 
This study has provided valuable information about the effect of a DHA-rich fish diet and 
oil supplements on plasma fatty acid and fat soluble vitamins in healthy school children. 
While this study has yielded previously unavailable data, there are a number of limitations 
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that need to be taken into account, particularly for the design and interpretation of studies 
that seek to extend the research undertaken here. The intervention period, 12 weeks, was 
relatively short, and the amount of DHA was not equalised across treatment groups (fish 
diet vs. fish oil supplementation). Students were recruited only from the capital area of 
Oman, limiting the generalisability of the study findings. In addition, we were unable to 
collect important information about the students’ nutritional intake, despite efforts to gather 
these data about the children’s habitual diet using 24-hour recall. This was due, in large part, 
to the study’s reliance of parental reports, and the tendency to either over- or under-estimate 
the intake of certain foods by their children. 
Additionally, this study’s reliance the Vanderbilt Scales for measuring the cognitive and 
behavioural functioning of students is another area that could be improved, particularly 
since they have not been standardised for use with an Omani population. The development 
of a reliable and valid version of these Scales that is translated into Arabic would greatly 
improve our confidence in the measure, particularly if this process of standardisation is 
carried out with an eye toward the cultural specificities relevant to the Omani school 
population. 
7.4 Future investigations 
The original data generated from the current investigation has provided valuable insights 
into the dietary habits and nutritional status of pre-adolescent children from the greater 
metropolitan area of Muscat. However, these findings cannot be legitimately extrapolated to 
adolescents and young adults, pregnant women or even to preadolescent children who reside 
in small towns and rural regions of the country where fast food outlets, convenience stores 
and supermarkets are fewer and less accessible. Therefore, further studies are required to 
identify the extent of the westernisation of Omani dietary habits and its impact on the 
nutritional status of the aforementioned population groups with a particular focus on 
essential nutrients such as n-3 (omega 3) fatty acids and the fat-soluble vitamins A, D and E. 
Thus, one line of extending the current study would address this issue of sampling (with an 
eye towards generalisability), while others would broaden the population in question 
(beyond a focus only on pre-adolescent children): 
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• Dietary intake, body composition, circulating blood lipids and red blood cell fatty 
acid profile of preadolescent and adolescent children and young adults living in the 
fishing towns of Sur and Quriyat, Sultanate of Oman.  
• Dietary intake, body composition, circulating blood lipids and red blood cell fatty 
acid profile of adolescents and young adults who reside in the greater metropolitan 
area of Muscat, Sultanate of Oman. 
Additional attention can be given to the role of maternal nutrition and health for the 
questions investigated in this study: 
• Red blood cell omega 3 fatty acid index of Omani pregnant women and their 
neonates at birth, and their implications for maternal health and foetal neuro-visual 
development and health.  
• Comparative study of breast milk fatty acid composition of Omani mothers from the 
fishing towns of Sur and Quriyat, and the greater metropolitan area of Muscat.  
Finally, the pencil-and-paper measures of cognitive and behavioural functioning, can be 
supplemented by other, objective measures of physical functioning: 
• Combine the current use of cognitive and behavioural measures (the Vanderbilt 
Scales) in conjunction with functional brain scan imaging, such as PET, fMRI, and 
related in-vivo neuro-imaging data. 
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Low dose omega 3 fatty acids reduce fat mass and systolic blood pressure 
in school children  
Al-Ghannami SS1, 3, Sedlak E1, Hussein IS1, Min Y1, Al-Shmmkhi SM3, Al-Oufi HS2, Al 
Al-Mazroui A2, Ghebremeskel K1 
1 Lipidomics and Nutrition Research Centre, Faculty of Life Sciences and Computing, 
London Metropolitan University, London, UK 
2 Ministry of Agriculture and Fisheries Wealth, Muscat, Sultanate of Oman  
3 Ministry of Health, Muscat, Sultanate of Oman 
 
BACKGROUND: Several investigations provide evidence that high and moderate intakes 
of long chain omega 3 polyunsaturated fatty acids (LCPUFA) reduce systolic and diastolic 
blood pressure, particularly in hypertensive adults. However, it is not fully elucidated 
whether or not these fatty acids have such effects in healthy children.  
OBJECTIVE: To investigate the effect of a low dose omega 3 LCPUFA on body 
composition and systolic and diastolic blood pressure in school children.  
METHOD: Eighty six Omani School children, aged 9 and 10 years, were given one omega 
3 fatty acid capsule containing 403 mg DHA and 53 mg EPA, four days a week, for twelve 
weeks. Red blood cell fatty acids, body composition and blood pressure were measured at 
baseline and at the end of the supplementation period.  
RESULTS: The children had higher DHA (6.2±1.5 vs. 3.8±1.5, p<0.0001), body weight 
and fat-free mass (p<0.001) and lower body mass index (16.4±3.1 vs. 16.6±3.2, p<0.01), 
body fat (p<0.05) and systolic blood pressure (p<0.001) after twelve weeks of intervention 
with omega 3 fatty acids compared with baseline. There was no difference in diastolic blood 
pressure between the two time points (p>0.05). 
CONCLUSION: The findings of this small study suggest that omega 3 LCPUFA might 
play a role in reducing fat mass and latent high blood pressure in obese children.  
 
Declaration of Interest: the authors have no relevant interest to declare  
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The effect of omega 3 fatty acid supplementation on plasma vitamin 
D status of school children 
 
Al-Ghannami SS1,3, Sedlak E1, Hussein IS1, Min Y1, Al-Shammakhi SM3, Al-Oufi 
HS2, Al-Mazroui A2, Ghebremeskel K1 
 
1 Lipidomics and Nutrition Research Centre, Faculty of Life Sciences and Computing, 
London Metropolitan University, London, UK 
2 Ministry of Agriculture and Fisheries Wealth, Muscat, Sultanate of Oman 
3 Ministry of Health, Muscat, Sultanate of Oman 
 
Background: Cell culture, animal and human studies suggest that omega 3 fatty 
acids, particularly docosahexaenoic, have beneficial effects on bone metabolism. However, 
although there are several postulations, the mechanisms through which these fatty acids 
influence bone structure and composition are yet to be fully elucidated. 
Objective: To investigate the effect of long-chain omega 3 polyunsaturated fatty acid 
(omega 3 LCPUFA) supplementation on plasma 25 hydroxy vitamin D (25(OH)D) level of 
children. 
Procedure: Omani children, aged 9 and 10 years, from two randomly selected schools in 
Muscat were assigned to either omega 3 LCPUFA (n=86) or control (n=120) group. The 
former group received one omega 3 fatty acid capsule containing 
403 mg DHA and 53 mg EPA four days a week for twelve weeks. The control group, who 
continued on their habitual diet, did not receive any supplement. Red blood cell fatty acid, 
plasma 25(OH)D, parathyroid hormone and calcium levels were assessed at the end of the 
intervention period. 
Results: The omega 3 LCPUFA group compared with their control counterparts had higher 
levels of red cell EPA (0.34±0.12 vs. 0.25±0.14%, p<0.0001), DHA (6.2±1.5 vs. 
4.4±1.5%, p<0.0001), 25(OH)D (54.1±17.5 vs. 42.4±17.3 nmol/L, p<0.0001). There 
was no difference in parathyroid hormone (5.79±2.1 vs 5.78±2.0 pmol/L, p>0.05) and 
calcium (2.46±0.09 vs. 2.52±0.07 mmol/L, p>0.05) concentrations.  
 
Conclusion: DHA-rich omegas 3 LCPUFA enhance plasma vitamin D level in children. 
This may be one of the mechanisms by which these fatty acids influence bone 
mineralisation and structure. 
 
Acknowledgements: Sincere thanks are due to the children, parents and their teachers, the 
Ministry of Agriculture and Fisheries Wealth, Sultanate of Oman, for financial support and 
Efamol Ltd. UK for providing the omega 3 fatty acid supplements.  
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Short term supplementation of fish and fish oil improves cognitive ability 
in children attending school in Muscat Oman 
 
BACKGROUND: Consumption of fish in the regular diet is highly recommended globally 
for its benefit for all and especially for children. Current study was aimed at assessing the 
effect of short term consumption (4 months) of fish meals feeding on cognitive ability 
among children attending the schools in Muscat governorate, Sultanate of Oman 
METHODS: 66 Omani School children, aged 9 and 10 years, from Muscat, were given a 
150 -200 g fish meal in four times a week for 16 weeks. The fish species were Grouper, Sea 
bream, Kingfish, Emperor, and Snapper. We have analysed the body composition and 
mental ability (trial making test and verbal fluency) before and after supplementation of 
fish. Data (Mean ±S.D) were analyzed using the SPSS version 15 and p ≤ 0.05 was 
considered as significant. . 
RESULTS: Verbal fluency was significantly increased (p ≤ 0.001). Girls showed better 
performance than boys in number of words generated per minute. The performance of both 
boys and girls were significantly improved in trail making test and when compared with 
boys, girls performed.  
CONCLUSION: Our study results suggest that supplementation of fish for four months 
enhanced the children’s cognitive ability of those are attending schools in Muscat, Sultanate 
of Oman. Further studies are warranted to find out the effect of fish in biochemical 
parameters on these children. 
 
Acknowledgements: Support provided by Ministry of Agriculture and Fisheries Wealth, 
Ministry of Education, Ministry of Health, Sultan Qaboos University Oman and London 
Metropolitan University, UK were gratefully acknowledged. 
  
Key words: Fish, Fish oil, Verbal fluency test, trail making test, Oman 
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The effect of fish consumption, fish oil supplementation on iodine, vitamin 
A and D deficiency  
 
BACKGROUND: It has long been recognized that fish, seafood and marine products are 
valuable foods. Fish and seafood are low in saturated fat and a good source of protein, 
iodine, iron, vitamin D , selenium and other trace elements as well as long-chain omega-3 
polyunsaturated fatty acids. 
OBJECTIVES: To examine the impact of fish and fish oil intake on iodine, vitamin D, and 
A we have studied a total of three hundred fifty four (n=354) school children of 9-10 years 
old (4 grade) from three schools in Muscat Governorate in Oman. The children were 
randomly divided in to fish, fish oil capsule and control groups. The fish group (n=118) 
received fish menu lunch 4 times a week. The fish oil capsule group (n=118) were given 
fish oil capsules  the third group (n=118) will not receive fish or fish oil capsules. The 
intervention period was sixteen weeks (four months). The study aimed to assess urinary 
iodine concentration: a significant number of the children had low levels of vitamin D, 
iodine and omega 3 fatty acids. 
RESULTS: The study revealed that a significant number of the children had low levels of 
vitamin D, iodine and omega 3 fatty acids. The low levels of vitamin D, iodine and omega‐3 
fatty acids were ameliorated to a variable degree by fish consumption as well as 
supplementation with fish oil. 
 
Authors:  
Presenter poster : Izzeldin Hussein 
Dr Samia Al Ghnamia , Dr Izzeldin Hussein, Dr Kebreab Ghebremeskel 
MOH OMAN- London metropolitan     
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(FORM 5.3) Sultanate of Oman (Fish Group) 
Ministry of Health- /Department of Studies & Research Research and Ethical Review & Approve Committee 
 
Certificate of Informed Consent 
 
Consent form of participating in the project: The impact of eating fish and fish oil on 
fatty acids (Omega-3), and perception of school students in the governorate of Muscat 
 
Project goal: 
 
Researchers have suggested that there is a close relationship between eating fish, especially 
rich in Omega-3 fatty acids and health in general. There is little knowledge about the 
potential impact of eating fish and health in the Sultanate of Oman. the goal of this project 
was to study the effect of local Omani fish consumption and seafood on the health and also 
on the level of perception, especially among school children. 
 
The study will be conducted on 354 students in the age group 9-10 years (Grade 4) in three 
schools in Muscat governorate. Students will be distributed randomly into three groups, 
where one of them will consume fish and the other fish oil capsules while the third group 
remains neutral. Your son or daughter has been selected randomly to be in fish group and 
will be providing a fish meal for them 4 times a week for 4 months. 
Their body composition, food intake will be evaluated by food frequency questionnaires, 
complete blood picture, blood lipids and iodine concentration in the urine through the use of 
established protocols.  The school performance and attention will also be evaluating to both 
male / female student. All evaluations will be conducted at the beginning of the intervention 
and when it is completed. 
How you can help? 
Assent to join us where research will include: 
 
Interview: We would like to ask some questions that will help us to fill the questionnaire; 
24 hour reall questionnaire will be used to assess your child dietary intake. 
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Cognitive assessment: a questionnaire will be given to you about your child cognitive 
behavior, and another one will be filled by the class teacher.  
Physical measurements: such as height, weight and measure the body fat percentage. 
Physical fitness: a team from London will assess your child physical activity  
All of this will be done at school 
Other clinical tests will be taken at the health centre: 
  
Laboratory tests: such as a blood test, urine test, sample will be taken by taking into 
account safety and hygiene measures. 
 
 We will send part of a sample of blood to the London Metropolitan University in Britain for 
analysis of fatty acids and antioxidant vitamins under the approval of the Research Ethics 
Committee, which were obtained from a national committee in the UK health service. 
 
Personal data will be dealing in the strictest confidence and will not be used for any other 
purpose and not be transferred to others without the written consent of the parents of the 
students. All the data collected from this study will store in a password-protected computer 
and access will be limited to researchers. 
 
Please note this study will be conducted under full compliance with the principles of data 
protection law. You are free to withdraw from the study at any time without giving any 
reason. 
 
Is there any benefit derived for others?  
This study will help us to assess the relationship between dietary sources of fatty acids and 
its potential health and the level of awareness among school students. 
 
What if you do not want to share my son / daughter in the project? 
This would not constitute any difference in our dealings with you; you will always get the 
best deal possible. 
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Recognition 
 
 
I certify that I have read and understood the information pertaining to study above. I 
understand that my participation is voluntary and that I have absolute freedom to withdraw 
at any time without affecting me or my son / daughter. 
 
I agree to participate in the study 
 
Participant's name 
 
 Date  Signature  
Researcher's name 
 
 Date  Signature  
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(FORM 5.3) Sultanate of Oman (Omega-3 capsules  Group) 
Ministry of Health- / Department of Studies & Research 
Research and Ethical Review & Approve Committee 
 
Certificate of Informed Consent 
 
Consent form of participating in the project: The impact of eating fish and fish oil on 
fatty acids (Omega-3), and perception of school students in the governorate of Muscat 
 
Project goal: 
 
Researchers have suggested that there is a close relationship between eating fish, especially 
rich in Omega-3 fatty acids and health in general. There is little knowledge about the 
potential impact of eating fish and health in the Sultanate of Oman. the goal of this project 
was to study the effect of local Omani fish consumption and seafood on the health and also 
on the level of perception, especially among school children. 
 
The study will be conducted on 354 students in the age group 9-10 years (Grade 4) in three 
schools in Muscat governorate. Students will be distributed randomly into three groups, 
where one of them will consume fish and the other fish oil capsules while the third group 
remains neutral. Your son or daughter has been selected randomly to be in a fish oil capsule 
group which containing 200 g of DHA 4 times a week for a period of 4 months. Their body 
composition, food intake will be evaluated by food frequency questionnaires, complete 
blood picture, blood lipids and iodine concentration in the urine through the use of 
established protocols.  The school performance and attention will also be evaluating to both 
male / female student. All evaluations will be conducted at the beginning of the intervention 
and when it is completed. 
How you can help? 
Assent to join us where research will include: 
Interview: We would like to ask some questions that will help us to fill the questionnaire: 
24 hour reall questionnaire will be used to assess your child dietary intake. 
Cognitive assessment: a questionnaire will be given to you about your child cognitive 
behavior, and another one will be filled by the class teacher.  
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Physical measurements: such as height, weight and measure the body fat percentage. 
Physical fitness: a team from London will assess your child physical activity  
All of this will be done at school 
Other clinical tests will be taken at the health centre: 
Laboratory tests: such as a blood test, urine test, sample will be taken by taking into 
account safety and hygiene measures. 
 
We will send part of a sample of blood to the London Metropolitan University in Britain for 
analysis of fatty acids and antioxidant vitamins under the approval of the Research Ethics 
Committee, which were obtained from a national committee in the UK health service. 
 
Personal data will be dealing in the strictest confidence and will not be used for any other 
purpose and not be transferred to others without the written consent of the parents of the 
students. All the data collected from this study will store in a password-protected computer 
and access will be limited to researchers. 
 
Please note this study will be conducted under full compliance with the principles of data 
protection law. You are free to withdraw from the study at any time without giving any 
reason. 
 
Is there any benefit derived for others?  
This study will help us to assess the relationship between dietary sources of fatty acids and 
its potential health and the level of awareness among school students. 
 
What if you do not want to share my son / daughter in the project? 
This would not constitute any difference in our dealings with you; you will always get the 
best deal possible. 
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Recognition 
 
 
I certify that I have read and understood the information pertaining to study above. I 
understand that my participation is voluntary and that I have absolute freedom to withdraw 
at any time without affecting me or my son / daughter. 
 
I agree to participate in the study 
 
Participant's name 
 
 Date  Signature  
Researcher's name 
 
 Date  Signature  
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(FORM 5.3) Sultanate of Oman (Control Group) 
Ministry of Health- / Department of Studies & Research 
Research and Ethical Review & Approve Committee 
 
Certificate of Informed Consent 
 
Consent form of participating in the project: The impact of eating fish and fish oil on 
fatty acids (Omega-3), and perception of school students in the governorate of Muscat 
 
Project goal: 
 
Researchers have suggested that there is a close relationship between eating fish, especially 
rich in Omega-3 fatty acids and health in general. There is little knowledge about the 
potential impact of eating fish and health in the Sultanate of Oman. the goal of this project 
was to study the effect of local Omani fish consumption and seafood on the health and also 
on the level of perception, especially among school children. 
 
The study will be conducted on 354 students in the age group 9-10 years (Grade 4) in three 
schools in Muscat governorate. Students will be distributed randomly into three groups, 
where one of them will consume fish and the other fish oil capsules while the third group 
remains neutral. Your son or daughter has been selected randomly to be in the neutral group 
so he/she will not receive fish meal or fish oil capsules. Their body composition, food intake 
will be evaluated by food frequency questionnaires, complete blood picture, blood lipids and 
iodine concentration in the urine through the use of established protocols.  The school 
performance and attention will also be evaluating to both male / female student. All 
evaluations will be conducted at the beginning of the intervention and when it is completed. 
How you can help? 
Assent to join us where research will include: 
Interview: We would like to ask some questions that will help us to fill the questionnaire 
24 hour reall questionnaire will be used to assess your child dietary intake. 
Cognitive assessment: a questionnaire will be given to you about your child cognitive 
behavior, and another one will be filled by the class teacher.  
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Physical measurements: such as height, weight and measure the body fat percentage. 
Physical fitness: a team from London will assess your child physical activity  
All of this will be done at school 
Other clinical tests will be taken at the health centre: 
Laboratory tests: such as a blood test, urine test, sample will be taken by taking into 
account safety and hygiene measures. 
 
We will send part of a sample of blood to the London Metropolitan University in Britain for 
analysis of fatty acids and antioxidant vitamins under the approval of the Research Ethics 
Committee, which were obtained from a national committee in the UK health service. 
 
Personal data will be dealing in the strictest confidence and will not be used for any other 
purpose and not be transferred to others without the written consent of the parents of the 
students. All the data collected from this study will store in a password-protected computer 
and access will be limited to researchers. 
 
Please note this study will be conducted under full compliance with the principles of data 
protection law. You are free to withdraw from the study at any time without giving any 
reason. 
 
Is there any benefit derived for others?  
This study will help us to assess the relationship between dietary sources of fatty acids and 
its potential health and the level of awareness among school students. 
 
What if you do not want to share my son / daughter in the project? 
This would not constitute any difference in our dealings with you; you will always get the 
best deal possible. 
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Recognition 
 
 
I certify that I have read and understood the information pertaining to study above. I 
understand that my participation is voluntary and that I have absolute freedom to withdraw 
at any time without affecting me or my son / daughter. 
 
I agree to participate in the study 
 
Participant's name 
 
 Date  Signature  
Researcher's name 
 
 Date  Signature  
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